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ABSTRACT
An investigation into the migration of fenestrated aortic stent-grafts
Andrew England
Rupture of an abdominal aortic aneurysm (AAA) is usually lethal. Fenestrated stent-grafts provide a 
valuable treatment option for patients with complex AAA. However, complications from this 
treatment have been reported. One possibility is that the device moves (migrates) under the force of 
pulsatile blood, leading to reperfusion of the AAA, with the possibility of rupture or occlusion of a 
side-branch with disastrous consequences. Within the literature, there is an absence of information 
regarding the migration of fenestrated aortic stent-grafts, in addition, there are no validated 
techniques available for assessing migration. This thesis describes work with the following aims: (i) to 
validate a computed tomography (CT) central luminal line (CLL) technique for quantifying stent-graft 
migration, (ii) to report the incidence, timings and related sequelae for proximal and distal migration 
of the Zenith fenestrated AAA stent-graft (iii) to investigate the predictive factors for proximal 
migration of a fenestrated stent-graft.
Results from the validation experiment (where 2 mm MDCT scans were used) showed that it is 
possible to detect stent-graft migration > 4 mm. The CT CLL technique was piloted on a single centre 
cohort of 55 patients treated with a Zenith fenestrated AAA stent-graft. The 1st postoperative CT scan 
was considered as the baseline. Stent-graft position (proximal and distal) was then compared against 
all subsequent CT scans. Survival analysis, using interval censored data, estimated that 9% (95% Cl 0% 
to 17%) and 22% (95% Cl 7% to 34%) of patients will experience proximal migration at 12 and 36 
months, respectively. Distal iliac limb migrations were less frequent, 5% (95% Cl 0% to 11%) and 15% 
(95% Cl 3% to 24%) at 12 and 36 months, respectively. Data from a larger multicentre cohort (154 
patients, 9 UK centres) were also analysed. Proximal migrations were all caudal in direction (median 
+6.0, IQR +4.5 to +7.9 mm), distal migrations were cranial (median -6.1, IQR -7.8 to -5.1 mm). For 
proximal migration, at 12 and 36 months, rates were 18% (95% Cl 11% to 25%) and 23% (95%CI 15% 
to 30%), respectively. Distally, iliac migration was seen in 15% (95% Cl 8% to 21% and 35% (95% Cl 
20% to 48%) of patients, at 12 and 36 months, respectively. Analysis of survival curves identified no 
differences in proximal migration rates in patients with and without complications (P=0.84), or who 
required reintervention (P=0.81).
Multivariate analysis, using a Cox proportional hazards model, identified 1st postoperative CT neck 
length as a consistent risk factor for proximal migration (Hazard ratio 0.90, 95% Cl 0.78 to 0.97, 
P<0.05). A 10% reduction in proximal migration hazard exists for every mm increase in aortic neck 
length. Follow-up aortic diameter changes at the caudal renal artery, contralateral iliac limb diameter 
and changes in the SMA to cranial renal artery length during follow-up were identified as risk factors 
based on certain assumptions of event times. An absence of preoperative CT scans for some patients 
did place some limitations on the overall risk factor analysis.
This research has introduced new literature on the quantification, incidence, related-sequelae and 
risk factors for fenestrated stent-graft migration. Overall, the results from this thesis estimate that 
migration occurs in around a third of patients by four years, but is not associated with an increase in 
sequelae. Future research should investigate migration in new devices and help devise more robust 
methods for capturing multicentre imaging data and tracking patients lost to follow-up.
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1. Rationale and summary of investigations
An abdominal aortic aneurysm (AAA) is a permanent localised dilatation of the abdominal 
aorta (Metcalfe et ai, 2011). For those aged between 65 and 80 years the incidence of an 
AAA is 7.6% in men (Ashton et aL, 2002) and 4.2% in women (Singh et al., 2001). If left 
untreated, Wilmink and Quick estimate that a third of these aneurysms will eventually 
rupture (Wilmink and Quick, 1998). Rupture of an AAA is usually lethal with overall mortality 
rates of up 90% common (Bengtsson and Bergqvist, 1993). Historically, management of an 
AAA was based on elective open surgical repair (OSR), replacing the aneurysmal segment 
with a vascular prosthetic graft. OSR has now largely been superseded by the deployment of 
a covered stent (stent-graft) delivered by minimal surgical access through the common 
femoral arteries. Stent-graft repair, or more precisely endovascular aortic aneurysm repair 
(EVAR) is now the most common method for the elective management of an AAA (Jackson et 
al., 2012). Potential advantages of EVAR over OSR include a reduced time under general 
anaesthesia, elimination of pain and trauma associated with major abdominal surgery, 
reductions in total hospital stay and in the intensive care unit, and reductions in blood loss 
(National Institute for Health and Care Excellence, 2009).
EVAR involves the internal lining of the diseased segment of aorta using a stent-graft. 
The stent-graft comprises a metallic (stainless steel or nitinol) skeleton covered with an 
impermeable (polytetrafluoroethylene or polyester) fabric and is implanted using 
fluoroscopic guidance. The goal of the procedure is to divert blood away from the weakened 
aortic wall and this is achieved by the stent-graft sealing in the aortic wall above the
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aneurysm and in the common iliac arteries below. This results in the exclusion the aneurysm 
from systemic circulation and the prevention of a potentially fatal rupture.
The major randomised controlled trials (RCTs) which have compared EVAR with OSR 
have consistently demonstrated lower mortality rates favouring EVAR (based on the first 30- 
days following repair). In the UK EVAR 1 trial 30-day mortality was 1.7% for EVAR versus 
4.7% for OSR (Greenhalgh et aL, 2004). The Dutch DREAM trial produced similar results/ 30- 
day mortality rates were 1.2% for EVAR versus 4.6% for OSR (Blankensteijn et o/.,2005). The 
more recent US OVER trial showed lower 30-day mortality rates for both EVAR (0.5%) and 
OSR (3.0%) (Lederle etal., 2009). The improved results in both arms of the OVER trial may be 
attributable to the inclusion of smaller AAA (43% had a maximum diameter <5.5 cm), 
differences in pre, intra- and post-operative care and the restriction to using only Food and 
Drug Administration (FDA) approved stent-grafts. EVAR is not without its limitations, 
complications such as endoleak, renal impairment, device migration, aneurysm growth and 
rupture are occurring at a higher rate than anticipated (Clagett, 2008). Large RCTs have also 
documented a 20-30% higher complication rate for EVAR when compared to OSR (United 
Kingdom EVAR Trial Investigators, 2010; De Bruin et al., 2010). A further limitation of EVAR 
is that it is only feasible in patients who satisfy certain anatomical requirements. It has been 
suggested that around 50% patients are not candidates for standard EVAR (Ricotta and 
Oderich, 2008). These patients would normally have required more complex OSR which is 
associated with increased mortality and morbidity from cardiopulmonary and renal 
complications (Svensson etal., 1993, Cambria etal., 2002, Saraceto/., 2002).
The extension of the fabric component of the stent-graft above the level of the renal
arteries has further allowed the expansion of EVAR into more complex AAAs. This treatment
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was first described by Park and colleagues in 1996 (Park et ai.,). Initial reports of this 
technology, fenestrated endovascular aneurysm repair (FEVAR), have demonstrated that it 
can be successfully and safely performed (Anderson et al.t 2001, McWilliams et al„ 2004). To 
date more than 3,000 fenestrated stent-grafts have been implanted worldwide and feasibility 
is now no longer an issue (Amiot et at., 2010). Internationally, the bulk of the FEVAR 
experience rests with the Zenith fenestrated AAA endograft (Cook Medical Inc, Bloomington, 
IN). Over the past few years several other manufacturers have developed fenestrated 
devices and these also provide a treatment option for complex AAA (Bungay et at., 2011, 
Holden et at., 2013).
All stent-grafts, including fenestrated, are subjected to downwards displacement 
forces from pulsatiie blood leaving the heart. These downward displacement forces act 
longitudinally and challenge the fixation of the stent-graft. Failure of fixation will lead to 
migration of the device with the possibility of late type I or III endoleaks and associated risk 
of aortic rupture (Harris et at., 2000; Wyss et at., 2010). Additional problems may also result 
and include stent-graft distortion and kinking, which may in turn lead to a secondary 
thrombosis. For fenestrated stent-grafts, migration could be even more catastrophic. 
Fenestrated stent-grafts typically incorporate the origins of the renal and visceral arteries 
within the fabric component of the device. Caudal migration of a fenestrated stent-graft 
migration could, therefore, result in the graft fabric shuttering down over the visceral artery 
ostia and causing a visceral artery occlusion.
For standard (infrarenal) stent-grafts the reported incidence of stent-graft migration
ranges from 0 to 21% (England and McWilliams, 2008). Cases of fenestrated stent-graft
migration have also been reported within the literature (O'Neill et at., 2006a; Ziegler et at.,
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2007; Scurr et ai, 2008a; Verhoeven et al., 2010; Greenberg et al., 2009a; Triosi et al., 2011).
However, within these FEVAR series, follow-up durations were heterogeneous, migration 
assessment methods were poorly defined and rates were commonly based on cases resulting 
in associated complications or requiring reintervention. Such approaches are likely to be 
inadequate; Greenberg and colleagues argued that subtle stent-graft migration must be 
detected early, preferably before complications arise {Greenberg et al., 2004b). Virtually all 
aortic stent-grafts are based on a bifurcated design with an ipsilateral and contralateral iliac 
limb deployed in the respective common iliac artery. Migration of an iliac limb is also a 
possibility. Back in 2001, Beebe and colleagues reported on cases of iliac limb migration 
(Beebe et al.,}. Migration at the distal landing zones can also result in complications, these 
include endoleak and thrombosis. The report by Beebe et al., is one of the few reports 
documenting cases of migration of a distal iliac limb and reflects the need for more research 
in this area.
With the possibility of post-EVAR complications it is mandatory that all patients are 
entered into a planned surveillance programme. For fenestrated stent-grafts this usually 
consists of multi-detector computed tomography (MDCT) scans at 1-month, 6-months and 
annually thereafter. From these serial MDCT scans it is possible to track the position of the 
aortic stent-graft, at both the proximal and distal landing zones, overtime.
There are concerns within the vascular community that migration of a fenestrated
stent-graft could be potentially disastrous. There is an absence of data on the incidence,
timings and related sequelae for fenestrated stent-graft migration. Understanding the causal
factors for migration is also important. Identification of risk factors could guide patient
selection, identify the need for modifications to stent-graft design and direct follow-up
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strategies. These points are particularly important since the clinical and cost-effectiveness of 
FEVAR is a huge issue for both funding bodies and regulatory agencies.
There is clearly an absence of literature investigating migration of fenestrated aortic 
stent-grafts. Cases of migration can significantly impact on the patient and can also increase 
the total cost of the procedure. The aim of this thesis was to undertake an investigation into 
the migration of fenestrated aortic stent-grafts. In doing so, this thesis reports the incidence, 
timings and related complications and reinterventions of fenestrated stent-graft migration. 
Additional analyses were also conducted in order to establish any risk factors for the 
migration of fenestrated aortic stent-grafts.
THESIS OUTUNE:-
Chapter 2: Abdominal aortic aneurysms, endovascular repair, outcomes and complications.
This chapter provides an in-depth review of the literature underpinning this thesis. Areas of 
research that this thesis focuses on are described in detail.
Chapter 3: Aortic displacement forces and stent-graft migration. This chapter introduces 
the physiology of aortic displacement forces and provides a more detailed outline of stent- 
graft migration, including its assessment and the fixation mechanisms for an aortic stent- 
graft.
Chapter 4: Study into the accuracy of CT central luminal line measurements in the 
quantification of stent-graft migration. This chapter uses a combination of aortic phantoms 
and clinical CT data to experimentally assess the validity of using a CT CLL measurement 
technique for the quantification of stent-graft migration. Data from this experiment is used
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in subsequent chapters to provide a definition of stent-graft migration and confirm the 
validity and reliability of the assessment technique.
Chapter 5: Study into the single centre experience of fenestrated stent-graft migration.
This was a pilot study investigating the incidence, timings and related sequelae for proximal 
and distal (iliac) migration of a Zenith fenestrated AAA stent-graft at a single UK institution.
Chapter 6: Study into the multicentre experience of fenestrated stent-graft migration. This 
study expanded on the previous single centre work and reports fenestrated stent-graft 
migration data from a series of large UK vascular centres. Incidence, timings and related 
sequelae for both proximal and distal (iliac) migration were again reported.
Chapter 7: Study into the predictive and protective factors for proximal migration of a 
Zenith fenestrated AAA stent-graft. Based on the incidence and timings of fenestrated 
stent-graft migration described in the previous chapter; this study sought to identify any 
predictive or protective factors. Consideration was also given to whether any potentially 
predictive or protective factors identified had clinical significance.
Chapter 8: Discussion and future recommendations. An overview of the main findings from 
this thesis are presented here. There is also a full discussion of the advantages and 
disadvantages of the methodological approaches used. Suggestions for future research are 
made and finally, the contributions of thesis to the body of knowledge are given, together 
with an overall conclusion.
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2. Introduction
2.1 Abdomina! aortic aneurysms (AAA)
An abdominal aortic aneurysm (AAA) is a permanent dilatation of the abdominal aortic > 3 
cm in diameter (Metcalfe et a!., 2011). The incidence of AAA varies on the basis of age and 
gender; reports suggest that 1.7% of women and 5% of men have an aortic diameter > 3 cm 
by the age of 65 years (Scott et al., 1991). The prevalence of an AAA then increases by 6% 
per additional decade of life thereafter (Greenhalgh and Powell, 2008). Male gender, 
smoking, hypertension, hyperlipidaemia, chronic obstruction pulmonary disease (CORD) and 
family history are all strong risk factors for the development of AAA (Vardulaki et al., 2000, 
Brady et al., 2004).
The pathogenesis of AAA formation is complex and not yet fully understood. 
Atherosclerotic plaques are a feature of an AAA and there is some belief that AAA formation 
is a consequence of advanced atherosclerosis (Nordon et al., 2009). Commonly the natural 
history of atherosclerotic arterial disease is progressive arterial stenosis eventually leading to 
occlusion. If atherosclerosis is the initiating event in AAA pathogenesis then it is unclear why 
some individuals progress to an occlusive state and others to aneurysmal disease (Baxter and 
Worth, 2008). Other theories include a systemic dilating diathesis which is primarily 
governed by genotype (Kuivaniemi and Elmore, 2012) or the option that changes in the 
abdominal aorta may be a demonstration of a diseased vascular tree resulting from a chronic 
inflammatory process (Jagadesham et al., 2008). Although the pathophysiology remains 
unclear it is likely to be due to a genetic predisposition (Bown et al., 2011) combined with 
environmental factors contributing to the formation of aneurysms in anatomically vulnerable
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vessels (Nordon et ah, 2009). AAA are typically characterised by the destruction of elastin 
and collagen in the aortic wall, loss of media smooth muscle cells with thinning of the vessel 
wall and transmural infiltration of lymphocytes and macrophages. The result is a permanent 
localised dilatation of all three vessel layers of abdominal aorta and if left untreated, disease 
progression may lead to aneurysm rupture and death.
For the majority of patients AAA are asymptomatic and are detected incidentally. 
Clinical symptoms usually arise from complications relating to the arterial aneurysm - namely 
rupture, thrombosis, or distal embolisation (Thompson and Bell, 2000). For many 
symptomatic patients the first clinical manifestation is rupture (Brown et ai, 1999). Autopsy 
and clinical studies have suggested that the risk of rupture accelerates with increasing aortic 
diameter (Darling, 1970, Glimaker et al., 1991). For AAA less than 5.5 cm in diameter the risk 
of rupture is generally low, above this threshold the risk increases markedly (Greenhalgh and 
Powell, 2008). In a population-based study by Nevitt and colleagues no ruptures were 
reported during a 5 year follow-up for AAA <5 cm, but a 5% annual rupture risk was 
demonstrated for AAA >5 cm in diameter at initial presentation (Nevitt et al., 1989). Data 
from the UK Small Aneurysm Trial (UKSAT) calculated the annual rupture risk for AAA <4 cm 
at 0.3%. This rose to 1.5% for 4.0-4.9 cm AAA and 6.5% for 5.0-5.9 cm AAA (Brown and 
Powell, 1999). There is almost universal agreement that the rupture risk is very low for AAA 
<5 cm in diameter and that the risk increases substantially after 6 cm. Variation does exist 
within the literature regarding the estimation rupture risk for specific AAA diameters 
(Brewster et al., 2003) (Table 2.1). Such differences may reflect differences in the number of 
females (Brown and Powell, 1999), mean blood pressures (Cronenwett et al., 1985) and the
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smoking status (MacSweeney et al., 1994) of individuals included in the different comparator
studies.
Table 2.1 Estimated annual rupture risk. Source: 
Brewster et al., 2003
AAA diameter (cm) Rupture risk (%/yr)
<4 0
4-5 0.5-5
5-6 3-15
6-7 10-20
7-8 20-40
>8 30-50
In England and Wales ruptured AAA accounts for approximately 7,000 deaths per year 
(Office for National Statistics, 2012). These are similar numbers as for gastric, oesophageal 
and prostatic malignancies (Office for National Statistics, 2000). Rupture is usually lethal and 
overall mortality rates of up to 90% have been reported (Bengtsson and Bergqvist, 1993). 
The management of AAA places a large burden on healthcare resources, in England it 
accounts for over 11,000 hospital admissions per year (Thompson and Bell, 2000). 
Interestingly, unlike other atherosclerotic vascular disorders, the incidence of AAA appears to 
be rising (Acosta et al., 2006). Reasons for this are unknown. Norman and Powell (2007)
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have suggested that since AAA formation appears to be a late event following smoking 
exposure, these trends may reflect temporal changes in smoking prevalence (Norman and 
Powell, 2007). Rupture of an AAA is now the 13th commonest cause of death in the Western 
world (Choke et aL, 2005).
The first treatment of an AAA by open surgical repair (OSR) was undertaken in Paris 
by Charles Dubost in 1951 (Cervantes, 2003). This approach has remained the mainstay of 
AAA repair for over forty years. OSR involves the open surgical exposure of the abdominal 
aorta, aortic and iliac clamping followed by replacement of the diseased aortic segment using 
a prosthetic graft. Reports from two large RCTs, the Dutch DREAM and UK EVAR trials 
reported 30-day mortality rates for OSR of between 4.6% - 4.7% (Prinssen et aL, 2004, 
Greenhalgh, 2004). A report by Conrad and colleagues stated that for OSR actuarial survival 
was 71% and 44% and 5 and 10 years post procedure, respectively (Conrad et aL, 2007). 
However, in the same report Conrad and colleagues identified a limited number of 
anastomotic pseudoaneurysms, graft occlusion and infections which occurred infrequently 
during follow-up. Procedure-related reinterventions after OSR are also required in 
approximately 10.5% of patients (Kieffer et al., 2012). Despite this OSR is considered to be a 
predominantly durable and effective procedure. The decision to operate on a patient with 
an asymptomatic AAA is based on the analysis of the risk of rupture compared to the possible 
mortality from the elective surgical repair (Thompson and Bell, 2000). OSR in the majority of 
instances requires intensive or critical care nursing and the use of a general anaesthetic. 
There are also reports of significant levels of post-operative pain following OSR (Greenhalgh 
and Powell, 2008). As a result some patients are considered to be less suitable candidates 
for OSR. This is mainly due to the presence of coexisting medical conditions which place the
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patient at a heightened risk. Two large registries have investigated OSR outcomes in high- 
risk patients (Bush et al., 2007, Sicard et a!., 2006). The study by Bush and colleagues 
identified 1580 high-risk patients who underwent OSR. All patients were aged >60 years, had 
American Society of Anesthesiologists (ASA) physical grading classifications 3 or 4 and a range 
of co-morbidities (history of cardiac, respiratory, or hepatic disease; cardiac 
revascularisation, renal insufficiency, or low serum albumin level). Early (within the first 30- 
days of the procedure) and 1-year mortality rates were 5.2% and 12.4%, respectively. Such 
long-standing high mortality rates amongst high-risk patients have generated demand for the 
development of minimally invasive techniques (Wahlgren and Malmstedt, 2008).
2.2 Endovascular repair and aortic stent-grafts
Endovascular aortic aneurysm repair (EVAR) was developed as an alternative to OSR in order 
to reduce the risks from open surgery and to provide a treatment option for patients who 
would be otherwise unfit. The EVAR technique uses an endoprosthesis (stent-graft), which is 
delivered through small holes in the femoral arteries and seeks to exclude the aneurysm 
from the circulation by internally lining the aorta (Thompson and Bell, 2000). The stent-graft 
is a tube composed of a fabric suspended on a metallic mesh called a stent (Figure 2.1).
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Figure 2.1 Anatomical diagram illustrating a deployed stent-graft within the infra renal aorta. 
Source: (www.medtronic.com)
The stent helps to ensure rapid and stable expansion when the device is deployed within the 
aorta. According to Thompson and Bell (2000) there are several distinct advantages of stent- 
graft repair over conventional OSR (Table 2.2).
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Table 2.2 Potential advantages of endovascular repair over 
conventional OSR. Source : (Thompson and Bell, 2000)
• No need for abdominal incision
• Avoidance of aortic cross clamping
• No retroperitoneal dissection
• Improved perioperative cardiorespiratory function
• Reduction in metabolic stress response to aortic 
aneurysm repair
• Improved renal and gastrointestinal function
• Reduced hospital stay
The EVAR procedure varies somewhat, depending on the specific device used. 
Commonly the stent-graft is an inverted Y-shape, with a main trunk for the proximal aorta 
and two branches for the iliac arteries. The iliac components are given the term ipsi- and 
contralateral depending on the deployment side of the main proximal component. Devices 
are generally modular and usually composed of two or three components which interconnect 
and are assembled within the patient. The main component is inserted through the 
ipsilateral common femoral artery and is advanced into the infrarenal abdominal aorta. The 
proximal end of the endograft is deployed immediately below the most caudal renal artery. 
The distal ends of the graft are then deployed within their respective common iliac arteries.
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EVAR is only feasible in patients who satisfy certain specific anatomical requirements 
(Figure 2.2). It has been estimated that around 50% of patients with AAA are not candidates 
for conventional EVAR because of unfavourable anatomy (Ricotta and Oderich, 2008). These 
include patients with short or angulated necks or complex aneurismal involvement of the 
juxtarenal, paravisceral, and thoracoabdominal aorta.
Figure 2.2 Criteria typically used to assess anatomical suitability for EVAR for three commonly
implanted stent-grafts
Devices described in the above illustration are the Cook Zenith AAA endograft, Gore C3 Excluder device
and the Medtronic Endurant stent-graft.
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Two series have suggested that as many as 54% of patients with AAA, or as few as 
14%, met the routinely used anatomical criteria for conventional EVAR (Cotroneo et al., 
2006, Elkouri et aL, 2004}. Such differences can be attributed to variations in patient 
selection criteria between manufacturers, treatment thresholds of individual centres and 
improvements to preoperative and intraoperative imaging. Patients who are not eligible for 
standard EVAR often require complex OSR which is associated with increased mortality and 
morbidity from cardiopulmonary and renal complications (Svensson et al., 1993, Cambria et 
al., 2002, Sarac et al., 2002). These increased rates are believed to be due to the need for 
higher aortic cross clamping resulting from an inadequate infrarenal aortic neck and the 
potential need for reimplantation of vital aortic side branches. Good surgical candidates may 
tolerate complex OSR but patients with large aneurysms and poor cardiac, pulmonary or 
renal performance have limited options (Ricotta and Oderich, 2008).
2.3 Modes of device failure
Despite lower 30-day mortality rates for EVAR when compared with open surgery (UK EVAR 
trial, EVAR 1.7% vs OSR 4.7%; Dutch DREAM trial, EVAR 1.2% vs OSR 4.6%)(Greenhalgh et al., 
2004, Blankensteijn et al., 2005} and its popularity amongst the vascular community, EVAR is 
not without its limitations. Complications such as infection, renal impairment, device 
migration, endoleak, aneurysm growth, and rupture are occurring at a higher rate than 
anticipated (Clagett, 2008). EVAR is substantially different from OSR in that the aneurysm 
remains within the abdomen but is excluded from the systemic blood flow leaving the heart.
A fall in estimated glomerular filtration rate (eGFR) can often be seen following EVAR
but usually reverts back to preoperative levels. Permanent damage to renal parenchyma
may result from deliberate or unintentional coverage of a renal artery by the stent-graft
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fabric, toxic effects of the iodinated contrast media and cholesterol emboli (Pisimisis et a!., 
2013). The risk of acute renal impairment is lower for EVAR patients than those undergoing 
OSR, however, the overall renal function at 1-year is comparable (Greenberg et al., 2004a).
Occlusion of a stent-graft can result from poor blood flow due to either graft kinking 
or a poor outflow (Cochennec et al., 2007). The incidence within the literature varies 
between 2 and 40% depending on the stent-graft type and the length of follow-up 
(Maldonado et al., 2004, Carroccio et al., 2002, Erzurum et al., 2004, Laheij et al., 2000, 
Ouriel et al., 2003). Graft thrombectomy and adjunctive stenting may be undertaken to 
correct any related symptoms. If a stent-graft limb is lost through occlusion then, for some 
patients, a femoro-femoral crossover graft may be necessary.
Infection of an aortic stent-graft is rare and single-centre case series estimate an 
incidence of between 0.5 to 1.3% (Ducasse et al., 2004, Sharif et al., 2007, Heyer et al., 2009). 
Bacterial contamination of the stent-graft can occur during implantation, in the 
periprocedural hospitalisation or later due to an aortoenteric fistula (Veger et al., 2013). If 
infection is present then treatment with appropriate antibiotic therapy is recommended and 
management should be similar to that for an infected surgical graft (Sharif et al., 2007).
Vascular access for EVAR is typically performed with bilateral femoral cut-down 
arteriotomies. Serious groin access complications are rare but can include haematoma, 
infection and seroma with a reported incidence of between 1 and 10% (Liaw et al., 2009). 
Occasionally a groin will need to be re-explored in order to repair a false aneurysm or 
evacuate a haematoma. Very rarely patients who have undergone EVAR may suffer 
embolisation of the lower limb from arterial debris dislodged during the stent-graft
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implantation (Greenhalgh et al., 2004). Treatment is generally difficult and care must be
taken when manipulating the device within the aorta especially for cases where there is 
severe mural thrombus within the aortic neck. If distal embolisation does occur then 
treatment will be predominantly guided by the level of underlying ischaemia.
Systemic Inflammatory Response Syndrome (SIRS) or post-implantation syndrome can 
occur within a few days of the EVAR procedure and is seen in around 35% of patients 
(Arnaoutoglou et al., 2011). Signs and symptoms generally include fever, leucocytosis and 
raised inflammatory markers.
Wireform fractures have been reported for most stent-grafts (Jacobs et al., 2003). 
These fractures may lead to diminished stent strength and loss of radial force which can 
result in migration. Additionally the jagged ends of fractured metal may cause tears in the 
fabric and subsequent endoleaks. Stent factures are best demonstrated on plain abdominal 
radiographs. The use of serial plain radiographs during follow-up is well established. 
Migration, metallic fractures and conformational changes can all be detected using a 
combination of AP and lateral abdominal radiographs (Verhoeven et al., 2011). The 
diagnostic accuracy of this examination is improved by adherence to specific plain 
radiography protocols (such as the LIVERPOOL/PERTH post-EVAR radiography protocol) 
(Murphy et al., 2003).
An endoleak is defined as blood flow within the aneurysm sac but outside of the 
stent-graft and can be either graft-related or non-related (White et al., 1998, White et al., 
1997). Endoleaks are relatively common and several classification systems have been
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proposed for describing endoleaks (White et al., 1997, White et al., 1998, Veith et al., 2002) 
(Figure 2.3).
Figure 2.3 Illustration of endoleaks using the classification system devised by White and May. 
Adapted from Veith et al., 2003
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Amongst 2463 patients in the EUROSTAR registry, 171 (6.9%) had an endoleak on 
their 1-month follow-up, and 317 (12.9%) patients developed one during the remaining 
follow-up period (mean 15.4 months) (van Marrewijk et al., 2002). More recent data from 
the UK EVAR 1 trial reported the presence of endoleaks in 118 (22.2%) patients (UK EVAR 
Trial Participants, 2005). These included 27 type I, 79 type II, 8 type III and 4 unspecified 
endoleaks. The most serious endoleaks are types I and III which are associated with 
aneurysm enlargement and rupture. Secondary intervention to correct these endoleaks is 
almost always necessary. Rupture in the presence of a type II endoleak has also been 
reported within the literature (Jones et al., 2007), however, these are generally considered to
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have a more benign course and a conservative management approach is usually adopted 
unless there is evidence of continuing aneurysm sac enlargement (Bashir et a!., 2009).
Stent-grafts are subjected to distraction forces due to the relentless force of pulsatile 
blood flow. These distraction forces act longitudinally and challenge the fixation of the graft 
and the overlap zones. The stent-graft resists these forces due to its fixation mechanisms 
which include radial force of the sealing stent and the barbs which engage into the aortic 
wall. The columnar strength of a device is also important in resisting distraction. Distraction 
forces are dependent on a patient's blood pressure and the cross-sectional area reduction 
between the proximal/aortic and distal/iliac sealing stents (Sutalo et aL, 2005). Failure of 
fixation will lead to migration or modular disconnection with late type I or type III endoleak 
and the risk of aortic rupture. Graft limb distortion with subsequent thrombosis can also 
arise secondary to device migration.
Failure of the stent-graft may lead to the aneurysm becoming exposed to pulsatile 
blood and, therefore, exposing the patient to the risk of potentially lethal rupture. In one of 
the largest registry series published the EUROSTAR collaborators reported rupture-free 
survival rates following EVAR (Figure 2.4) and noted that post-EVAR rupture was associated 
with a 60% mortality (Fransen et aL, 2003b).
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Figure 2.4 Life table of rupture-free survival in the entire EUROSTAR cohort of 4291 patients. Figures 
next to the curve represent number of patients at risk for each interval (Fransen et a!., 2003)
Period (months)
The EUROSTAR registry demonstrated that migration, type 1 and 3 endoleaks, and 
graft kinking are predictive of graft rupture and generally these complications necessitate 
some form of reintervention (Harris et a!., 2000). A more recent publication by Schlosser and 
colleagues in 2009 reported on 270 cases of post-EVAR rupture (Schlosser et al., 2009). In 
this series the cause of rupture was identified in 218 (81%) out of 270 cases. Endoleaks 
accounted for 160 cases (59%), graft migration 41 (15%), graft disconnection 11 (4%) and 
infection 6 (2%). This work also identified that the majority of post-EVAR ruptures occurred 
within years 2 and 3 following repair, however, this report was based on a review of 110 
journal articles and the overall follow-up was not specified.
2.4 Follow-up imaging surveillance
In view of the distinct possibility of complications during follow-up it is mandatory
that all patients are entered into a planned graft surveillance programme. Evidence suggests
that post-EVAR rupture is more likely in patients with a previously reported complication or
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signs of failed EVAR (Wyss et aL, 2010). The EUROSTAR registry reported on outcomes of 
2846 patients who had EVAR between 1999 and 2004. Reintervention rates at 1, 2, 3 and 4 
years in this registry were 6%, 9%, 12% and 14%, respectively (Hobo and Buth, 2006). The UK 
EVAR trial reported similar rates of 8%, 8%, 11% and 16%, respectively (Brown et at., 2010). 
The incidence of complications and reinterventions appears to be greatest during the first six 
months following graft deployment (particularly the first 30 days post-implantation), with a 
lull from 6 to 24 months and then a new increase. This late increase has also been 
demonstrated with the EUROSTAR registry data (Hobo and Buth, 2006). Studies which have 
reported EVAR outcomes beyond five years have continued to report complications and 
secondary interventions in years 6 and 7 (Coppi et aL, 2008, Nordon et aL, 2010). 
Complications can, therefore, occur at any time point and often require the need to 
reintervene. Based on current evidence post-EVAR foliow-up surveillance must be 
recommended for life, the exception would be patients with contraindications to secondary 
intervention e.g. severe comorbidities.
2.5 Extending the scope of EVAR
According to vascular surgical reporting standards, short-neck infrarenal AAA are classified as
juxtarenal aneurysms if the aneurysm extends up to, but does not include the renal arteries
(Chaikof et aL, 2002b). Suprarenal aneurysms, therefore, extend above and involve the renal
arteries and possibly the splanchnic arteries (Amiot et aL, 2010). The classification of
juxtarenal aneurysms is complicated and depending on the definition the incidence ranges
from 2% to 20% for all AAA (Crawford et aL, 1986, Qvarfordt et aL, 1986, Taylor et aL, 1994).
Regardless of the definition, all patients with a short-neck (<10 mm), juxta- or suprarenal
AAA will have an insufficient amount of normal aorta (aortic neck) between the renal arteries
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and the aneurysm sac in order to allow a standard (infrarenal) stent-graft to obtain a seal and 
provide protection from rupture. These patients fall into a group who are deemed to have 
an 'unsuitable aortic neck1. The cut-off length is usually <10 mm between the most caudal 
renal artery and the start of the aneurysm (Schanzer and Messina, 2012). However, the 
concept of an unsuitable aortic neck has been further expanded and includes patients who 
have highly angulated (>60°) aortic necks and/or where there is the presence of significant 
thrombus/atheroma or calcification (Green, 2002, Dillavou et a!., 2003). This concept of an 
unsuitable aortic neck is a well-established term for excluding a patient from EVAR but its 
presence can also make OSR more challenging (Malina et al.f 2008).
The first reported use of an endovascular stent-graft was by Nicholas Volodos in 
Kharkov, Soviet Union in 1987 (Volodos et ai, 1988). It was the later publication by Juan 
Carlos Parodi and associates in 1991 (Parodi et al.t 1991) that was responsible for the 
widespread introduction of EVAR across the globe. Since these two reports substantial 
advances have been made in every aspect of endovascular technology. Techniques have 
now evolved which allow the endovascular implantation of specialised stent-grafts into the 
realms of complex AAA (Resch et ai, 2010). Several recent studies have highlighted the use 
of conventional stent-grafts outside of the manufacturer's Instructions for Use (IFU) for 
patients with complex AAA (Schanzer et ai, 2011, Igari et ai, 2013). Schanzer and colleagues 
further highlighted that post-EVAR aneurysm sac enlargement was higher in patients treated 
outside of the IFU and raised concerns about the long-term risk of aneurysm rupture in such 
patients. It is clear that for complex AAA both OSR, and EVAR outside of the IFU can 
generate additional problems. Even with EVAR outside of an IFU there will still be some
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patients where a definitive surgical option (open or endovascular) remains unavailable. In
view of this restriction further expansion of stent-graft technology has been warranted.
Chimney techniques have been proposed as an option for extending the reach of 
EVAR in patients with complex AAA (Moulakakis et a!., 2012). The chimney procedure 
involves the deployment of a stent-graft into aortic side-branches and the deployment of the 
aortic stent-graft such that the proximal parts of the visceral stents are parallel to the main 
aortic endoprothesis and extend above (Figure 2.5).
Figure 2.5 A standard aortic stent-graft deployed with fabric above the origin of the renal arteries.
Bilateral renal artery chimney grafts are in place to maintain visceral artery perfusion. Source:
www.vasculardiseasemanagement.com
Two recent systematic reviews (Moulakakis et a!., 2012, Tolenaar et a!., 2012) 
included 168 patients treated using the chimney EVAR technique. These reviews reported 
99% technical success rates and chimney stent-graft patency rates of > 97%. Technical
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success was defined as successful implantation of the stent-graft along with exclusion of the 
aneurysm. It should be noted that the follow-up periods for both reviews were relatively 
short (Moulakakis et al., mean 9.0 SD 1.0 months; Tofenaar et ai, range 2 days to 52 
months). In spite of these results there still appears to be reasonable hesitation within the 
vascular community to embrace this method for treating complex AAA.
2.6 Fenestrated stent-graft technology
In order to achieve a durable seal for short-necked, juxta- and supra-renal AAA the first 
covered portion (sealing stent) of the stent-graft must be placed over the orifices of the renal 
and possibly superior mesenteric and coeliac arteries. This can be achieved using a standard 
endovascular stent-graft when the procedure is combined with either open visceral 
revascularisation (Verhoeven et al., 2009) or as previously described, using a chimney 
procedure. The chimney procedure has many opponents and there are still patients who 
would be considered unfit for an open revascularisation hybrid procedure. There is a further, 
completely endovascular procedure, available for short-necked, juxta- and supra-renal AAA 
and uses individually customised fenestrations within the graft fabric (Malina et al., 2008). 
Such fenestrations allow essential blood flow to the aortic side-branches whilst allowing a 
seal to be achieved at or above the level of the renal arteries (Figure 2.6).
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Figure 2.6 Options for preserving blood flow into aortic side-branches using a Zenith fenestrated
stent-graft (Cook Medical Inc, Bloomington, IN)
Fenestrated stent-grafts are individually customised devices based on the 
precise plans of the location of the visceral arteries generated using pre-operative thin-slice 
CTA data. The fenestrations and scallops are carefully located within the graft fabric in order 
to match the ostia of the renal, superior mesenteric and coeliac arteries. Stent-graft 
deployment must, therefore, be precise and is significantly more complex than for standard 
infrarenal EVAR. The incorporation of the visceral arteries into the fenestrated repair does, 
however, generate additional (FEVAR-specific) complications (Halak et al., 2006).
Historically, the only commercially available CE-marked fenestrated stent-graft was 
made by Cook Medical Inc (Bloomington, IN) and was based on the Zenith AAA endovascular 
graft. The Zenith device comprises a woven polyester fabric suspended on Gianturco 
stainless steel stents. The main configuration of the Zenith fenestrated stent-graft is a 
bifurcated stent-graft device, although aorto-uniliac and simple tube devices are available for 
order (Figure 2.7).
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Figure 2.7 Three typical configurations of endovascular stent-graft
TUBE BIFURCATED AORTO-UNMLIAC
WITH TEMOBOf EMO*Al CROSSOVER CRAFT
A bare metal anchor stent is available proximally which has additional barbs mounted 
on the bare metal in order to improve device fixation. Immediately below the bare metal 
anchor stent sits the fabric covered sealing stent. A device may consist of multiple fabric 
covered seal stents and these would include up to four customised fenestrations and provide 
a proximal seal whilst preserving blood flow into the visceral arteries. The device is modular 
with an individually customised proximal component. The distal bifurcated body has a long 
ipsilateral iliac limb and a short contralateral limb. The manufacturer recommends a 
minimum overlap with the proximal body of two stents. It is also recommended that the iliac 
limbs cover the entire common iliac artery segments where possible.
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There are three distinct types of fenestration options available on the Zenith AAA 
endovascular graft (scallop, small and large fenestration) (Figure 2.6). There are 
manufacturing limitations to the height, width and vertical positioning of the fenestrations 
within the respective Gianturco stents.
A scallop describes a U-shaped gap within the proximal fabric of the stent-graft. Small 
and large fenestrations are generally circular and are placed below the start (proximally) of 
the endograft fabric. Scallops and small fenestrations typically have no metallic struts across 
them and, therefore, are generally stented to help maintain alignment and resist longitudinal 
as well as rotational migration. Large fenestrations traditionally had a stent strut crossing 
the opening but are now available strut free and are commonly used for securing the SMA or 
CA.
The extension of the fabric component of the stent-graft above the level of the renal 
arteries using a fenestrated stent-graft was first described in 1996 (Park et ai., 1996). This 
was then followed by the development of a more versatile fenestrated device by Lawrence- 
Brown, Anderson, and Hartley (Anderson et aL, 2001). Fenestrated stent-grafts (Figure 2.8) 
are designed to extend the proximal sealing zone from the infrarenal segment to the juxta- 
and suprarenal aorta, thereby removing the limitations of the short or absent aortic necks. 
Initial reports of this technology (Anderson et aL, 2001, McWilliams et aL, 2004) have 
demonstrated that FEVAR can be successfully and safely performed. All of these early 
experiences were limited to a small number of patients and more recent reports have sought 
to establish the mid-term efficacy of this technology (BSET and GLOBALSTAR Collaborators, 
2012, Haulon etaL, 2010, Tambyraja etaL, 2011).
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Figure 2.8 Components of the Zenith AAA fenestrated aortic stent-graft (Cook Medical Inc,
Bloomington, IN)
To date more than 1,000 fenestrated stent-grafts have been implanted worldwide 
and feasibility is now no longer an issue (Scurr et ai, 2008a) (Table 2.3). As previously stated 
the bulk of fenestrated stent-graft experience has been confined to a single device, Zenith 
fenestrated AAA endovascular graft (Cook Medical Inc, Bloomington, IN). Over the past few 
years several newer devices have become available including the fenestrated Anaconda
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device (Vascutek, Ichinnan, Scotland)(Bungay et a!., 2011) and the Ventana fenestrated stent- 
graft (Endologix, Irvine, CA)(IVIertens etal., 2012).
Long-term performance of a sutured vascular graft in open abdominal aortic 
aneurysm (AAA) repair depends on the durability of the anastomosis and graft material. 
With the introduction of stent-grafts, the anastomosis has changed, and in the process has 
introduced some doubts regarding the long-term durability of stent-grafts. With newer 
stent-grafts (fenestrated) raising the stent-graft sealing zone above the level of the renal 
arteries this has also introduced new modes of failure (Table 2.4).
Two of the more worrisome complications in FEVAR are stent-graft migration and 
target vessel loss. Migration can lead to late type 1 endoleak, aneurysm enlargement, and 
eventually rupture (Harris et al., 2000, Tonnessen et a!., 2004). Stent-graft migration can be 
potentially evermore catastrophic for a FEVAR device where any dislodgement of a 
fenestration may adversely affect the blood supply to visceral aortic side branches (Malina et 
al., 2008).
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2.7 Chapter 2 - summary
Over the past 20 years there has been an accumulation of evidence showing a reduction in 
30-day mortality rates for standard EVAR when compared to OSR. Additional advantages 
have also been reported and include a reduction in morbidity, shorter hospital stays, less 
demand for ICU/HDU beds and less post-operative pain. However, standard EVAR is not 
amenable to all patients and there are specific anatomical limitations which can exclude 
certain aneurysm morphologies from this type of repair.
Techniques are now readily available which expand the applicability of endovascular 
repair to those patients with complex (short-necked, juxta- and suprarenal) AAA. FEVAR has 
now started to emerge as the dominant treatment option repair of these more complex AAA. 
Currently FEVAR requires carefully planned and manufactured fenestrations to be cut into a 
custom-made device. During deployment this device must be carefully aligned in order to 
position the fenestrations against the corresponding visceral side-branch ostia and thus allow 
the preservation of blood flow.
For standard EVAR there is a higher rate of complications arising during follow-up 
when compared to OSR. Several of these complications have been associated with post­
treatment aneurysm rupture. It is now accepted that rupture following EVAR is more likely 
than in patients undergoing OSR. Treatment with a fenestrated stent-graft is also not devoid 
of the risk from complications. The added complexity of FEVAR, including the carefully 
planned fenestrations within the fabric, and increased modularity, has brought additional 
complications. Evidence surrounding the use of FEVAR is in its infancy. Robust 
methodologies must be available to allow accurate outcomes data to be presented. This is
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urgently required in order to satisfy both patients and the vascular community that FEVAR is
a long-term durable solution for complex AAA.
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3. Device migration
3.1 Assessment
3.1.1 Definition
Device migration can simply be defined as the movement of a stent-graft from one position 
to another over time (Zarins, 2004). The most common scenarios involve caudal movement 
at the proximal attachment site or cranial movement of the iliac limb at the distal attachment 
site (Figure 3.1).
Figure 3.1 CT 3D volume rendered reconstructions illustrating cases of proximal (A) and distal (B) 
migration of a Zenith AAA fenestrated stent-graft
33
With increasing interest in migration there are many proposed definitions. Currently,
the most widely used definition is from the reporting standards of the Society of Vascular 
Surgery (SVS) and the Institute of Cardiovascular and Venous Surgery (ICVS) which defines 
migration as >10 mm of stent-graft movement relative to anatomical landmarks or any 
migration leading to symptoms or requiring reintervention (Chaikof et al., 2002b). The 
definition of migration is in itself complex; factors such as the imaging modality, precise 
assessment methodology and experience of the observer can limit the ability to identify 
small changes in stent-graft position. Greenberg and colleagues argues that a stricter 
definition of migration is needed and suggests that migration can be accurately categorised 
as movement of more than two times the reconstructed resolution of the imaging study 
(Greenberg et al., 2004b). For example, in CT if using a 2mm reconstructed slice thickness 
then the definition of migration would be movement of >4 mm. Any assessment of stent- 
graft migration also requires that the remaining aortic neck must be taken into consideration 
together with the presence or absence of an endoleak. This will in turn reflect the risk of 
aneurysm sac pressurisation and can help guide management.
3.1.2 Identification
In the early years following the introduction of EVAR there was a major emphasis on the 
detection and management of endoleaks and on the assessment of changes in aortic sac 
morphology. Device migration has never occupied centre-stage and still many surveillance 
imaging examinations are not routinely scrutinised for any evidence of migration. Migration 
can be detected on virtually all follow-up imaging modalities (CT, abdominal radiography, 
MRI and ultrasound) (Uthoff et al., 2012). Currently, the most common surveillance imaging 
examination following EVAR is MDCT angiography (van der Vliet et al., 2011, Uthoff et al.,
2012). At many centres, MDCT angiography is considered to be the gold standard for post- 
EVAR follow-up (Uthoff et a!., 2012, Shah and Stavropoulos, 2009). Van der Vliet and 
colleagues in 2011 argued that MDCT angiography has the advantage of being potentially 
able to visualise most threats to stent-graft durability including migration, kinking, structural 
disintegration, endoleaks and aneurysm growth (van der Vliet et ai, 2011).
There are several post-processing image reconstruction techniques from which stent- 
graft migration can be detected when using serial CT examinations. In the early years of 
EVAR CT technology was very limited. MDCT systems were not readily available and in order 
to cover the required anatomy, within a single breath-hold and with sufficient arterial system 
enhancement, the use of thick (>5 mm) collimation was mandatory. At the same time, 
options for digital image review were limited. Picture Archiving and Communication Systems 
(PACS) were sparse and advanced computer processing techniques were still being 
developed. As a result the assessment of post-EVAR follow-up images almost universally 
relied on the evaluation of single axial CT images. From these images, migration was often 
identified only by the presence of an associated complication or when comparing CT images 
from similar table positions between follow-up examinations (Figure 3.2).
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Figure 3.2 Comparison of axial CT slices (acquired in a similar position) between serial CT 
examinations. There is an absence of metallic struts on the 2-year CT scan suggesting the possibility 
of caudal migration (CA - coeliac axis)
1st post-operative 2-year post-operative
CT scan CT scan
• ••
^ CA
^CA
%
• • •
i i(
With improvements in CT scanner technology (thinner slices and faster scanners) 
together with advances in computer post-processing (dedicated 3D workstations), the option 
of reviewing follow-up CT data as a 3D volume became available. Using these techniques the 
deployment position of the 1st post-operative (baseline) CT scan could be displayed using 
multi-planar reformatted projections (MPR). Images in the sagittal plane provided a view of 
the stent-graft relative to vascular branches and the lumbar vertebral bodies. When 
compared with similar projections from subsequent examinations (Figure 3.3) this provided 
the option for both subjective and objective (using electronic measurements) assessments of 
changes to the position of the stent-graft.
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Figure 3.3 Sagittal CT reformatted MIP images from the 1st post-operative (baseline) and 2-year CT 
scans. There has been caudal migration of the stent-graft indicated by a difference in the position of 
the proximal bare stent struts (*) between the two examinations
There are, however, accepted limitations when using MPR images to provide precise 
length measurements along the axis of a tortuous vessel. These have been previously 
acknowledged within the literature (Wyers et al., 2003) and as a result catheter angiography 
was often used to provide measurements along the length of a vessel prior to EVAR. This can 
also generate problems since the catheter does not always follow the central channel of the 
vessel and there are also well established risks from catheter angiography (Bell and Gaspar,
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1982). Reports in the literature have suggested that such deviations in catheter position can
cause length measurement errors. Beebe and colleagues reported that errors greater than 1 
cm were present in over 19% of cases undergoing catheter angiography (Beebe et a!., 1995). 
Nowadays pre-operative catheter angiography prior to EVAR has been virtually eliminated by 
the combined use of MDCT with specialised 3D measurement software (Diehm et al., 2004). 
Software algorithms on these 3D systems allow the generation of images along the centre of 
the contrast-enhanced lumen in the aorta and iliac arteries (Lell et al., 2006). This provides a 
facility for precise length measurements even in the presence of tortuous or angulated 
anatomy (Diehm et al., 2004). Such a system is likely to be superior to other techniques 
where measurements are based solely on a 2D projection. These central luminal line (CLL) or 
central flow line (CFL) measurement techniques have been validated for the preoperative 
assessments of vessel lengths and diameters prior to EVAR (Wyss et al., 2009, Ghatwary et 
al., 2012). No such validation data currently exists for measurements obtained from follow­
up CT examinations or when assessing stent-graft migration. Stent-grafts are often deployed 
in tortuous or angulated anatomy and the device will typically follow the path of the vessel. 
Such complex anatomy is even more likely to be present if the patient is treated by FEVAR. It 
is, therefore, essential to have a robust migration assessment technique, such as a CLL/CFL 
technique, which generates accurate measurements of stent-graft position even in event of 
extreme vessel tortuosity or angulation (Figure 3.4).
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Figure 3.4 CT central luminal line (CLL) technique used to quantify changes in the position of a stent- 
graft during follow-up. In this example there has been 14 mm of cranial migration of the iliac limb 
between the 1st post-operative (A) and last follow-up CT scan at 24 months(B)
CT surveillance following thoracic EVAR follows similar patterns to abdominal EVAR. 
One difference is that the assessment of migration for a thoracic stent-graft is aided by the 
measurement of stent-graft position using both proximal and distal aortic reference points. 
The proximal reference point is usually a patent aortic arch branch and the distal reference 
point the coeliac axis (CA). In thoracic EVAR (O'Neill et al., 2006b) have demonstrated the 
importance of using 3D CLL technique when faced with tortuous or angulated anatomy. They 
reported significant advantages of using this type of technique when assessing for thoracic 
stent-graft migration.
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Alternative imaging examinations can be used in the identification of stent-graft 
migration. Migration may be detected by ultrasound or be inferred by surrogate markers of 
possible migration. Ultrasound is not suitable for the surveillance of thoracic aneurysms but 
is now increasingly used as an alternative test to CT scanning in the surveillance of abdominal 
stent-grafts (Harrison et al.f 2011). Migration may be assessed with reference to a fixed 
aortic reference point such as the superior mesenteric artery (SMA) which is more reliably 
seen than the renal arteries. Migration is diagnosed if the distance from the SMA to the top 
of the stent-graft increases in excess of an arbitrary threshold which reflects the 
measurement error. Migration must also be considered when a graft-related endoleak is 
observed or if there is reduced limb blood flow. Graft distortion may be secondary to 
migration and this is the reason that altered limb blood flow must prompt a search for stent- 
graft migration. Ultrasound is not the optimal test for the assessment of migration and its 
use in surveillance is primarily to measure the sac diameter and detect endoleak. Despite 
this, ultrasound surveillance is typically combined with plain radiography as an alternative to 
MDCT.
Plain radiographs when performed to a standardised radiographic protocol such as 
the LIVERPOOL/PERTH protocol (Murphy et a!., 2003) have been suggested as being an 
acceptable test for migration and modular component separation. In this application 
migration is typically assessed by reference to non-aortic landmarks such as the vertebral 
bodies. It is possible that vertebral body height could change as a result of musculoskeletal 
degenerative processes (Allbrook, 1956). If this was to happen then cases of migration could 
be mimicked or cases of true migration could be masked. It would also be difficult to 
ascertain the proportion of aortic neck which is still covered by endograft fabric. In the
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future it may be possible that implanted aortic markers, deployed as part of the initial 
surgical procedure, could be used to further improve the accuracy of the plain radiographic 
assessment of migration (Koning et al., 2006).
3.2 Biomechanics of stent-graft migration
3.2.1 Displacement (drag) force
Migration can be considered as a failure of attachment within an unchanged aorta or as a 
failure related to changes in aneurysm morphology. Since 1998, a number of studies have 
attempted to determine the force required to cause the migration of an implanted aortic 
stent-graft using devices implanted in sections of bovine aorta (Malina et al., 1998, Lambert 
et al., 1999, Resch et al., 2000, Veerapen et al., 2003). The downward displacement (drag) 
force acting on the stent-graft includes a downward component and a transverse (or 
sideway) component. In general, the downward force affects the proximal neck fixation and 
the transverse force influences the iliac neck fixation.
The drag force on a stent-graft is not constant and will vary between patients and 
have some dependency on the type of stent-graft deployed. In order to explain the 
haemodynamic forces acting on a bifurcated stent-graft Mohan and colleagues proposed a 
simple model (Mohan et al., 2002). In this model several assumptions were made, 1) the 
bifurcation is planar and symmetrical and 2) the blood flow is distributed evenly through the 
iliac limbs (Figure 3.5A). As the fluid enters the device it divides into two outlets of equal 
diameter and undergoes a change in both the direction and velocity due to the effect of the 
angle and the reduction in diameter. The associated change in the momentum of the fluid
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and the pressure forces acting at the inlet and outlets produce forces on the device that must
be opposed to prevent stent-graft migration (Figure 3.5B).
In the same report Mohan and his research group further described how the 
displacement forces (Figure 3.5) acting on the stent-graft can be calculated using the Massey 
momentum equation (Massey, 1989).
Figure 3.5 Mathematic model for studying stent-graft displacement forces (Mohan et ai, 2002)
A BD
Q
In the above figure the following terms are used Dj = proximal cross-sectional area, D2 = distal cross- 
sectional area, Ui = proximal velocity of blood, U2 = distal velocity of blood, Ax = proximal cross- 
sectional area, ?! = proximal pulse pressure, A2 = distal cross-sectional area P2 = distal pulse 
pressure, fx = distal displacement force, fy = transverse force, 0 = iliac angle from vertical, Q = volume 
flow rate (Ai,U!), p = density of the fluid.
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When calculating forces it is often assumed that fluid has negligible viscosity (no fluid 
sheer stress and that the velocity profile is uniform) and that the bifurcation is in a horizontal 
plane (no gravitational forces). If this is the case then the forces acting in the axial direction 
(x) are summed and equated with the change in fluid momentum in the axial direction (see 
references included in Mohan et ai, 2002):
2P2A2COSO - fx= pQ (y cosO + y cosO - U^j (1)
Where P1; Ai7 Lb and ?2, &2, U2 are the pressure, cross-sectional area, and velocity at 
the inlet and outlet, respectively. The density of the fluid is defined by p and Q is the volume 
flow rate. The first two terms on the left-hand side of Equation (1) represent the pressure 
forces at the inlet and outlet acting on areas Ai and A2, respectively. fx is the axial 
component of the force exerted by the bifurcation of the fluid. The right-hand side of 
Equation (1) represents the rate of increase of the axial component of momentum. In the 
transverse direction, the pressure and momentum forces cancel out due to the assumption 
of symmetry and equal flow distribution and therefore fy~0.
Since P2 in Equation (1) is not known, the Bernoulli and continuity equations:
(2)
A±U-l — 2A2U2 (3)
are substituted for P2 and U2 in Equation (1). The volume flow rate (Q) is also substituted by 
A1U1 to obtain the following relationship for fx\
fx ~ PiA± + pPiAi PlT2Ui2cose - 2A2C0S6 h + Px(1 “$)] (4>
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By Newton's third law, there is a force on the bifurcation equal in magnitude to fx but 
in the opposite direction. In order to calculate the distal displacement force, blood flow rates 
down the infrarenal aorta and each iliac limb need to be measured or assumed. Diameters 
or areas of the proximal aorta and the common iliac arteries can be measured using CT 
imaging. The pulse pressure (pressure that is felt when feeling a pulse) can also be 
measured, assumed based on suggestions within the literature or varied within a 
displacement force model.
3.2.2 Factors affecting drag force
Using Equation (1) it can be seen that the displacement force can be affected by small 
changes in blood flow rate or systemic blood pressure (Q) (Volodos et ai, 2003) (Figure 3.6).
Figure 3.6 Plot of the systemic blood pressure with the means of the minimal loads required to hold a 
stent-graft in position assessed using an in vitro model (Source: Volodos et ai, 2003)
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Calculations by Li and Kleinstreuer (2006), using a fluid-structure interactions (FSI) 
model, concluded that blood pressure is the main contributor to drag force on a stent-graft 
Lambert et a!., in 1999 raised the question as to whether sudden rises in blood pressure may 
even instigate cases of migration. This latter point may be hard to prove in practice without 
methods for long-term ambulatory blood pressure monitoring and the simultaneous 
measurement of graft movement. However, hypertension has been shown to be a risk factor 
for migration in the EUROSTAR registry (Mohan et al., 2002) and the authors again supported 
the conclusion that blood pressure is a major contributor to the in vivo distraction force.
Other variables which have an influence on the drag force upon a stent-graft include 
the size and shape of the aortic neck. For aortic neck diameter, the maximum drag force is 
only about 2N when the stent-graft diameter is 18 mm, however at 32 mm the force 
increases to 7 N. The almost linear dependence observed by Li and Kleinstreuer (2006) was 
also reported five years earlier by Liffman et al., (Liffman et al., 2001). This relationship has 
also been illustrated graphically (Figure 3.7).
Figure 3.7 Relationship between stent-graft drag force and stent-graft size in terms of main lumen 
diameter (Source: Li & Kleinstreuer, 2006)
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Lambert et al., in 1999 conducted an in vitro study assessing the load needed to
remove a deployed stent-graft in a series of cadaveric aortas (n=10). Their report also 
concluded that wider diameter aortas need less load to remove the stent-graft when 
compared to smaller diameter aortas (P=0.01). These findings by can be explained when 
considering the position of the cross-section inlet area within Massey's momentum equation 
(Equation 4).
Another influential geometrical factor is the stent-graft main body to iliac limb 
diameter ratio. As reported by Li and Kleinstreuer (2006) using FSI a non-linear increase in 
drag force of around 5 N (1.5 to 6.5 N) can be observed when the ratio doubles from 1.5 to 
3.0 (Figure 3.8). The reason for this is that more blood needs to converge suddenly into the 
smaller iliac limbs resulting in a significant net momentum change. To decrease the risk of 
stent-graft migration the main-body/iliac-limb diameter ratio should be as close to 1 as 
possible. There must be some caution when considering cross-sectional diameter 
measurements and the resultant displacement forces. More recent reports have utilised the 
cross-sectional area of a vessel, describing this as a potentially a more powerful indicator of 
force. This is illustrated within Massey's momentum equation where cross-sectional area is 
shown to have a greater influence on displacement force (Equation 4). Cross-sectional area 
can be determined from cross-sectional diameter, this would, however, assume that the 
segment being measured is perfectly circular and not-distorted. Such a situation can be 
difficult to achieve using radiological imaging and thus the cross-sectional diameter is often 
more commonly quoted. It must, however, be made clear that more precise estimations of 
stent-graft displacement force can be obtained when using cross-sectional area 
measurements.
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Figure 3.8 Relationship between stent-graft drag force and main-body/iliac-leg diameter ratio
(Source: Li & Kleinstreuer, 2006)
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Increasing stent-graft displacement forces have been associated with increasing 
degrees of aortic neck angulation. Force analysis work by Li and Kleinstreuer (2006) reported 
that the effect of neck angle is negligible if less than 40°, however, the drag force can 
increase significantly if the aortic neck angle is above 40° (Li and Kleinstreuer, 2006a). Iliac 
angle also influences the possibility of device migration. A larger angle between the iliac 
limbs and main device body produces a larger drag force, the reason being that a large AAA 
iliac angle results in a large net momentum change. Mohan and colleagues in 2002 and more 
recently Morris and colleagues in 2004 demonstrated that the drag force increases in a 
nonlinear manner with iliac angle (Morris et ai, 2004). The relationship between both aortic 
neck (a) and iliac ((3) angles and the resultant stent-graft displacement force is illustrated in 
Figure 3.9. In clinical studies both Albertini et al., and Sternbergh et ai, confirmed an 
association between graft neck angulation and migration (Albertini et ai, 2000) (Sternbergh 
et al., 2002).
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Figure 3.9 Relationship between stent-groft drag force and neck angle a as well as iliac bifurcation
angle 6 (Source: Li & Kleinstreuer, 2006)
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There are other physiological parameters which affect the drag force on the stent- 
graft. Time variations in systemic blood pressure will affect the overall drag force during 
each cardiac cycle. Such time-specific variations have been described by Li and Kleinstreuer 
(2006) (Figure 3.10). There are variations in the blood pressure waveform between patients, 
this will have a resultant effect on the drag force (Li and Kleinstreuer, 2006a) (Figure 3.11). 
Such variations are likely to depend on the presence of any underlying cardiac and blood 
vessel pathologies and affect the acceleration of arterial blood leaving the heart. Supporting 
this Kelly and colleagues have previously described age related changes to the peripheral and 
carotid arterial pulse waveforms (Kelly et ai, 1989).
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Figure 3.10 Time-variation of stent-graft drag force during the cardiac cycle (Source: Li &
Kleinstreuer, 2006)
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Figure 3.11 Relationship between stent-graft drag force and the type of blood pressure waveforms 
(Source: Li & Kleinstreuer, 2006)
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3.2.3 Factors affecting fixation
In order to oppose migration and maintain positional stability within the aorta, there 
are contact pressure interactions between the stent-graft and the aortic wall. 
Experimentally, it can often be challenging to correctly capture and understand the 
interaction between the stent-graft and the aorta. Frictional forces are responsible for 
resisting the motion which may take place between the aortic wall and the stent-graft. 
Radial force from the stent-graft metallic skeleton and its contact with the aortic wall also 
resist migration (Figure 3.12).
Figure 3.12 Forces opposing proximal stent-graft migration
frictional!
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Many reports investigating the contact mechanics between the arterial wall and 
stents have assumed frictionless contacts (Bedoya et a!., 2006, Gijsen et al., 2008, Early et ai, 
2009, Theriault et al., 2006). Friction is commonly described using the term Coefficient of 
Friction (CoF) which is a unitless number measuring the degree of how a surface affects the 
motion of objects in contact with it (Nanota et al., 2003). Wu and colleagues assumed a
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friction coefficient of 0.05 between a carotid stent and the artery in their computational 
analysis (Wu et aL, 2007). For aortic stent-grafts Vad et al., determined a range of 
Coefficients of Friction (COF) for three commercially available stent-grafts (Vad et al., 2010). 
In their report CoFs varied from 0.01 to 0.45 and were also shown to decrease with 
increasing oversizing. CoFs are also likely to vary with differing levels of aortic neck thrombus 
and calcification and as such there are likely to be differences in CoFs derived from 
computational techniques when compared with any in vivo measurements.
The radial spring force is dependent on the stent-graft construction but also the 
degree of oversize. Vad et al., (2010) showed that by increasing the device oversize (stent- 
graft diameter versus native aortic diameter) this caused the contact pressure between the 
device and the aortic wall to increase. What was also found was that pullout forces generally 
increase when increasing the oversize, there is however, a plateauing point for exoskeleton 
nitinol based devices. In the report by Kratzberg and colleagues a plateauing point in the 
force needed to displace the device was seen when beyond 30% for barbed nitinol based 
stent-grafts (Kratzberg et al., 2009). Concerns have also arisen regarding the excessive use of 
oversizing which may lead to gradual dilatation of the artery (Rodway et al., 2008). In the US 
Zenith multicenter trial, stent-graft oversizing greater than 30% was the only significant 
predictor of migration at 12-months (Sternbergh et al., 2004). For non-nitinol based devices 
there is an almost linear relationship between oversize and pullout force. This suggests that 
the radial spring force is highly important in maintaining positional stability but must be used 
carefully in order to prevent other complications.
There are other factors that can affect the frictional and radial forces exhibited by the
stent-graft. The constitution of the aortic wall has been shown to affect the load needed to
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remove a deployed stent-graft in a series of cadaveric aortas (Lambert et oL, 1999). Lambert
et al,, (1999) showed that differing calcification levels affected the loads needed to cause 
displacement but to a lesser effect than aortic neck length and diameters. Severe 
calcification of the aortic neck may restrict the barbs engaging in the aortic wall and thus 
reduce the frictional effectiveness of the device. Research using cadaveric aortas (Malina et 
al., 1998) has demonstrated that by adding hooks and barbs to stent-graft devices the 
fixation of the device could be increased tenfold. Early clinical experience using hooks and 
barbs yielded relatively high migration rates, 66%, 75% and 75% at 3, 5 and 7 years, 
respectively (Alric et al., 2003). With improvements in device technology and stent-graft 
implantation expertise the incidence of migration has fallen considerably. The Zenith stent- 
graft (with hooks and barbs) now has an accepted low migration rate, however, this has not 
been found to be significantly better than other stent-grafts systems which do not utilise 
hooks and barbs (Ouriel et al., 2003, Brown et al., 2007). There are also additional questions 
about the influence of aortic neck thrombus. The majority of clinicians are cautious about 
deploying a stent-graft in a thrombus lined neck in view of the likelihood of endoleak 
(Antoniou et al., 2013). Further to this there is also some unease about the additional 
possibility of microembolisation (Saratzis et al., 2013). As a result it would be difficult to 
ascertain the influence of aortic thrombus on migration using in vivo methods.
Shorter aortic necks have also been shown to require a smaller load in order to 
displace the stent-graft (p<0.001) (Lambert et al., 1999). This relates to the contact pressure 
which will depend on the contact area between the aortic stent-graft and the vessel wall. As 
highlighted in Figure 3.13, there can also be differences in the area of aortic wall directly in 
contact with the device (apposition). Even in the presence of the same cardiovascular
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physiology and identical devices there will be differences in the drag resistance because of 
differences in contact area. This feature is likely to be highly variable for fenestrated stent- 
grafts since there will be varying amounts of aneurysmal disease across the visceral aortic 
segment.
Figure 3.13 An illustration to show possible differences in aortic wall/stent-graft interface which 
would affect resistance to the displacement force
Even when good initial fixation has been achieved, progression of the aneurysmal 
process is still possible (Nasim et ai, 1996, Rodway et al., 2008). Aortic neck dilatation has 
been identified as a risk factor for migration by many authors (Cao et al., 2002, England et al., 
2004). Following EVAR up to one third of patients will experience proximal neck dilatation 
whilst the prevalence of device migration is much lower (Oberhuber et al., 2010). It is 
notoriously difficult to predict patients who will experience proximal neck dilatation and 
subsequent migration. Late neck dilatation (>30-days following implantation) following EVAR
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is a major cause of concern because of the potential loss of a proximal attachment site seal.
Significant neck dilatation should be taken into consideration when outlining the surveillance 
programme for a particular patient, even in the absence of any adverse events. Surveillance 
intervals should be kept under regular review as initial neck expansion may plateau out over 
time {May et al., 1996). A contributing factor to neck dilatation is the radial force from the 
stent-graft, this may vary between devices and is certainly affected by the degree of stent- 
graft oversizing. Experimental work has been undertaken which suggests that self-expanding 
stents may be superior to balloon-expandable stents in the presence of a dilating vessel 
(Mangell et al., 1996). Opposing opinions have suggested that aortic neck dilatation results 
from using self-expanding stent-grafts (Dalainas et al., 2007).
Studies have shown that the net downward displacement force on a stent-graft is 
significantly reduced in the presence of an endoleak (Li and Kleinstreuer, 2006b). For 
patients with endoleaks both sides of the stent-graft are exposed to pressure forces (Ellozy et 
al., 2004). Even in the presence of an excluded aneurysm the will still be some pressure 
between the stent-graft and the aneurysm wall. Any reduction in sac pressure will not occur 
immediately and according to Sonesson et al., this could take up to several months 
(Sonesson et al., 2003). Hynecek and colleagues reported on the complete radiological 
exclusion of an AAA in 13 subjects with near complete elimination of intrasac pressure 
(<20%) {Hynecek et al., 2007). Part of the net downward displacement force will be a 
function of the remaining intrasac pressure. In addition to endoleak, residual sac pressure is 
likely to depend on multiple factors including the presence or absence of patent side 
branches, the nature of the aneurysm thrombus and the overall anatomy of the aneurysm 
(Sanchez et al., 1997, Pacanowski et al., 2002b, Vallabhaneni et al., 2003). Device related
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factors are also responsible for sac pressurisation and include the porosity of the device, 
compliance and pulsatility (Paries et aL, 1997). When modelling stent-graft drag force it is 
also extremely important to include the effects of residual sac pressure, presence of stagnant 
blood and AAA wall characteristics within any calculations (Li and Kleinstreuer, 2006a).
The longitudinal columnar strength of a stent-graft can vary between manufacturers. 
Many researchers believe that longitudinal columnar support can help opposite proximal 
migration (Corbett et aL, 2010). Additional fixation is provided by the longitudinal stiffness 
of the stent-graft together with the degree of iliac artery implantation. For a bifurcated or 
AUI device the importance of these distal seal zones has received relatively little attention in 
its ability to prevent migration. Heikkinen et aL, was first to report on the potential 
importance of iliac fixation, in their study migration was identified in 10% of patients, all 
were found to have suboptimal iliac fixation on the post-implantation CT (Heikkinen et aL, 
2006). In this study, iliac fixation was categorised according to the fixation length which was 
the distance from the distal iliac limb to the common iliac bifurcation. The study by 
Heikkinen et aL, (2006) failed to take into consideration the CIA diameters, presence of 
calcification, tortuosity and other potentially influential factors. A more recent publication 
by Benharash et aL, found that suprarenal and infrarenal stent-graft devices may rely heavily 
on iliac fixation to maintain long-term positional stability (Benharash et aL, 2007).
Other individual features of stent-graft configuration may impact on device fixation.
Zhou et aL, (2007) undertook an in vitro comparison of the fixation between a standard
stent-graft and one with a single stented fenestration. Zhou and colleagues concluded that
the inclusion of a stented fenestration increases the fixation strength (PcO.OOl). With
reference to fenestrated stent-grafts Scurr et aL, (2008) investigated, using an in vitro model,
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the ability of different covered and uncovered stents to resist migration of a fenestrated
stent-graft (Scurr et al., 2008b). Scurr and colleagues concluded that out of the three stents 
tested, the Jostent (Abbott Vascular, Abbott Park, II) provided the greatest resistance to a 
50% reduction in cross-sectional area.
3.3 Prevalence of proximal migration in infrarenal stent-grafts
Varying approaches to the detection of migration are likely to explain much of the different 
reported rates of migration for both thoracic and abdominal stent-grafts. Reports of 
migration for thoracic stent-grafts vary between 0 to 30% (O'Neill et al., 2006b). Different 
fixation mechanisms are used for abdominal grafts and this is likely to partly explain the 
different rates of migration with different devices; however, even with the same infrarenal 
device there are widely varying reported migration rates: 0 to 21% for the Aneurx graft 
(Medtronic, Santa Rosa, CA), 2 to 18% for the Talent graft (Medtronic,Santa Rosa, CA) and 2 
to 8% for the Zenith graft (Cook Medical Inc, Bloomington, IN)(Table 3.1).
Migration is typically classified based on pre-established definitions (movement >5 
mm or > 10 mm). Several reports have sought only to document cases of migration if they 
result in an associated complication e.g. proximal type 1 endoleak or require reintervention 
e.g. insertion of a proximal cuff. Such cases of migration are often described as clinically 
significant migration and have been reported as outcomes for some of the major RCTs and 
stent-graft registries (UK EVAR Trial Participants, 2005, BSET and GLOBALSTAR Collaborators, 
2012), In very few instances has the magnitude of stent-graft migration been measured and 
reported. By way of an example England et al., (2004) reported migration rates for the 
Talent (Medtronic, Santa Rosa, CA) of mean 4.8 SD 4.2 mm at 2-years. By contrast the early
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results from the recent manufacture sponsored ENGAGE registry (Endurant stent-graft, 
Medtronic, Santa Rosa, CA) indicated that migration was assessed during follow-up but failed 
to provide a precise definition or any descriptive statistics (Stokmans et ai, 2012). This was 
also similar for the short-term outcome report on the C3 Excluder stent-graft (W.L. Gore & 
Associates, Flagstaff, AZ)(Smeds et al., 2013). The absence of any device migration was 
introduced into the discussion section of their report yet there was no indication on the 
definition used or the assessment method e.g. CTA or radiography.
Table 3.1 Incidence of device migration for conventional (infrarenal) stent-grafts
Device/Study Author, Year Year n Follow-up, Definition Migration
mo (mm) (%)
Zarins et al. 1999 190 12 ND 6.0
Cao et al. 2002 113 28 >10 15.0
AneuRx Conners et al. 2002 49 24 >5 20.4
Sternbergh et al. 2002 81 26 >5 8.6
Tonnessen etal. 2008 77 39 >10 18.2
Lee et al. 2002 40 17 >10 17.5
Talent
Criado et al. 2003 240 13.5 >5 2.0
Ouriel et al. 2003 39 12 >10 0.0
England et al. 2004 38 24 >10 15.8
Greenberg etal. 2001 301 14 >5 2.7
Zenith
Ouriel et al. 2003 144 12 >10 8.2
Sternbergh etal. 2004 261 12 >5 2.3
Tonnessen etal. 2005 53 30.8 >5 7.5
Excluder
Kibbe et al. 2003 235 24 ND 1.0
Ouriel etal. 2003 25 12 >10 0.0
EUROSTAR Mohan et al. 2002 2862 1-6 years >5 3.5
ND-Not defined. n, number of patients.
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When considering the haemodynamic forces within the abdominal aorta it is easy to
understand why proximal stent-graft migration should be in a caudal direction. There have 
been a small number of reports suggesting apparent cranial migration of the proximal 
portion of infra-renal stent-grafts (Katzen et ai, 2005). The typical scenario is that a 
completion angiogram is performed demonstrating patent renal arteries. A subsequent 
investigation reveals renal artery occlusion and, therefore, proximal migration of the stent- 
graft is assumed. The report from Katzen et al. bases this on a catheter angiogram without 
any CT confirmation, it must be noted that significant renal artery coverage with graft fabric 
may be present and yet not impair flow immediately after deployment. Unless the image 
intensifier is aligned optimally with the renal ostia, typically using cranial and oblique 
angulation, then the operating team may be unaware of this partial renal coverage. When 
these renal arteries occlude in a delayed manner, as may happen, then it is possible for an 
erroneous conclusion of proximal stent-graft migration to be made. Unless comparative high 
quality CT datasets are available at different time points to clearly show movement in 
relation to aortic reference points, then the inference of cranial stent-graft migration solely 
based on delayed renal artery thrombosis may be inaccurate.
3.4 Distal iliac limb migration
Changes in the position of the distal iliac limbs can be interpreted as distal iliac limb
migration. Distal migration can be calculated in a similar manner to proximal migration using
a fixed iliac reference points e.g. hypogastric arteries. Parodi and colleagues initial
description of six tubular endografts each had only a single proximal attachment site (Parodi
et ai, 1991). It was reported that the distal (unattached) end of these tube grafts frequently
migrated back into the aneurysm (Thomas and Sanchez, 2009). This is perhaps not surprising
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in that blood flow through a curved stent-graft generates traction on both of its ends 
(Chuter, 2002). Early EVAR aorto-aortic (tube) grafts were particularly prone to distal 
migration and secondary endoleak. Even some bifurcated stent-grafts have experienced the 
graft limbs being slowly pulled out of the common iliac arteries (Beebe et al., 2001). As the 
limbs bent the forces became higher until the limb either thrombosed or popped back into 
the aneurysm causing an endoleak.
It is clear from the reports both by Beebe et aL, (2001) and more recently Tim Chuter, 
in 2002, that migration of an iliac limb does exist and that there are haemodynamic reasons 
to explain this. Despite its existence, migration of an iliac limb is scarcely reported within the 
literature (Alerci et al., 2005, Maleux et al., 2001). This may be due to a lack of association 
with adverse clinical sequelae. A distal type 1 endoleak is one of the most likely 
complications from the cranial migration of an iliac limb. However, distal type 1 endoleaks 
are often thought of as an early complication relating to patient selection or stent-graft 
deployment issues. These endoleaks are generally treated as part of the primary procedure 
using either a moulding balloon or extension of the device (Karch et al., 1999). Paries and 
colleagues reported on their experience of 597 EVAR procedures over a 6-year period (Paries 
et al., 2003). Distal type 1 endoleaks were reported in 12 (2%) patients, over a series of 
different time points. All but one of these distal type 1 endoleaks were successfully treated 
by extension of the iliac limb. Despite the reported incidence, these high-flow type I lesions 
were not identified as a statistically significant risk factor for rupture in the EUROSTAR 
registry (Vallabhaneni and Harris, 2001). This may be due to the fact that these endoleaks 
are easily detected and most commonly managed using an endovascular approach. 
Confirming the need to treat a distal type 1 endoleak, the EUROSTAR registry did identify
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distal type 1 endoleaks as a risk factor for open surgical conversion, risk ratio 2.6 (95% Cl 1.3 
to 5.3, P=0.01) (Vallabhaneni and Harris, 2001). Iliac limb occlusions are also a possible 
complication from stent-graft migration. Cochennac and colleagues reported on a series of 
iliac limb occlusions in EVAR patients during a mean 9.5 month follow-up (range, 0-71 
months). Thirty-three (7.2%) patients experienced an iliac limb occlusion but only one case 
was attributed to stent-graft migration (Cochennec et al.t 2007). Overall there appears to be 
a relatively low incidence of iliac-related secondary events in patients undergoing EVAR.
There are several factors that are known to influence the stability of the distal 
attachment sites. Perhaps unsurprisingly, there is some overlap with the risk factors for 
proximal migration. Stiffness of the stent-graft, curvature of the aorta, the diameter of the 
CIA, and the length of uncovered CIA have been all been reported as factors (Maleux et o/., 
1998, Resch et al., 2000, Ebaugh etal., 2002).
3.5 Migration of fenestrated stent-grafts
Fenestrated grafts incorporate the renal and other visceral arteries in the seal zone and 
therefore caudal migration of the proximal sealing stent could result in catastrophic visceral 
artery occlusion. The Zenith fenestrated graft (Cook Medical Inc, Bloomington, IN) is based 
on a composite body design and the fenestrated proximal component is tubular. The distal 
component incorporates the graft bifurcation where the largest forces act (Howell et al., 
2007) and this design is intended to minimise the risk of caudal migration of the proximal 
component. The bifurcated distal component, subjected to the longitudinal distraction force, 
may migrate caudally and adequate overlap is needed to allow for this potential distraction. 
The renal stents contribute to the stability of the proximal component and as previously
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stated, experimental data show a significant increase in the pullout force of a fenestrated 
graft compared to a standard device (Zhou et al., 2007).
Cases of fenestrated stent-graft migration have been identified within the literature 
(O'Neill et al., 2006a, Ziegler et al., 2007, Scurr et al., 2008a, Verhoeven et al., 2010, 
Greenberg et al., 2009a, Troisi et al., 2011). In these short and mid-term reports (Table 3.2) 
device migration was generally poorly defined and rates were based on cases resulting in 
clinical signs or requiring re-intervention (clinically significant migration). Migration of 
conventional (infrarenal) stent-grafts is often classified using the SVS/ICVS reporting 
standards as any movement >10 mm or that led to symptoms or required re-intervention 
(Chaikof et al., 2002a). This definition is likely to be insufficient for fenestrated stent-grafts 
where smaller movements have been associated with sequelae (Verhoeven etal., 2010).
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Table 3.2 Proximal migration rates for currently available fenestrated stent-grafts
Author(s) Year Device N
Follow-up,
months
Migration
definition
Migration
rate, %
Semmens et al., 2006 Zenith 58 16.8 ± 14.4 CS 3.4
O'Neill etai, 2006 Zenith 119 19 (0-42) > 4mm 0.8
Sun etai., 2006 Zenith 317 17.7 (0-46) NR NR
Ziegler et al., 2007 Zenith 63 14 (6-77) CS 3.2
Scurr etai., 2008 Zenith 45 24 (1-48) CS 2.2
Kristmundsson et al., 2009 Zenith 54 25 (12-32) CS 3.7
Greenberg et al., 2009 Zenith 30 24 (1-24) > 10 mm 3.3
Bicknell etai., 2009 Zenith 29 12 (9-14) NS NR
Haulon etai., 2010 Zenith 80 10 (1-38) NS NR
Amiot et al., 2010 Zenith 134 15 (2-53) NS NR
Verhoeven et al., 2010 Zenith 100 24 (1-87) CS 1
Trios! et al., 2011 Zenith 96 25 (1-94) CS 23.5+
Bungay etai, 2011 Anaconda 4 1 (1-6) NS NR
Tam by raj a etai., 2011 Zenith 29 17 (8-21) NS NR
GLOBALSTAR, BSET 2012 Zenith 318 11 (1-54) CS 12
Quinones-Baldrich et al., 2013 Ventana 31 15.6 > 10 mm 3.2
Guo etai., 2013 Zenith 19 6 (1-12) NS 0.0
Metcalfe et al., 2013 Zenith 42 8 (1-14) NS NR
NR - not recorded; NS - not stated; CS - clinically significant. ^ data contains both branched and 
fenestrated stent-grafts.
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3.6 Prevention and treatment of migration
Manufacturers have been aware of the need to oppose the drag force and a series of stent- 
graft design features are placed on the stent-graft to help maintain fixation. Such features 
include friction, barb or hook penetration (Figure 3.14), suprarenal attachment, columnar 
strength and arterial ingrowth (Li and Kleinstreuer, 2006).
Figure 3.14 Barbs (image a) are incorporated into proximal component of many stent-grafts in order 
provide additional fixation for the device. Differences between the angle of the barb and the bare 
suprarenal stent struts, when viewed on abdominal radiography (image b), can provide useful 
information regarding positional stability. A change in angle could provide an indication of impending 
migration as shows stress on the fixation system.
Most EVAR preoperative imaging protocols rely on contrast-enhanced CT angiography 
with three dimensional post-processing for sizing the endograft and planning the procedure. 
The resulting images are static and may not fully demonstrate the degree of aortic 
conformational changes during the cardiac cycle. With current high-speed CT scanners the 
time taken to scan the aneurysm neck is only a fraction of the cardiac cycle and, therefore, 
the images could be acquired during diastole (minimum diameter) or systole (maximum 
diameter), or somewhere in between. Following the work by van Herwaarden and 
colleagues there may be significant changes within the aortic neck during the cardiac cycle
63
which may lead to improper endograft sizing, with subsequent graft migration, intermittent 
type 1 endoleaks, and poor patient outcome (van Herwaarden etal., 2006). Herwaarden and 
colleagues continued to stress the need to consider the role of dynamic imaging tools in the 
assessment of preoperative aortic morphology and suggested that this could help in the 
assessment of migration.
Freedom from stent-graft migration will be aided by optimal implantation. Ultimately 
this depends on the stent-graft delivery system, experience of the operator and real-time 
image guidance. The attachments sites must be adequately profiled to allow maximum 
engagement of the endograft. Maximising iliac fixation length has been shown to increase 
the migration resistance of a stent-graft (Arko et al., 2005) and maximum coverage of the 
infrarenal aortic neck has been also shown to benefit migration resistance proximally (Cao et 
al., 2002). The profiling of landing zones for infrarenal stent-grafts typically involves cranial 
and oblique angulation proximally and caudal and oblique angulation at the iliac landing 
zones.
The management of migration can be conservative, endovascular or surgical and 
depends on many factors including the extent of migration, stent-graft device implanted, 
fitness of the patient and local skills available. Not all migration will produce clinical sequelae 
or require reintervention. A stent-graft may migrate caudally and then stabilise without 
falling into the aneurysm sac and subsequently losing its seal. Migration can, however, lead 
to a seal failure and endoleak and would require secondary intervention. Using data from 
the EUROSTAR registry Hobo et al. (2006) reported that approximately 1.5% of patients will 
require a secondary procedure as a result of stent-graft migration (Hobo and Buth, 2006).
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Data from the more recent UK EVAR trial supports these figures, in this RCT 2.3% of patients
required a secondary interventional procedure as a result of migration (Brown et a!., 2007).
The endovascular management of proximal migration usually involves the insertion of 
a proximal cuff extension. If an endograft without barbs has migrated then it is logical to 
extend proximally with a cuff that has a greater pullout force by incorporating barbs. 
Proximal extension using a fenestrated cuff may be required if there is an inadequate seal 
zone in the infrarenal segment. Although fenestrated endografts are now widely used, it 
must be remembered that working within the confines of a pre-existing stent-graft makes 
the deployment of a cuff extension difficult. This is largely because of the risk of not having 
sufficient rotational control of the fenestrated graft which is required to safely position the 
fenestrations in relation to the target vessels.
A variety of endostaples and endoanchors have been designed to replicate the 
function of an interrupted aortic suture in maintaining device stability (Deaton, 2012). These 
devices are still in their infancy and can be deployed during the primary procedure or as a 
secondary response to treat migration (Perdikides et al., 2012). A more invasive treatment of 
laparoscopic aortic banding has also been suggested as a treatment for preventing vessel 
dilatation and stent-graft detachment from the aortic wall (Sonesson et al., 2001). 
Migration leading to device failure may also be managed with more aggressive open surgical 
conversion (Brinster et al., 2011). Mortality for open conversion remains high (Kelso et al., 
2009) and as a result there are early reports of a less invasive laparoscopic surgical 
conversion with removal of the original endograft (Lin et al., 2005).
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Cranial migration at the iiiac attachment sites can be managed by extension with 
another endovascular graft either to the lower common iliac artery, if there is a suitable 
landing zone or by graft extension to the external iliac. There have been cases of complex 
iliac limb migration which required an open conversion (Maleux et a!., 2001).
It is not uncommon to see a very small amount of caudal migration of the Zenith graft 
due to engagement of the downward pointing barbs. The migration distance required for this 
engagement to occur is typically 3-5mm. The barbs should remain downward pointing after 
engagement and the fixation force at this point should be much higher. If a graft without 
barbs migrates then it is possible that the distraction force has exceeded a constant fixation 
force and the level of concern should be higher in this circumstance. Review of the original 
infrarenal neck anatomy will sometimes indicate that the stent-graft has settled into a more 
stable position in a neck that has varying calibre. If there has been minor migration, some 
clinicians may elect to manage these conservatively. They may opt to increase the frequency 
of surveillance to 6-monthly review, at this point either the endograft will be shown to have 
moved into a new stable position or intervention will be mandated because of progressive 
migration.
3.7 Chapter 3 - summary
Any stent-graft deployed in the aorta faces a constant displacement or drag force (Liffman et 
ai, 2001, Mohan et al.t 2002, Morris et ai, 2004). Failure of the device to oppose this drag 
force will result in stent-graft migration {Zhou et ai., 2007). For fenestrated stent-grafts 
migration could result in distortion of the visceral artery stent and consequent loss of vessel 
patency. This may be in addition to the other serious consequences of migration e.g.
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proximal type 1 endoleak or iliac limb occlusion. For a fenestrated stent-graft inclusion of
target vessel stents should theoretically reduce the risk of proximal migration (Scurr et ai, 
2008b, Zhou eta/., 2007). Despite this, migration of fenestrated aortic stent-grafts has been 
reported.
As with any conventional stent-graft, migration of a fenestrated device may be an 
early or late occurring complication and may or may not necessitate a secondary 
intervention. There is an absence of data on the incidence, timings and related sequelae for 
fenestrated stent-graft migration within the literature. Additionally, as with all aortic stent- 
grafts, migration of fenestrated stent-grafts can occur at both the proximal and distal landing 
zones and specifically there is an absence of data on the frequency of iliac limb migration. 
The cause for migration is likely to be multifactorial. Identification of any risk factors is 
important as this may provide guidance on patient selection, stent-graft configuration and 
follow-up strategies.
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4. A study into the accuracy of CT central luminal line
measurements in the quantification of stent-graft migration.
4.1 Introduction
Imaging modality, measurement techniques and the experience of the observer can affect 
the ability to identify small changes in stent-graft position following implantation. Multi­
detector computed tomography, when undertaken to an appropriate protocol, is considered 
a reasonable method for assessing stent-graft migration (Greenberg et al.f 2004b, O'Neill et 
a!., 2006b). There is, however, a wide range (0 to 20%) in the reported incidence of infrarenal 
stent-graft migration when assessed using CT (England et al., 2004, Cao et al., 2002, Conners 
et al., 2002, Criado et al., 2003, Sternbergh et al., 2004, Tonnessen et al., 2005). One possible 
explanation for this variability is the range in the assessment methods used. Historically, 
migration was assessed using axial CT images mounted on an X-ray viewing box. 
Improvements in CT and workstation technology subsequently allowed the quantification of 
stent-graft position using multiplanar reformatted (MPR) images directly displayed on a 
computer workstation. The assessment of stent-graft migration is difficult using either 
technique. The main reason for this is the difficulties in performing length measurements 
along tortuous vessels, which commonly run along the z-axis of the patient (e.g. abdominal 
aorta and iliac arteries). These limitations are well acknowledged within the literature and 
are dependent on both the measurement technique and the quality of the CT data (Ota et 
ai, 2005, Rengier etai, 2009).
In the thoracic aorta, outlining the exact position of the stent-graft using a computer
generated line drawn through the centre of the aortic lumen (CLL) has been proposed as a
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valid method for assessing stent-graft migration (O'Neill et al., 2006b). Around the time of
O'Neills report there was a step change in availability of CT technology, MDCT scanners were 
widely available and examinations commonly consisted of thin-slice CT datasets with 
excellent contrast enhancement of the arterial tree. From around 2001 onwards it was 
possible to scan the entire length of aorta, within a single breath hold, and with optimal 
arterial enhancement whilst maintaining a near isotropic resolution. Using these datasets, 
techniques had become available which allowed precise measurements along the length of a 
vessel even in the presence of severe vessel tortuosity or angulation. O'Neill and colleagues 
(2006) successfully utilised these newer techniques (CLLs) to perform accurate 
measurements of stent-graft migration in the thoracic aorta. However, no such validation 
has been made for CLLs used in the abdominal aorta. It should be feasible to monitor 
changes in abdominal stent-graft position in a similar manner to that reported by O'Neill et 
al., (2006). If a CLL measurement technique is to be used in the abdominal aorta, then it is 
essential to generate robust evidence on the accuracy of the technique in quantifying stent- 
graft migration.
4.1.1 Aims
The purpose of this chapter is to evaluate the accuracy of the CT CLL measurement technique
in quantifying stent-graft migration. It is exceptionally difficult to quantify the absolute in
vivo position of an aortic stent-graft and measure any changes (migration) over time. Direct
visual access to the intraluminal aorta is invasive and not practical, for this reason medical
imaging examinations have been used as a surrogate for identifying aortic stent-graft
position. The true position of a stent-graft cannot be known and only estimated using a
clinical test. To address this limitation migration was simulated in a series of aortic phantoms
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in order to provide a range of known migrations. Each simulation was subject to a series of 
CT scans (before and after migration), so that the CLL assessment technique could then be 
tested using a group of observers. This initial phase of the experiment provided information 
on both the reliability and reproducibility of the CT CLL measurements. There are obvious 
differences between CT datasets acquired using aortic phantoms and those from patients. 
The second phase of this experiment was to evaluate the CT CLL technique using clinical CT 
scans from patients with aortic stent-grafts implanted. The following aims were met in this 
chapter:-
Aim 4.1. Quantify the bias (or systematic deviation from the true migration value) for 
the CT CLL technique when measuring stent-graft migration simulated in 
phantoms.
Aim 4.2. Report the intra- (within an observer) and inter-observer (between observers) 
variability for stent-graft migration measurements obtained using a CT CLL 
technique, from a series of cases of simulated migration using aortic 
phantoms.
Aim 4.3. Report the intra- (within an observer) and inter-observer (between observers) 
variability for stent-graft migration measurements obtained using a CT CLL 
technique using serial CT data, from a series of patients with aortic stent-grafts 
implanted.
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4.2 Materials and Method
4.2.1 Phantom study
A hollow plastic aortic phantom was created from acrylonitrile butadiene styrene using a 
stereolithography rapid prototyping system. Stereolithography is a system whereby an 
ultraviolet laser beam is used to selectively polymerise and solidify a photosensitive 
polymeric plastic liquid. Such a system has been used previously in the creation of aortic 
phantoms for image analysis (Canstein et ol., 2008). The phantom consisted of a hollow 
aortic neck and two patent side-branches representing the superior mesenteric artery (SMA) 
and right renal artery (RRA) (Figure 4.1).
Figure 4.1 A 3D computer-aided design (CAD) image of the aortic neck phantom used in the validation
of the CT CLL migration measurement technique
A stent-graft either a Zenith (Cook Inc, Bloomington, IN) or a Talent (Medtronic, 
Santa Rosa, CA) was deployed inside the phantom at a measured distance from each of the
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two aortic side-branches. The exact position of the stent-graft was determined by using a
small internal ruler (one millimetre major divisions) and by measuring from the apex of one 
of the wireforms of the bare suprarenal stent relative to the two side-branches. The 
deployment position was verified once in the anterior, posterior and left and right lateral 
positions in order to exclude any stent-graft tilt. The phantom was then filled with iodinated 
contrast medium mixed with gelatine. In order to accurately simulate the density of blood 
during arterial phase CT angiography, the precise concentration of contrast medium within 
the gelatine solution was determined. This information had been previously acquired by 
experimental work (Oshin, 2009). The iodine-gelatine mix contained 2% w/v Visipaque 
240mgl/mL (GE Healthcare, Cork, Ireland) and generated a mean aortic enhancement of 280 
HU. Aortic enhancement of between 250HU and 320HU has been previously reported within 
the literature as clinical acceptable for CT angiography examinations (Fischbach et al., 1999). 
The gelatine was chilled, allowed to set and the phantom was then suspended in a Perspex 
box containing water. The phantom was then subjected to a MDCT scan which was 
performed according to a standard clinical EVAR follow-up protocol (Table 4.1). The 
resultant Digital Imaging and Communications in Medicine (DICOM) imaging data were then 
sent to a departmental Picture Archiving and Communication System (PACS). Solidified 
gelatine was then carefully removed from the phantom using warm water and the position of 
the stent-graft was re-measured and recorded. There were no differences in the pre- and 
post-gelatine positions of the stent-graft for any of the phantoms. The stent-graft was then 
displaced downward by traction of the ipsilateral limb with a pair of forceps; the new 
position was then measured and recorded. The phantom was again filled with the iodine- 
gelatine mix, subjected to a second CT scan and then the gelatine removed and the stent-
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graft position re-verified. This created a single case of simulated stent-graft migration; the
procedure was repeated in order to generate a range (n=15) of known but variable stent- 
graft migrations using a combination of Zenith (n=7) and Talent (n=8) stent-grafts. The 
Zenith (Cook Medical Inc, Bloomington, IN) and Talent (Medtronic, Santa Rosa, CA) aortic 
stent-grafts were specifically chosen since at the time of the experiment they were the two 
most commonly used aortic stent-grafts (Brown et ai, 2007). An additional advantage of 
using the Zenith and Talent devices is that they are different in construction. The Zenith is 
manufactured from stainless steel and the Talent from a nickel titanium alloy (Nitinol). With 
differences in construction and materials there are likely to be some differences in the 
visibility of the devices when using CT.
Table 4.1 CT scan protocol used to generate the phantom CT datasets
Scanner Siemens Sensation 16
kV 120
Effective mAs 200
Rotation time (sec) 0.5
Detector collimation (mm) 16x0.75
Slice thickness (mm) 2.0
Feed/rotation (mm) 24.0
Reconstruction interval (mm) 1.0
Reconstruction Kernel B30f medium smooth
Field of view (cm) 38.0
Scan direction Craniocaudal
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4.2.2 Clinical study
Following the phantom study a retrospective review of clinical follow-up CT scans was 
undertaken. A list of patients from a local hospital, who had been treated by EVAR, were 
made available. Patients were eligible for inclusion if they had a Zenith aortic stent-graft 
implantation and a baseline (l-month) and a further follow-up CT scan available (> 6 months 
from the implantation procedure). In the event that several follow-up scans were available 
then the latest CT scan was used (minimum 6 months post-repair). Patients must have been 
scanned to a standard follow-up protocol (Table 4.2) which was also consistent with the 
technique described previously in the phantom experiment. For all included studies 
acquisition followed an intravenous injection of 100 ml ioversoi (Optiray 300, Mallinckrodt, 
Hazelwood, MO) at 5mL/s. Scanning was commenced when the aortic enhancement 
exceeded 120 HU; this was determined by the in-built bolus tracking function on the CT 
scanner. Out of the available cohort nine patients were selected at random. Both the 
number of patients and landing zones assessed were determined by the reading time 
available for the observers. Each observer was able to commit two half day sessions in order 
to complete the image analysis. Ethics committee approval was granted (07/Q1502/43) and 
this allowed the CLL migration measurement technique to be validated using clinical data.
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Table 4.2 CT scan protocol used to generate the clinical follow-up CT datasets
Scanner Siemens Sensation 16
kV 120
Effective mAs 200
Rotation time (sec) 0.5
Detector collimation (mm) 16 x 0.75
Slice thickness (mm) 2.0
Feed/rotation (mm) 24.0
Reconstruction interval (mm) 1.0
Reconstruction Kernel B30f medium smooth
Field of view (cm) 38.0
Scan direction Craniocaudal
Patient position Supine
Oral contrast No
Intravenous contrast 100 mL Optiray 300
4.2,3 Three-dimensional imaging software
Phantom and clinical CT data were loaded on to a departmental PACS workstation (Kodak 
Carestream PACS, 10.2, Kodak, Rochester, NY) which had an in-built vessel analysis module. 
Each individual CT scan was loaded on to the workstation and an observer created a semi­
automatic CLL through the aorta. This was done by using the semi-automated centreline 
algorithms on the workstation. The CLL was then checked by scrolling through the axial,
coronal and sagittal reformats to ensure that it travelled through the centre of the arterial
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lumen. Oblique axial reconstructions perpendicular to the CLL were displayed in a two 
dimensional format from which the position of the stent-graft against a reference vessel 
could be determined.
4.2.4 Measurement protocol
Phantom dataset
A team of three observers independently used CLLs to calculate the stent-graft migration on 
each of the 15 cases of simulated migration. All observers had previous experience in pre- 
and post-EVAR CT image post-processing and measurements. Workstation training and clear 
instructions including measurement definitions and pictorial examples were provided in 
order to explain the CLL construction process and measurement technique. Using the CT 
scans obtained using aortic phantoms, the distance between the proximal portion of the 
stent-graft (first oblique axial CLL reformatted image with two stent struts visible) and the 
inferior border of each of the reference vessels (Li - superior mesenteric artery; L2 - right 
renal artery) were recorded using the CLL image (Figure 4.2). The first oblique axial CLL 
reformat which contained a minimum of two visible stent struts was used to help define the 
proximal margin of the stent since this helped reduce the risk of selecting calcification over 
actual stent-graft. The first oblique axial CLL reformat which demonstrated clear separation 
of the reference vessel (Li or L2) from aortic wall was used to define the inferior border of 
each reference vessel. Stent-graft migration was then calculated by subtracting the proximal 
stent-graft to reference vessel position on the 1st CT scan from the same measurement on 
the 2nd CT scan. All CLL measurements were repeated on two separate occasions by each of 
the three observers in order to assess intra-observer variability.
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Figure 4.2 CLL images with corresponding oblique axial reformats demonstrating the technique used
to record stent-graft position against the superior mesenteric artery (LJ and right renal artery (LjJ. 
The two lines perpendicular to the CLL correspond to the centre of the reformatted images used to 
confirm the locations for the two measurement positions
Clinical study
Using the clinical CT scans, evaluation of the proximal and distal landing zones were 
undertaken in seven and nine patients, respectively. The proximal native vasculature 
reference point was the superior mesenteric artery (SMA). The distance between the inferior 
border of the SMA and the first appearance of the stent-graft (two struts) was measured. 
The inferior border of the SMA was defined as the first oblique axial CLL reformatted image 
where there is clear separation of the SMA from the aortic wall (Figure 4.3A).
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Figure 4.3 A clinical CLL measurement taken at the proximal landing zone of the stent-graft (Image A). 
The first axial reformatted image, where at least two stents struts were visible (dotted line), was 
considered indicative of the proximal stent position. The first reformatted slice where there was a 
clear space between the superior mesenteric artery (SMA) and the aortic wall was considered the 
inferior border of the reference vessel (solid line). Image B illustrates a clinical CLL measurement 
taken at the distal landing zone of the stent-graft. The position of the distal stent-graft is recorded 
relative to the bifurcation of the CIA. The first reformatted slice where there was a clear space 
between the EIA and the IIA was considered as the iliac bifurcation (solid line). For all CLLs lines drawn 
perpendicular to the central flow channel demonstrate the projection of each oblique reformat and 
indicates the central point within each reconstructed slice
The iliac bifurcation was used as the distal reference point for the assessment of iliac 
limb migration. The iliac bifurcation was defined as the oblique axial CLL reformatted image 
which first displayed clear separation of the external and internal iliac arteries (Figure 4.3B). 
Length measurements were obtained using the CLL from the proximal stent-graft to the SMA 
and from the distal stent-graft to the iliac bifurcation bilaterally using the 1st post-operative 
CT scan. Each CLL measurement was then compared with the same measurement on the
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latest available CT scan. Measurement differences between the two CT scans, for the same 
anatomical location, would suggest stent-graft migration. All clinical measurements were 
performed independently by two experienced observers in order to test inter-observer 
variability. To test intra-observer variability repeat measurements by the same observer 
were obtained at a different time point (a minimum of one month apart). Any caudal 
migration of the stent-graft was indicated by a plus sign e.g. +5.1 mm and movement in a 
cranial direction was indicated using a minus sign e.g. -5.1 mm. Throughout the study CT 
workstation measurements were recorded using electronic callipers to one tenth of a 
millimetre.
4.2.5 Statistical analysis
The first aim of this chapter is to assess the accuracy (bias) of the CT CLL technique in 
quantifying migration (Aim 4.1). For the phantom study, the difference between the CT CLL 
migration estimate and the actual (true) migration was calculated for each of the simulated 
migrations. The mean of the differences and the corresponding 95% limits of agreement 
were obtained as described in Bland and Altman (1999).
The following calculations can be applied to both the Li and L2 migration reference 
vessels. Let us denote da. as the true migration and di as the CT migration measurement for
each phantom simulation i where i — 1,.....n. The mean difference (x) can then be
expressed as:
n
where
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xi dai
and where n is the number of phantom migration simulations (n = 15). The standard 
deviation of the migration difference is calculated using:
N n
Under the assumption that the differences (d* — da.) are normally distributed, then 
it is expected that 95% of the differences would lie within the interval:
(x — 1.96sd(pc), x + 1.96sd(x)) (1)
whose lower and upper bound are defined as the 95% limits of agreement.
Agreement between the CT technique and the actual stent-graft migration can be 
presented graphically by using the method described by Bland and Altman (1999). For each 
case of simulated migration the difference between the actual migration da. and the CT 
migration estimate dt is plotted against the mean of the two values (dj — da.)/2. This plot is 
useful in that it shows any extreme or outlying observation; inferences can be made as to 
whether the differences have a relationship against the mean (i.e. whether the mean 
difference is greater for large migration distances than smaller).
Furthermore, the precision of the bias estimates can be assessed by calculating the 
standard errors and confidence intervals. Under the assumption that the data are 
independent and normally distributed, the variance of x can be estimated using sd(x)/n) 
where n is the sample size. The variance of the bias can then be approximated by (see Bland
& Altman, 1999):-
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Var((x) + 1.96sd(x)) = 1.712^^-
Therefore, the standard error for x ± l,96sd(x) is = 1.71SE(x), where
1.71SE(x) is the standard error of the mean difference. In turn, the 95% confidence intervals 
can be calculated by finding the t distribution with n = 1 degrees of freedom. The 
confidence intervals will therefore, be t standard errors either side of the observer value (See 
Bland & Altman, 1999).
A similar method was also used to assess variability for intra- and inter-observer 
measurements for both the aortic phantoms and the clinical CT scans (Aims 4.2 and 4.3). To 
assess intra-observer variability. Bland and Altman (1999) proposed a similar analysis method 
to the limits of agreement approach. Repeat migration measurements for the same rater, on 
different occasions, were obtained. For the phantom study one rater (Rater A) undertook CT 
migration measurements on each of the 15 simulated cases of migration (phantoms) on 
three separate occasions(dl£, tf3.). The mean difference for the paired CT migration 
estimates by the same observer is obtained in the following way:-
As mentioned above, the phantom study involves 3 repeated measurements of each 
of the 15 simulated cases of migration by each observer. Let us denote dli as the CT 
estimated of migration for measurement set one and d2l and rf3.for measurement sets 2 and 
3, respectively, for one observer. Each of the phantom migration simulations is denoted by i
where i = 1,.....n. For example, the mean intra-observer difference (pc) for migration
based on sets 1 and 2 can then be expressed as:
xi = ~ ^2£
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X =
•=1 Xi
n
Where n is the number of phantom migration simulations (n = 15). The standard deviation 
of the difference can then be calculated using:
sd(x) =
Under the assumption that the differences — d2i) are normally distributed, then 
it is expected that 95% of the differences would lie within the interval described by Equation 
(1). Variability between paired measurements undertaken by the same observer can be 
presented graphically, using the method described by Bland and Altman (1999). The first 
paired measurement d1. and the second d2l are plotted against the mean of the two values 
(dli —d2i)/2. This plot is useful in that it shows any extreme or outlying observation; 
inferences can be made as to whether the differences have a relationship against the mean 
(i.e. whether the mean difference is greater for large migration distances than smaller). 
Confidence intervals for the population mean difference can be described as in Equation (1).
The within-observer standard deviation for CT migration assessments using the 
phantom data based on the 3 sets of measurements can be estimated from the square root 
of the residual mean square. In turn this standard deviation can be used to calculate the 
limits in which we expect the differences by the same rater to lie. Ideally, the differences 
between two repeat measurements by the same rater are expected to equal zero. The 
repeatability coefficient (RC) has been defined by the British Standards Institute as the value
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below which the difference between paired measurements will lie with a probability of 0.95 
(British Standards Institute, 1979). For each rater this can be calculated as follows:-
= 196x pli(rfz, - ril,)2 + (rf3l - dlt)2 + (d3i - d2lf 
aJ n — 1
Repeatability coefficients have been calculated for the within-observer variability in 
both the phantom and clinical element of this chapter. The RC, was further defined by Bland 
and Altman (1983) and is based on the one-way analysis of variance with the observer as the 
factor and provides a measure of the precision that represents the value below which the 
absolute difference between the two repeat measurements by the same observer is 
expected to lie with a 95% probability after extracting biological variability.
The reproducibility of migration measurements between different raters (inter­
observer variability) is also of importance (Aims 4.2 and 4.3). Whilst a repeat measurement 
by the same rater could show a high repeatability, measurements obtained using direct 
observations of anatomical landmarks may show variability between raters. For novices this 
may represent a lack of experience if the measurements were compared to more 
experienced raters. Such variability differences between raters can be assessed using the 
95% limits of agreement method previously described. For the phantom migration 
simulations paired observations exist for raters A, B and C. If just the first measurement set 
for each observer (d) is considered then the mean difference for rater A vs B can be 
calculated following a similar procedures as described earlier.
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Let us denote dA as the CT assessed migration value for rater A and dB as the CT 
migration measurement for rater B, i is each of the phantom migration simulations where 
i ~ 1,..... n. The mean difference Qe) can then be expressed as:
%i d-Ai
X =
n
Where n is the number of phantom migration simulations (n = 15). The standard 
deviation of the migration difference between raters A and B is calculated using:
sd(X) =
Y.f=1((dA[-dBi)-x)2
N 71
Under the assumption that the differences (dA — dB) are normally distributed, then 
it is expected that 95% of the differences would lie within the interval described by Equation 
(1).
The agreement between the two raters (A and B) can be presented graphically by 
using the method described by Bland and Altman (1999). For each case of simulated 
migration the difference between the CT migration for rate A dAi and the CT migration 
estimate for rater B, dB. is plotted against the mean of the two values (d^. — dB.)/2. This 
plot is useful in that it shows any extreme or outlying observation; inferences can be made as 
to whether the differences have a relationship against the mean (i.e. whether the mean 
difference is greater for large migration distances than smaller). The differences for Rater A 
vs C can be calculated in a similar manner and also for assessments using the L2 reference
point. Confidence intervals for the population mean difference can be described as in
84
Equation (1). All analyses described were undertaken using IBM SPSS Statistics for Windows, 
Version 21.0 (IBM Corp, Armonk, NY).
4.3 Results
4.3.1 Migration in aortic phantoms
The mean overall simulated migration was +20.0 (SD, 11.9; range, +2.0 to +39.0) mm (Table 
4.3).
Table 4.3 A description of the cases of 
simulated migration in the aortic phantoms
Simulated Actual Migration, mm
Case (da)
1 14
2 35
3 39
4 20
5 2
6 21
7 25
8 6
9 12
10 4
11 15
12 33
13 19
14 37
15 18
Mean 20
SD 11.9
Minimum 2
Maximum 39
For observer A (measurement set 1), the mean difference between the actual (simulated) 
migrations and the CLL calculated migrations (bias estimate) was +0.4 mm (95% limits of 
agreement -2.5 mm to +3.3 mm). The estimate of bias was therefore small with a 95%
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confidence interval of -0.5 to +1.2 mm. This indicates that the bias of the CLL technique is
different from zero although small, and that the range of possibilities is narrow. Similar 
accuracy was found for observers B and C where the mean difference (together with the 95% 
limits of agreement) were 0.0 mm (-2.8 mm to +2.8 mm) and -0.3 mm (-3.6 mm to +3.0 mm) 
respectively (Figure 4.4). The confidence interval for the mean difference in these two cases 
were within the interval (-1.3 mm, +0.8 mm). A full description of the parameters used to 
report the bias are provided in Table 4.4.
Table 4.4 Bias of the CT CLL migration measurement
technique assessed using phantom simulations
Bias
Obs. A Obs. B Obs. C
n 15 15 15
Mean 0.4 0.0 -0.3
Standard deviation 1.5 1.4 1.7
Standard error 0.4 0.4 0.4
Mean, 95% Cl Lower
-0.5 -0.8 -1.3
Upper 1.2 0.8 0.6
95% LoA Lower
-2.5 -2.8 -3.6
Upper 3.3 2.8 3.0
Lower LoA, Lower -3.3 -3.6 -4.4
95% Cl Upper -1.7 -2.0 -2.7
Upper LoA, Lower 2.4 2.0 2.1
95% Cl Upper 4.1 3.6 3.9
LoA, limits of agreement. Cl, confidence interval. Obs,
observer. All distances are in millimetres, n, number of
cases.
The mean paired differences between repeated measurements by the same observer 
were evaluated on three separate occasions. Mean differences for each of the three 
observers (measurement set 1 vs set 2) ranged from -0.5 mm to +0.5 mm (95% limits of 
agreement ranged from -2.1 mm to +2.1 mm). Intra-observer variability was highest for 
observer A (Table 4.7 and Figure 4.5) and the overall repeatability coefficient (RC) for within-
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subject paired measurements (all three measurement sets) was +3.2 mm. Inter-observer 
variability was assessed by calculating the mean paired difference in migration estimates 
between the two observers (for measurement set 1). The mean paired difference ranged 
from +0.5 mm to +0.8 mm (95% limits of agreement ranged from -2.4 mm to + 3.3 mm)(Table 
4.7 and Figure 4.7).
Based on this data sample, both the accuracy and variability of the CLL migration 
measurements did not appear to be influenced by the magnitude of migration.
Table 4.5 Intra-observer variability data generated from 
assessment of the CTphantom data
Intra-observer variability 
Obs. A Obs. B Obs. C
n 15 15 15
Mean -0.5 0.1 0.5
Standard deviation 0.8 0.4 0.8
Standard error 0.2 0.10 0.2
Lower
Mean, 95% Cl ,, -0.9 -0.1 0.1
Upper 0.0 0.4 1.0
95% LoA ^Wer -2.1 -0.7 -1.0
Upper 1.2 0.9 2.1
Repeatability coefficient (RC) 3.2 1.1 1.6
LoA, limits of agreement. Cl, confidence interval, 
distances are in millimetres, n, number of cases.
Obs, observer. All
Table 4.6 Inter-observer variability data generated from assessment of 
the CT phantom data
Inter-observer variability
Obs. A vs Obs. B Obs. A v Obs. C
n 15 15
Mean 0.5 0.8
Standard deviation 1.5 1.3
Standard error 0.4 0.3
.. nr.n/ Lower
Mean, 95% C -0.3 0.1
Upper 1.3 1.5
95% LoA L°Wer -2.4 -1.7
Upper 3.3 3.3
LoA, limits of agreement. Cl, confidence interval, 
distances are in millimetres, n, number of cases.
Obs, observer. All
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Figure 4.4 Bland Altman plots displaying the bias (Observers A, B & C) for the CLL assessment of
stent-graft migration in aortic phantoms
Observer A - Bias Observer B • Bias
Mean-1 96SO
Observer C • Bias
The CLL bias for each observer was determined by calculating the difference between the actual stent-graft 
migration and the CT determined stent-graft migration using measurement set 1. Limits of agreement 
(mean±1.96 standard deviations) (outer solid lines).
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Figure 4.5 Bland Altman plots displaying the intra-observer variability for the CLL assessment of stent-graft
migration in aortic phantoms
Wr» •fc<«rv»r variability faf Otoaarvar A Intra-observer variability for Observer B
____ ft.
1 9tSO
Intra-observer variability for Observer C
Intra-observer variability refers to the differences between repeat measurements of migration by the same 
observer (Observers A, B & C). The difference between the paired measurements has been plotted against the 
mean of the paired measurements for each observer (measurement set 1 vs 2). For simplicity, the migration 
values illustrated are based on average values of /.j and L2. Limits of agreement (mean±1.96 standard 
deviations) (outer solid lines).
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Figure 4.6 Bland Altman plots displaying the inter-observer variability for the CLL assessment of stent-graft 
migration in aortic phantoms
lnt»r-ob«»rY»r variability for Obaarvar A vs B Intar-obaarvar variability for Obaarvar A va C
Mean-1 96SO
Inter-observer variability for Observer B vs C
Mean *1 96SO
Mean - I 96SO
Inter-observer variability refers to the differences in migration measurements between observers. The difference 
between paired measurements for Observer A and Observer B, Observers A and C and Observers B and C are 
plotted against the mean of the two measurements rom set 1. For inter-observer variability all calculations were 
based on measurement set 1 for each observer. For simplicity, the migration values illustrated are based on 
average values of Lx and L2. Limits of agreement (mean±1.96 standard deviations) (outer solid lines).
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4.3.2 Clinical stent-graft migration
Clinically, the CLL technique was used to assess changes in stent-graft position in nine 
patients (median follow-up 37 months, range 24 to 39 months). Migration assessment 
required the evaluation of 18 follow-up CT scans; this allowed the CLL measurement 
variability to be assessed in seven proximal and nine distal landing zones. Based on the 
judgement by observer A (measurement set 1), the mean proximal and distal migration 
distance in the cohort was + 4.0 (SD, 3.5; range, 0.0 to +11.0) mm and -1.0 mm (SD, 2.4; 
range, -3.0 mm to +4.0 mm) respectively. When investigating stent-graft migration in 
patients all (100%) of the paired differences, both between and within observers, were 
within 4 mm or less of each other. Intra-observer variability was similar to the phantom 
experiment, mean paired difference between repeat measurements was +0.8 mm (95% 
limits of agreement -2.1 mm to +3.7 mm) at the proximal margins and -0.3 mm (95% limits of 
agreement -3.0 mm to +2.5 mm) at the distal margins (Tables 4.8 & 4.10; Figure 4.6). The 
repeatability coefficient for within-subject measurements was 2.9 mm for proximal 
measurements and 3.3 mm for distal. Inter-observer variability was again similar with mean 
paired differences proximaily and distally +0.2 (95% limits of agreement -3.4 mm to +3.8 mm) 
and +0.2 mm (95% limits of agreement -3.7 mm to +4.0 mm) respectively (Tables 4.9 &. 4.10; 
Figure 4.6). With visual inspection of the Bland-Altman plots (Figure 4.6) there was no 
apparent association between the magnitude of stent-graft migrations and measurement 
variability.
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Table 4.8 Intra-observer variability for the assessment of the clinical stent-
graft migration
Proximal Distal
Obs. A Obs. B Obs. A Obs. B
n 7 7 9 9
Mean 0.8 0.4 -0.3 0.3
Standard deviation 1.5 1.7 1.4 1.7
Standard error 0.6 0.6 0.5 0.6
Lower
Mean, 95% Cl
-0.6 -1.2 -1.4 -1.1
Upper 2.2 1.9 0.9 1.6
„ Lower
95% LoA
-2.1 -2.9 -3.0 -3.1
Upper 3.7 3.6 2.5 3.6
Repeatability coefficient (RC) 2.9 3.3 2.8 3.3
LoA, limits of agreement, 
distances are in millimetres.
Cl, confidence interval, 
n, number of cases.
Obs, observer. All
Table 4.9 Inter-observer variability for the assessment of clinical 
stent-graft migration
Inter-observer variability
Proximal Distal
n 7 9
Mean 0.2 0.2
Standard deviation 1.8 2.0
Standard error 0.6 0.7
LowerMean, 95% Cl -1.3 -1.4
Upper 1.7 1.8
nc-o/r a Lower95% LoA -3.4 -3.7
Upper 3.8 4.0
LoA, limits of agreement. Cl, confidence interval, 
millimetres, n, number of cases.
All distances are in
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Table 4.10 Intra- and inter-observer variability for the clinical CLL assessment of stent-graft migration
Variable Intra-observer variability Inter-observer variability (Obs. A vs Obs. B)
Lower Mean difference Upper Lower Mean difference Upper
limit (%)* limit limit (%)* limit
Proximal: +4.0 [-
0.1 to +10.6]
-2.1 +0.8 (+20.0%) +3.7 -3.4 +0.2 (+5.0%) +3.8
Distal: -0.6 [-4.4 to
+4.0]
-3.0 -0.3 (-50.0%) +2.5 -3.7 +0.2 (-33.3%) +4.0
Average: +1.4 [-4.4
to +10.6]
-2.6 -0.6 (42.9%) +3.1 -3.5 +0.2 (+14.3%) +3.9
Migration distances are in mm. Variable values refer to the mean value of the 1st measurement of observer A
[range]. The upper and lower limits represent the limits of agreement (+1.96 standard deviations from the
mean difference). *Mean difference expressed as a percentage of the mean value for that variable. Intra
observer variability refers to the differences between repeat measurements for observer A. Inter observer
variability refers to the differences between the 1st measurements of observer A and observer B.
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Figure 4.7 Blond Altman plots displaying the CLL variability, intra-observer (Observer A) and inter­
observer (Observer A vs B)for the assessment of stent-graft migration when using clinical CT scans
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Intra-observer variability refers to the differences between repeat measurements of stent-graft migration for the 
same observer (within observer). Inter-observer variability refers to the differences between migration 
measurements (measurement sets 1) for observer A when compared to observer B (between observers). For 
both intra- and inter-observer the differences have been plotted against the respective mean of the two 
comparative measurements. Limits of agreement (mean±1.96 standard deviations) have also been plotted in 
order to delineated the extremes of any variability (outer solid lines). The migration values illustrated are based 
on average values of both proximal and distal migrations.
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4.4 Discussion
Movement of any aortic stent-graft can have disastrous consequences. Identifying and 
addressing late device failures before they translate into clinical sequelae may reduce 
morbidity and mortality. Traditionally, changes in aortic stent-graft position have been 
assessed by direct review of thick-slice axial CT images. Crude changes in the position of the 
stent-graft on serial axial CT images were considered indicative of stent-graft migration and 
may have only been found following during a retrospective review for a related sequela. 
Improvements in both CT scanner and workstation technology allowed the analysis of stent- 
graft migration to move forward. Serial MPRs not only allowed the position of the stent-graft 
to be tracked relative to a fixed landmark but also provided a numerical indication of the 
magnitude of any displacement. MPRs have led to a more accurate indicator of positional 
changes but are problematic when attempting to profile tortuous vessels, especially the iliac 
arteries. Over recent years there was further advancement in imaging technology (O'Neill et 
al., 2006b, Lumsden et al., 2011, Clough and Taylor, 2013). Modern MDCT now routinely 
allows for thin-slice {<2mm) CT acquisitions, achievable within a single breath-hold and with 
optimum arterial enhancement. Software developments in workstations have provided new 
opportunities for the three-dimensional analysis of each severe vessel tortuosity. Even with 
these improvements, there has still been a lack of a validated method for assessing stent- 
graft migration.
In this chapter a CLL technique was successfully validated under laboratory and
clinical conditions for the quantification of abdominal stent-graft migration. The assessment
of migration requires the computer-based construction of a CLL together with judgements by
the reader on the position of the stent-graft and aortic references points. Using a CLL to
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assess stent-graft migration appears to overcome many of the limitations of the traditional 
assessment techniques (direct axial and MPR review). In validating CLLs, firstly the 
performance of CLLs was assessed in detecting stent-graft migration in a series of aortic 
phantoms. The validation experiment established that the bias of the CLL technique is small 
and insignificant from a practical perspective, with a worst case being over or 
underestimation of migration by up to 4.0 mm. Observer variability in the phantom 
experiment was low, limits of agreement are also within 4.0 mm, with all of the within- 
observer and between-observer paired measurement differences being < 4 mm. On the 
basis of the phantom experiment, it can be proposed that migration > 4mm, established from 
CLL calculations is representative of true in vivo stent-graft movement and can form the basis 
for defining stent-graft migration within this thesis. Observer variability for the clinical phase 
of the study was also low. Limits of agreement for both intra- and inter-observer 
measurements were within 4 mm, with all of the paired clinical measurement differences < 4 
mm.
Within the literature there are limited reports investigating the variability of observer 
performed CT measurements along the length of a vessel. There are no reports which have 
sought to quantify the bias and variability of any CT technique assessing stent-graft 
migration. England et al., (2008) investigated the variability of pre-EVAR CT measurements in 
30 patients (England et al., 2008). This study, which involved both radiologists and 
radiographers, reported an inter-observer mean difference of 6 mm. Measurements of 
aneurysm morphology were obtained using MPRs and this may offer one explanation for the 
relative lower levels of agreement when compared to a CLL technique. The authors also 
noted a lack of standardisation in their measurement definitions which may also explain the
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decrease in reproducibility. Oshin et alv (2010) investigated the measurement of target 
vessel separation prior to fenestrated endovascular aneurysm repair (Oshin et alv 2010). In 
their study they demonstrated similar mean paired differences but with slightly greater limits 
of agreement. A major difference in Oshin's study was that they opted to use a CLL 
technique for some of the vessel length measurements. The conclusion of this study was 
that the subjective interpretation of anatomical landmarks has a greater role in affecting 
measurement variability than the choice of measurement technique (MPR or CLL). Ghatwary 
et al., (2012) more recently reported on the use of the St George's Vascular Institute Protocol 
for the characterisation of infrarenal abdominal aortic aneurysms (Ghatwary et al., 2012). In 
their study the measurement of vessel length generated intra- and inter-observer 
repeatability coefficients of 2.5% to 11%. A CLL technique was used to quantify 
measurements along the length of a vessel, the authors concluded that the measurement of 
aortic neck length and CIA length generated the highest repeatability coefficients of all length 
measurements. This provides further justification for the need to validate a CLL migration 
measurement technique. Migration measurements typically require a length measurement 
along the suprarenal aorta and in the common iliac arteries. Based on the report by 
Ghatwary et al., (2012) these measurements were subject to the greatest variation. The 
study by Ghatwary et al., (2012) used the CT reconstruction software BSurgery (SMensio 
Medical Imaging B.V., Bilthoven, The Netherlands) which uses a semiautomated CLL 
construction technique which is similar to that used by the Kodak Carestream system used in 
this chapter.
When discussing the findings in this chapter both the CT technique and CLL 
generation process must be considered. In this study CLLs were generated from 2.0 mm
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MDCT acquisitions with a soft (B30f) reconstruction kernel. The reconstruction kernel, also 
referred to as "filter" or "algorithm" within some texts, was described by Yu and Leng as one 
the most important parameters to affect image quality (Yu and Leng, 2013). Reports have 
also identified a link with between the reconstruction Kernel and resultant CT measurements 
(Gierada et al., 2010). This study was limited in that it investigated emphysema 
measurements on chest CT and not vessel lengths. The size of each voxel will have a role in 
determining the bias of the technique. Two millimetre CT acquisitions produced a CLL 
migration assessment bias which was relatively small (all 95% confidence intervals were 
within (-1.3 mm, +1.2 mm). If the slice thickness had increased to 5.0, 7.5 or 10.0 mm then 
this may have introduced a more measurable bias. It is also likely that the validation of our 
CLL technique is dependent on other CT parameters which may also include the 
reconstruction interval, table pitch and X-ray tube current (signal-to-noise ratio). The actual 
CLL rendering process could also affect the resultant assessment of migration. Currently, 
there are a range of techniques for generating CLLs which range from a fully automated 
technique with no observer input to a manual CLL technique where the user seeds multiple 
points along the centre of the aorta directly from axial images. The generalisability of the 
results in this chapter must, therefore, take into account the possibility of differences in CLL 
generation processes, which may exist between different software packages. All methods of 
producing CLLs can generate errors, in some instances CLLs may not conform to the central 
channel of the aorta. For an accurate analysis it is essential that the central path of the CLL is 
confirmed by visual inspection of MPR images. In this experiment neither the phantom nor 
clinical CLLs required any manual adjustment. Constructing a CLL reduces some of the 
human decisions when performing measurements along the lengths of a vessel. Human
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input is still required in order to identify the reference points from which to measure the 
position of a stent-graft; this will be prone to human variance. Defining the start/end of the 
stent-graft and the reference vessel, although subject to clear definitions is challenging at 
times, especially in patients with luminal calcification. It is for this reason that observer 
experience is undoubtedly a contributing factor and training considerations must be factored 
into any assessment of migration. There are potential differences in the visibility of the 
proximal and distal margins of different stent-grafts on the oblique axial CT reformatted 
images. Differences may exist because of variations in the metallic composition of the stent 
struts or the number of struts at the proximal and distal device margins. CT has an excellent 
ability in visualising metallic structures; since the assessment of migration requires the 
identification of identical stent-graft landmarks on serial examinations it is unlikely that the 
configuration will affect such measurements. Data from the phantom experiment included 
two devices with differing metallic compositions (stainless steel and nitinol) and a range in 
the number of proximal (12 vs 5) and distal (7 versus 5) stent struts. This situation allowed 
the testing of the CLL technique over a wide range of situations.
There are further advantages in the adoption of a CLL technique for assessing stent- 
graft migration. CLLs are now widely available on both dedicated CT and PACS workstations. 
With most systems designed around endovascular planning, CLLs displaying the aorta and 
both iliac arteries can be generated with just a few simple clicks of the mouse. With any 
post-EVAR surveillance programme efficient image analysis is essential; CLLs can provide a 
quick and accurate method for assessing stent-graft migration. It must be noted that this did 
not seek to compare a CLL technique against any of the previously documented CT migration 
assessment techniques. However, it could be argued strongly that CLLs are a valuable
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technique for assessing stent-graft migration and that they are likely to be superior to an 
assessment based on either acquired axial CT images or multi-planar reformatted images.
The possibility of aortic elongation has been raised briefly within the literature 
(O'Neill et al., 2006b, Litwinski et al., 2006, Shah et al., 2007) and will be discussed in detail in 
subsequent chapters of this thesis. It must be considered that it is possible for the SMA to 
stent-graft distance to increase during follow-up without any changes in the actual position 
of the fabric markers relative to the renal ostia. Likewise it may be possible for the CIA 
bifurcation to stent-graft distance to increase without any change in the portion of common 
iliac artery covered by the limb. If during follow-up there is a change in the CLL distance then 
a more detailed analysis is warranted. Cross-referencing of the CLL measurements against 
aortic calcification or non-aortic landmarks should also be considered. With this in mind CLLs 
can be used as a rapid screening tool for migration with more detailed evaluation in positive 
or equivocal cases (O'Neill et al., 2006b).
There are limitations when attempting to use static imaging (MDCT) to quantify the
position of a stent-graft within a moving (pulsatile) structure. Vos et al.,(Vos et al., 2003)
documented up to 1.99 mm of craniocaudal movement of the aneurysmal abdominal aorta
when imaged by cine MRI. Whether the stent-graft moves simultaneously within a pulsating
aorta is currently unknown. A static stent-graft in a mobile (pulsatile) aorta could lead to
pseudomigration, the relationship between the stent-graft and the aortic references vessels
could vary during the cardiac cycle and differ between serial CT scans. It is likely that there is
some degree of synchronisation in the longitudinal movement of the aorta and endograft.
Stent-grafts have various design features which encourage them to remain in a fixed position
within the aorta (suprarenal fixation, hooks and barbs, radial and columnar force). A more
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detailed understanding of this phenomenon could be obtained by studies involving gated
(cine) CT. At the time of this study prospective gated CT had limited availability and the 
alternative of retrospective gated CT was associated with a high radiation dose (Desjardins 
and Kazerooni, 2004).
In reporting this experiment, it is accepted that there are other limitations. The use 
of a plastic aortic phantom may raise questions. This was a simple but morphologically 
similar replica of the upper abdominal aorta but lacked angulation and tortuosity; many 
supporters of CLLs describe its benefits when evaluating tortuous vascular systems. 
Questions may arise regarding the extent of any bias and variability if the aortic phantoms 
contained some degree of vessel angulation and or tortuosity. The results in this chapter 
must take into account that the phantom study used stent-grafts deployed in only straight 
aortic necks. In contrast, the clinical CT scans were selected at random from the available 
DICOM CT data at a local hospital, this goes some way to validating the CLL technique for all 
eventualities. In this experiment CLLs were successfully applied to a clinical cohort to assess 
the proximal and distal landing zones; subsequently there was some variety in the quality of 
the aortic neck (angulation and calcification) and tortuosity to the iliac arteries. Tilting of the 
stent-graft may have an impact on the accuracy and variability of CLL migration assessments. 
In cases with challenging anatomy there is the likelihood of some degree of stent-graft tilt. 
This experiment did not seek to experimentally evaluate the effect of tilt on the accuracy and 
variability of CLL measurements and this must be considered when interpreting the data.
Finally, this experiment only sought to evaluate the accuracy of CLLs in quantifying 
longitudinal stent-graft displacement. With an increase in the number of fenestrated EVAR
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procedures performed globally each year a need may arise for a study to evaluate the 
quantification of aortic stent-graft rotation using radiological imaging.
4.5 Conclusion
In conclusion, the bias from CLL determined stent-graft migration is small and insignificant 
from a practical point of view. Based on data in this sample there is 95% confidence that the 
bias is less than 1.3 mm. When using 2.0 mm thick MDCT slices it should be feasible to 
detect stent-graft positional changes which are > 4 mm. A CLL analysis should not be used in 
isolation; if migration is suspected then a full and detailed evaluation using all CT imagery 
must be implemented. Minor measurement variability both between and within observers 
exists and this should also be factored into any clinical decision making. Within this thesis 
migration, either proximal or distal (iliac), will now be defined as movement of the stent-graft 
by > 4 mm.
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5. Migration of fenestrated aortic stent-grafts: a single centre
experience
5.1 Introduction
Approximately half of all AAA are anatomically unsuitable for standard infrarenal EVAR 
(Elkouri et ai, 2004, Keefer et ai, 2010). Complex endovascular techniques, such as 
fenestrated endovascular repair (FEVAR), have been developed especially for these situations 
where an inadequate infrarenal aortic neck may preclude the use of standard stent-graft.
Fenestrated stent-grafts are, however, subject to the same haemodynamic forces 
that have resulted in migration of standard infrarenal EVAR devices (see Chapter 3). 
Movement at the proximal seal zone of a fenestrated stent-graft could result in loss of 
alignment between the fenestrations and the target vessel ostia. This may be catastrophic 
and result in compromise of blood flow to the target vessels and or loss of an aortic seal.
Early identification of any migration is critical, recognition can alert the clinician to the 
presence of device instability and may allow early reintervention, which may avert serious 
clinical sequelae (Greenberg et al., 2004b). Migration of a fenestrated stent-graft has been 
previously reported (O'Neill et al., 2006a, Ziegler et al., 2007, Scurr et al., 2008a, Verhoeven 
et al., 2010, Troisi et al., 2011). In these short and mid-term efficacy studies, device 
migration was generally poorly defined and rates were based on cases resulting in clinical 
signs or requiring reintervention.
For standard infrarenal stent-grafts migration is often classified using the SVS/ICVS 
reporting standards as any movement >1.0 cm or that caused symptoms or required
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reintervention (Chaikof et at., 2002b). Even back in 2004, Greenberg and colleagues, argued 
that such a wide definition was insufficient and that adopting a smaller criterion would lead 
to improvements in patient selection and device modifications by the manufacturer. Such 
improvements would then hopefully help drive down the incidence of fixation failure. For 
fenestrated stent-grafts, a smaller definition is even more of a necessity since, smaller graft 
movements (e.g. 3 mm) have already been associated with adverse clinical sequelae 
(Verhoeven et at., 2010). It is now possible to revise the SVS/ICVS reporting standards and 
adopt a shorter definition of migration. Data from the previous chapter and its resultant 
publication (England et aL, 2012) confirmed that MDCT, when combined with a validated 
measurement technique, can facilitate the more subtle quantification of device migration.
The concept of distal iliac limb migration has almost escaped the attention of many 
researchers. Cephalad forces act on the distal iliac limbs (Melas et at., 2010) and can induce 
migration at the distal landing zones. In addition, Alerci et aL, (2005) reported that distal iliac 
limb migration, although infrequent, can occur at any point during follow-up. Together with 
proximal fenestrated stent-graft migration the incidence and consequences of iliac limb 
migration are not well understood.
5.1.1 Aims
Based on FEVAR experience from a single institution (Hospital A) this chapter quantified the 
extent of migration of fenestrated aortic stent-grafts. This data collection and analysis also 
served as a pilot in order to inform and justify the design of the larger multicentre 
investigation presented in the next chapter. The aims of this chapter are to:-
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Aim 5.1. Quantify the incidence of migration of the Zenith fenestrated aortic stent-graft.
Aim 5.2. Report the timings for proximal and distal (iliac) limb migration.
Aim 5.3. Investigate and report the associated (related) clinical effects of both proximal 
and distal stent-graft migration in patients treated with a Zenith fenestrated 
stent-graft.
5.2 Materials and methods
5.2.1 Study design and patient sample
This was a retrospective review of prospectively collected data for all patients treated 
for short necked and juxtarenal AAAs using a custom-designed fenestrated device based on 
the Zenith system (Cook Inc, Bloomington, Ind) in a single institution. Research ethics 
approval was obtained (07/Q1502/43) and patients were considered for inclusion, if they had 
a fenestrated device implanted between the start of the fenestrated programme in 2003 and 
2010. Patients were required to have had a baseline post-operative CT scan (1st) and, at 
least, one additional follow-up CT scan (minimum of 5 months from the baseline) available in 
Digital Imaging and Communications in Medicine (DICOM, National Electrical Manufacturers 
Association, Rosslyn, VA) imaging format.
5.2.2 Image acquisition and reconstruction
Follow-up imaging studies were typically undertaken within 1 month, then at 6 and 12 
months, and then annually thereafter. MDCT studies of the abdomen and pelvis were 
acquired using a Siemens Somatom Sensation 16 (Siemens, Erlangen, Germany). Collimation 
was set to 2.0 mm with a 1.0 mm reconstruction interval. All acquisitions followed an
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intravenous injection of lOOmL ioversol (Optiray 300, Maiiinckrodt, Hazelwood, MO) at 
5mL/s and were initiated using bolus tracking software. Aortic enhancement at the level of 
the 12th thoracic vertebra must have exceeded 120HU. Data were reconstructed using a B20f 
kernel and transferred to a CT workstation (Kodak Carestream PACS, 10.2, Kodak, Rochester, 
NY) for analysis. In essence, this protocol mirrored the clinical CT protocol used in the 
validation experiment (Chapter 4, Table 4.2).
5.2.3 Migration definition
The definition of stent-graft migration was derived from experimental work (Chapter 
4) using a combination of aortic phantoms and clinical CT data. The experiments in the 
previous chapter included an assessment of bias and intra- and inter-observer variability. In 
summary, migration was defined as cranial or caudal movement of the device, relative to a 
vascular landmark of > 4 mm. Migration assessments included an evaluation of both the 
proximal and both distal (iliac) landing zones. Component separation was not considered as 
migration but was defined as any movement between the proximal (fenestrated) tubular 
component and the distal bifurcated part.
5.2.4 Migration analysis
A central luminal line (CLL) was created using the semi-automated CLL algorithm on the 
workstation. The location of the CLL within the central channel of the vessel lumen was 
confirmed by scrolling through multi-planar reformatted images. Reconstructions 
perpendicular to the CLL were also evaluated in order to confirm exact locations when 
undertaking measurements from the CLL images (Figure 5.1). The proximal native vascular 
reference point was the superior mesenteric artery (SMA). The distance between the inferior
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border of the SMA and the first appearance of the stent-graft (two struts) was measured.
The inferior border of the SMA was defined as the first oblique axial CLL reformatted image 
where there was clear separation of the SMA from the aortic wall (Figure 5.1A). The iliac 
bifurcation was used as the distal reference point and was defined as the first oblique axial 
CLL reformatted image/ where there was clear separation of the internal and external iliac 
arteries (Figure 5.IB). Length measurements were obtained, using the CLL to measure from 
the proximal stent-graft to the SMA, and from the distal extremes of the stent-graft to the 
iliac bifurcation (bilaterally) using the 1st post-operative CT scan (baseline). Each CLL 
measurement was then compared with the same measurement on all available subsequent 
CT scans. Measurement differences between the baseline and subsequent CT scans, for the 
same anatomical location, would suggest device migration. Caudal migration of the stent- 
graft was indicated by a plus sign (e.g. +4.1 mm) and movement in a cranial direction was 
indicated using a minus sign (e.g. -6.4 mm). CT workstation measurements were recorded 
using electronic calipers to 1/10 of a millimetre.
Using the CLL data, any patient meeting our definition of device migration was 
subjected to further scrutiny. This included visual analysis of the reconstructed aortic 
segment from which specific landmarks were identified within the aortic wall (e.g. 
calcification). These images, in addition to the CLL data, were assessed by two observers in 
order to confirm whether the device had migrated with respect to its initial implanted 
position. Examples of images used in the further scrutiny of cases of quantifiable migration 
are illustrated in Figure 5.2 and Figure 5.3.
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Figure 5.1 An illustration showing the measurement of proximal and distal stent-graft migration. For 
proximal migration (Image A) the first oblique axial reformatted image, where at least two stents 
struts were visible (circles), was considered indicative of the proximal stent position. The first 
reformatted slice where there was a clear space between the superior mesenteric artery (SMA) and 
the aortic wall was considered the inferior border of the reference vessel (arrow). Distally (Image B), 
the position of the distal stent graft is recorded relative to the bifurcation of the common iliac artery. 
The first oblique axial reformatted image where at least two iliac stents struts were visible was 
considered indicative of the distal stent position (circles). The first reformatted slice where there was a 
clear space between the external iliac artery and the internal iliac artery was considered the level of 
the iliac bifurcation (arrow). For both landing zones the distances between the two reference points 
were measured (db) and compared between serial CT scans
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Figure 5.2 CLL image from the 2004 l5' post-operative follow-up CT scan (a), the proximal portion of 
the fenestrated stent-graft was 24.5 mm above the inferior border of the SMA. On the 2004 3D 
volume rendered (VR) image (b) the top of the bare stent struts were in line with the origin of the 
coeliac axis (arrow). By 2011 the stent-graft had moved caudally 8.0 mm, the proximal margins of the 
device are now resting 16.5 mm above the inferior border of the SMA (c). On the 2011 3D VR image 
(d) there is clear evidence of caudal migration with an absence of stent graft covering the infracoeliac 
aorta (arrow)
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Figure 5.3 CLL (a) and 3D VR images (b) from the 2005 1st post-operative follow-up CT scan, the distal 
portion of the left iliac limb was sitting 37.3 mm above the bifurcation of the right common iliac 
artery. By 2011 the limb had moved cranially 7.8 mm, the distal margins of the device are now resting 
45.1 mm above the common iliac artery bifurcation (c). On the VR images (d) cranial movement of the 
device between the two time points can clearly be seen in relation to vascular calcification (*)
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5.2.5 Statistical analysis
Initial statistical analyses were undertaken using SPSS for Windows Version 21.0 (IBM Corp, 
Armonk, NY). More detailed survival analyses were conducted using the statistical 
programming language R 2.2.1 (R Development Core Team, 2005), which included the use of 
the Survival (Therneau, 2013) package. In order to satisfy Aims 5.1, 5.2 and 5.3, descriptive 
statistics were first used to report proximal and distal migration data. A normality test based 
on the Shapiro-Wilk approach (Shapiro and Wilk, 1965) was carried out, if the corresponding 
P value was greater or equal to 0.05 (i.e. the null hypothesis that the data followed a normal 
distribution is not rejected at the 5% significance level), then the mean and standard 
deviation were reported as summary measurements. If the Shapiro-Wilk normality test 
produced a P-value <0.05, then these data were considered to be not normally distributed 
and median values together with the corresponding inter-quartile ranges (IQR) were 
reported. When describing the magnitude of migration (distance), descriptive statistics were 
generated only for those patients who met the migration definition {> 4 mm). Frequencies 
and their relevant percentages were also reported for migration (Aim 5.1) based on the 
validated definition {> 4 mm) at both the proximal and distal landing zones. The incidence of 
stent-graft migration (proximal and distal) was also reported by reflecting the overall sum of 
follow-up data. The frequency of a disease or event (complication) is often, from an 
epidemiological perspective, reported in person-years (Wood et al.t 1997).
For categorical variables statistical significance was calculated using the Chi-square
test (which may include the linear-by-linear association test) or the Fisher's exact test. The
linear-by-linear association Chi-square (or the Mantel-Haenszel test for linear association)
test is an ordinal measure of significance, which is preferred when testing the significance of
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linear relationship between ordinal variables (Agresti, 1996). The t test was used to assess 
statistical significance in continuous variables that were approximately normally distributed. 
For those variables that were not normally distributed, the Mann-Whitney U test was used, P 
values <0.05 were considered statistical significant.
Kaplan-Meier methods with and without interval censoring were used to 
construct survival curves for proximal, distal (iliac) and any device migration (Aims 5.2). In 
standard time-to-event or survival analysis, individuals are followed over time for the 
occurrence of a specific event (e.g. death). If the event is observed then the event is 
recorded as the time the event occurred, T, and the censoring indicator 8 would take the 
value 1. If by the end of the period of study the event has not been observed, the 
observation would statistically be considered to be right-censored. The value of T would be 
set to the last observation time and 5 would take the value 0. When the event is directly 
observed or is right-censored then there are numerous parametric, semi-parametric and 
non-parametric methods for estimating survival curves and for both hypothesis testing and 
the modelling the effects of covariates (Lindsey and Ryan, 1998). For stent-graft migration 
the precise time of the event is often unknown. Migration is generally asymptomatic and will 
occur within an interval of time between two serial CT scans. As an example, migration may 
not be appear on the 1st post-operative CT scan but could be present by the next (6-month) 
CT scan. In this case, T will fail within the time interval between 1st post-operative and the 6- 
month CT scan. Events which occur between two time points are known as interval-censored 
data (Lindsey and Ryan, 1998). Commonly available statistical packages e.g. SPSS cannot 
accommodate these kinds of data. One option is to assume that the event occurred at the 
beginning, midpoint or at the end of an interval and then apply standard methods for
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analysing time-to-event data (Lindsey and Ryan, 1998). Such techniques can, however, lead
to bias and potentially misleading results (Rucker and Messerer, 1988, Odell et al., 1992, 
Dorey et oL, 1993). Estimations of survival can be calculated, whilst taking into account the 
uncertainty in the precise time of the event, using non-parametric maximum likelihood 
estimations (Finkelstein, 1986, Goetghebeur and Ryan, 2000). To facilitate the latter 
approach, survival data were computed with the statistical programming language R. For the 
data presented within this chapter, estimations of migration free survival were generated 
using the following event time definitions: beginning of the interval, midpoint of the interval, 
end of the interval and also using an interval censored approach. Survival differences 
between individual iliac limbs (ipsi- and contralateral) were displayed using Kaplan-Meier 
curves. Differences between the limb types were assessed by visual inspection of the curves.
The effect of stent-graft migration on the incidence of complications and secondary 
interventional procedures were also investigated (Aim 5.3). Complications are often referred 
to as the Achilles' heel of EVAR and can arise for a variety of reasons, including stent-graft 
migration (Pacanowski et al., 2002a, Tang and Boyle, 2011). The site of migration either 
proximal or distal (iliac) can influence the type of complication. All images included in the 
analysis were reviewed for the presence of complications and there are well-recognised 
reporting standards available for documenting these (Chaikof et al., 2002a, Boyle et al., 
2011). Local endovascular databases were also reviewed in order to further establish the 
presence or absence of any complications. Using the previous review of the literature 
(Chapters 2 and 3), it has been identified that migration-related complications may lead to 
ischaemia (regional e.g. renal), aneurysm reperfusion or structural integrity issues e.g. 
component fracture. It is also important to evaluate follow-up imaging and patient records
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for any potentially new complications. A full list of the complications assessed within this 
thesis is described in Table 5.1, this list will also be relevant to the multicentre data 
presented in the next chapter. Although not identified within the tables or explicitly defined 
endpoints the incidence of post-treatment aneurysm rupture and any aneurysm-related 
mortality were investigated and reported within this thesis.
Table 5.1 Complications assessed within this thesis
Proximal
Aneurysm reperfusion ischaemic Structural
Endoieak 1-Proximal TV compromise Component fracture
Endoleak III Limb thrombosis Kinking
Distal (iliac)
Endoleak 1-Distal Iliac limb occlusion Component fracture
Kinking
TV, target vessel. Further details on the exact definition of endoleaks can be obtained from (White 
et a!., 1998, White et al., 1997, Ziegler et ai, 2007)
Many complications of FEVAR related complications can be managed conservatively, 
often by the use of surveillance imaging. For some patients, surgery or an endovascular 
procedure will be required in order to maintain long-term procedural success and prevent 
aneurysm rupture. Hospital records were also reviewed in order to identify any migration- 
related reinterventions within the sample. Typical reinterventional procedures have been 
described by Triosi and colleagues, which may include open surgical conversion, implantation
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of an additional stent/stent-graft, use of a suturing or stapling device or surgical by-pass 
(Troisi et ai, 2011). These methods for identifying and reporting of reinterventions are also 
relevant for the multicentre data presented in the subsequent chapter.
5.3 Results
A total of 83 patients with juxtarenal AAA were treated at Hospital A with a fenestrated 
stent-graft. Eight patients were followed up in other hospitals and have, therefore, been 
excluded from the analysis. Other losses are summarised in Figure 5.4. Overall, there were a 
total of 55 patients included in this analysis, 49 (89%) men and 6 (11%) women with a mean 
age of 74 SD 7 years. Preoperative co-morbidity and risk factors for both the included and 
excluded patients are listed in Table 5.2. Eighteen (33%) patients died during follow-up, 
review of local vascular databases and hospital computer records indicated that none were 
considered to be aneurysm-related.
Figure 5.4 Study inclusions and losses
Included 
n = 55
FEVAR Cohort
n = 83
Excluded
n= 28
External follow-up 
n = 8
Baseline CT scan 
only
n= 9
Local follow-up 
n= 20
No baseline CT 
scan
n = 11
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Median maximal AAA diameter was 65 (IQR, 59 to 73) mm. The total number of 
fenestrations was 162, including 104 renal artery fenestrations, 47 SMA fenestrations and 11 
coeliac artery fenestrations (Table 5.3). The most common combination included two small 
fenestrations for the renal arteries and a scallop for the SMA.
Table 5.2 Study group demographics and risk factors
Patient characteristics
Inclusions
(n = 55)
Exclusions
(n = 28)
P
Value
Mean age (years) 74 SD 7 71SD8 0.14
Hypertension 30 (55%) 14 (50%) 0.44
Diabetes 5 (9%) 4 (14%) 0.36
Coronary artery disease* 32 (58%) 15 (54%) 0.43
Cerebrovascular diseaset 8 (15%) 6 (21%) 0.31
Renal insufficiency5 8 (15%) 4(14%) 0.63
II 14 (25%) 8 (29%)
0.96
ASA Graden III 39 (71%) 19 (68%)
[0.79]
IV 2 (4%) 1(4%)
AAA diameter (mm) 65 IQR 59 to 73 63 IQR 58 to 73 0.65
Previous myocardial infarction, angina or ECG evidence of ischaemia. tPrevious stroke or transient ischaemic
attack. 5Pre-operative serum creatinine > 150 pmol/L. IQR, inter-quartile range. n P values reported were the Chi- 
square test [Mantel-Haenszel test for linear association]. SD, standard deviation. IQR, inter-quartile range.
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Table 5.3 Configuration of scallops and fenestrations used within the study group
Un-stented Stented
Scallop Fenestration Scallop Fenestration
CA 11
SMA 33 1 13
Renal 3 4 97
CA, coeliac axis; SMA, superior mesenteric artery.
Proximal migration
Of 55 patients with a median follow-up of 24 months (IQR, 13 to 49; range, 5 to 97 months), 
10 (18%) showed CT evidence of proximal migration (> 4 mm). Of the patients which met the 
definition of migration, the mean migration was +5.5 (SD 1.4, range +4.0 to +8.1) mm. All 
proximal migrations were caudally directed. Those cases of proximal migration that met the 
thesis definition, are presented in a histogram (Figure 5.5). Timings of proximal migration 
(based on the 1st CT diagnosis of migration) have also been plotted (Figure 5.6). Based on a 
follow-up of 130.2 person-years, there was a proximal migration rate of 1 migration per 12.5 
person-years of follow-up. Kaplan-Meier survival analysis, using interval censoring, 
estimated that the probabilities of being free from proximal migration at 12 and 36 months, 
were 91% (95% Cl 83% to 100%) and 78% (95% Cl 66% to 93%) respectively. For proximal 
migration, comparison of Kaplan-Meier survival curves using alternative event time 
definitions are summarised in Table 5.4 and illustrated in Figure 5.7.
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Figure 5.5 Frequencies of proximal stent graft migration
Figure 5.6 Time to 1st CT diagnosis of proximal migration
4
1-11 12-23 24-35 36-47 48-59 60-71 >72
Time to 1st CT diagnosis of migration, months
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Table 5.4 Comparison of survival estimates (Kaplan-Meier) between the four 
approaches considered for proximal stent-graft migration. Percentages relate to the 
proportion of patients free from migration.
Interval censoring Beginning of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 42 91% 83% to 100% 40 89% 81% to 98%
24 29 91% 83% to 100% 26 87% 78% to 96%
36 16 78% 66% to 93% 16 83% 73% to 95%
48 9 78% 66% to 93% 9 83% 73% to 95%
Midpoint of interval End of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 43 94% 88% to 100% 44 96% 90% to 100%
24 26 84% 74% to 96% 30 93% 87% to 100%
36 16 79% 67% to 95% 18 82% 70% to 97%
48 9 79% 67% to 95% 9 73% 57% to 92%
Mo, months, n, number of patients. Cl, confidence interval.
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Figure 5.7 Kaplan-Meier survival curves illustrating freedom from proximal stent-graft migration 
using a combination of event time definitions. Percentage values across the y-axis relate to the 
proportion of patients free from migration. Corresponding 95% confidence intervals are represented 
by the outer (dotted) lines.
Proximal migration - Intarval centering Proximal migration - boginning of interval
1M Mew-up CT acan.
Proximal migration - midpoint of interval
1M Mow-up CT Kan.
Proximal migration • endpoint of Interval
For those patients with CT evidence of proximal migration (n=10), 2 patients (20%) 
had device migration identified on the last follow-up CT scan. For the remaining eight 
patients there were only minor amounts of additional migration (mean +0.5 SD 0.8 mm)
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during the remaining follow-up (mean 36 SD 15 months). Graft-related events and re­
interventions are described in Table 5.5.
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Distal iliac limb migration
Using data from 55 patients, a total of 98 iliac limbs were assessed for the presence of distal 
migration. In eleven patients (12 CIA) a CLL was unable to be constructed, this was either 
due to a previously occluded internal iliac artery (n=7) or there were image quality issues 
(n=5) preventing the computer from generating a CLL e.g. poor contrast opacification. 
Further details on the inclusions and exclusions regarding the assessment of iliac limb 
migration are illustrated in Figure 5.8.
Figure 5.8 Iliac limb inclusions and exclusions (single centre cohort)
IQ/Ql issue 
n - 3
Sites assessed
n-55
Proximal
KVCIL issue 
n-2
Patients
n-55
Contralateral
Excluded 
n -0
Occluded HA 
n-5
Occluded HA 
n-2
Not assessedNot assessed 
n-8
Assessed
n -47
Available for 
assessment 
n-55
Distal 
(iliac limb)
Assessed
n = 51
Excluded 
n -0
11 A, internal iliac artery; IQ, image quality; CLL, central luminal line.
Of the 98 iliac limbs assessed, 10 (10%) showed CT evidence of device migration, all
were cranial in direction. Median distal migration was -5.0 (IQR, -8.5 to -4.4; range, -21.3 to - 
4.3) mm. The frequency and timings of iliac limb migrations, both ipsilateral and
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contralateral, are described using a histogram in Figure 5.9 and Figure 5.10. Based on iliac 
limb follow-up of 124.1 person-years, this study identified a distal migration rate of 1 
migration per 14 person-years of follow-up. For those patients with CT evidence of distal 
(iliac) migration, three out of 10 limbs (30%) were identified as migrated at last follow-up. 
For the remaining seven, there was only evidence of a small amount of further migration 
(mean -1.6 ± 1.4 mm) over a mean 27 ± 1 months.
Figure 5.9 Frequencies of distal (iliac) limb migration. In the two cases of iliac limb migration <-9 mm, 
one case (contralateral) had -10.6 mm and the second case (ipsilateral) had -21.3 mm of cranial 
migration
4
■ Ipsilateral
■ Contralateral
<-9 -8 to-8.99 -7 to-7.99 -6 to-6.99 -5 to-5.99 -4 to-4.99
Migration distance, mm
3
2
1
0
-Q
E
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Figure 5.10 Time to 1st CT diagnosis of distal (iliac) limb migration
■ Ipsilateral
■ Contralateral
it ii n
1-11 12-23 24-35 36-47 48-59 60-71 >72
Time to 1st CT diagnosis of migration, months
Kaplan-Meier survival analysis indicated that the probabilities of a patient being free 
from any iliac limb migration at 12 and 36 months were 95% (95% Cl 89% to 100%) and 86% 
(95% Cl 76% to 97%) respectively (Figure 5.11, Table 5.6). Analysis on an individual iliac limb 
basis estimated that the probabilities of being free from iliac limb migration, at 12 and 36 
months, were 96% (95%CI 91% to 100%) and 89% (95% Cl 78% to 100%) for ipsilateral and 
98% (95%CI 93% to 100%) and 89% (95%CI 73% to 100%) for contralateral limbs, respectively 
(Table 5.7, Figure 5.12, Figure 5.13). Complications in patients with distal iliac migration are 
summarised in Table 5.8.
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Table 5.6 Comparison of survival estimates (Kaplan-Meier) between the four 
approaches for any iliac limb migration. Percentages refer to the proportion of patients 
free from any iliac limb migration.
Interval censoring Beginning of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 40 95% 89% to 100% 37 89% 80% to 98%
24 25 86% 76% to 97% 24 86% 77% to 96%
36 17 86% 76% to 97% 16 86% 77% to 96%
48 11 70% 53% to 91% 11 75% 61% to 94%
Midpoint of interval End of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 40 94% 88% to 100% 41 96% 91% to 100%
24 24 83% 71% to 96% 27 90% 82% to 100%
36 16 83% 71% to 96% 18 86% 74% to 99%
48 11 71% 55% to 92% 12 69% 52% to 92%
Mo, months. n, number of patients. Cl, confidence interval.
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Figure 5.11 Kaplan-Meier survival curves illustrating freedom from any iliac limb migration using a
combination of event time definitions. Percentage values across the y-axis relate to the proportion of 
patients free from migration. Corresponding 95% confidence intervals are represented by the outer
(dotted) lines.
Any Mi*c limb migration • interval canaoring
Any Mac limb migration . midpoint of interval
Any Iliac limb migration • boginning of interval
Any Miac limb migration - andpoint of interval
lit totowMp CT *can.
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Figure 5.12 Kaplan-Meier survival curves illustrating freedom from iliac limb migration (Ipsilateral 
limbs only) using a combination of event time definitions. Percentage values across the y-axis relate 
to the proportion of iliac limbs free from migration. Corresponding 95% confidence intervals are
represented by the outer (dotted) lines.
Ipsilateral limb • interval cansoring Ipsilateral limb • baginning of interval
t>siteteral limb • midpoint of intarval Ipsilateral limb - andpoint of interval
1*1 toteoMjo CT scan.
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Figure 5.13 Kaplan-Meier survival curves illustrating freedom from iliac limb migration (Contralateral
limbs only) using a combination of event time definitions. Percentage values across the y-axis relate 
to the proportion of iliac limbs free from migration. Corresponding 95% confidence intervals are 
represented by the outer (dotted) lines.
Contralateral limb • interval canaoring Contralateral limb - boginning of intarval
Contralateral limb • midpoint of interval
HI Motmp CT Kan.
Contralateral limb - andpoint of intarval
Tma from Hi Mowm? CT Kan.
Upon visual inspection of Figures 5.13 and 5.14 suggested that there were no 
apparent differences between iliac limb types.
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Table 5.7 Survival estimates (Kaplan-Meier)for the four approaches for iliac limb 
migration. Percentage values relate to the proportion of iliac limbs free from migration.
Ipsilateral Interval censoring Beginning of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 31 96% 91% to 100% 28 90% 81% to 100%
24 19 89% 78% to 100% 18 90% 81% to 100%
36 13 89% 78% to 100% 12 90% 81% to 100%
48 9 78% 61% to 99% 9 82% 67% to 100%
Midpoint of interval End of interval
Time, mo n. risk Survival 95% Cl n. risk survival 95% Cl
12 30 95% 88% to 100% 31 98% 92% to 100%
24 18 87% 76% to 100% 19 90% 79% to 100%
36 12 87% 76% to 100% 13 90% 79% to 100%
48 8 80% 64% to 100% 10 83% 67% to 100%
Contralateral Interval censoring Beginning of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 37 98 93% to 100% 36 96% 90% to 100%
24 22 98 93% to 100% 20 93% 85% to 100%
36 13 89 73% to 100% 12 93% 85% to 100%
48 9 75 55% to 100% 9 85% 70% to 100%
Midpoint of interval End of interval
Time, mo n. risk survival 95% Cl n. risk Survival 95% Cl
12 37 98% 94% to 100% 37 98% 94% to 100%
24 20 90% 79% to 100% 22 98% 94% to 100%
36 12 90% 79% to 100% 13 91% 78% to 100%
48 9 81% 64% to 100% 9 74% 54% to 100%
Mo, months, n. number of patients. Cl, confidence interval.
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The concurrent migration of both iliac limbs was seen in one patient (2%). Migration 
at the proximal and at least one distal attachment site was seen in three patients (5%). 
Freedom from any (proximal or distal) migration at 12 and 36 months were 81% (95% Cl 71% 
to 93%) and 64% (95%CI 49% to 94%) respectively (Table 5.9, Figure 5.14).
Table 5.9 Comparison of survival estimates (Kaplan-Meier) between the four 
approaches considered for any migration (proximal or distal). Percentage values relate 
to the proportion of patients free from migration.
Interval censoring Beginning of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 36 81% 71% to 93% 32 76% 65% to 88%
24 24 76% 64% to 89% 21 73% 62% to 86%
36 12 64% 49% to 94% 11 69% 57% to 84%
48 7 52% 36% to 76% 7 63% 48% to 83%
Midpoint of interval End of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 39 88% 80% to 98% 41 92% 84% to 100%
24 21 67% 54% to 83% 28 84% 74% to 96%
36 11 62% 47% to 81% 15 68% 54% to 87%
48 7 55% 38% to 78% 7 43% 26% to 70%
Mo, months. n, number of patients. Cl, confidence interval.
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Figure 5.14 Kaplan-Meier survival curves illustrating freedom from any device migration (proximal 
and/or distal). Percentage values across the y-axis relate to the proportion of patients free from any 
migration. Corresponding 95% confidence intervals are represented by the outer (dotted) lines.
Any migration - Interval can tor tog
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5.4 Discussion
All commercially available infrarenal stent-grafts have had cases of stent-graft migration 
reported. Migration of these device can be serious and have been associated with 
complications including type I endoleak, rupture and open conversion. There is heightened 
concern regarding the migration of fenestrated stent-grafts. For these more complex 
devices, minor movements at the proximal margins of a device could be catastrophic and 
could result in visceral complications (e.g. mesenteric ischaemia, or the need for renal 
replacement therapy). For infrarenal stent-grafts there is a range in the reported incidence 
of migration. One hypothesis is that these are due differences in migration definitions and 
assessment methods. It has been further hypothesised that the assessment of more subtle 
levels of migration earlier could be advantageous and may even lower morbidity and 
mortality (Greenberg et al., 2004b). CT techniques have been developed that now allow the 
quantification of more subtle levels of stent-graft migration. Up until now, these techniques 
have not been formally applied to a fenestrated cohort in order to allow the assessment of 
migration. Following the validation of the CT CLL migration measurement technique, this 
technique was successfully applied to a cohort of patients with fenestrated aortic stent-grafts 
implanted.
Data presented in this chapter represents the first single centre quantification of
fenestrated stent-graft migration. From this 9% of patients had an estimated probability of
proximal migration (>4 mm) at 12 months. By 36 months, this had increased to 22% and by
48 months, it had remained at 22%. Iliac limb migrations were initially less frequent with 12
and 36 month probabilities of 5% and 14%, respectively. By 48 months the incidence of iliac
limb migration had increased to 30%. Two key aims of this chapter were to report the
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incidence and timings of migration. In doing so, it was important to compare these values 
against those reported within the literature. This was difficult since most reports were single 
centre efficacy studies, which documented short and mid-term outcomes and had very few 
references to device migration. There are, however, cases of proximal migration reported 
within these series (O'Neill et aL, 2006a, Ziegler et al., 2007, Scurr et a!., 2008a, Verhoeven et 
o/., 2010, Greenberg et al., 2009b, Troisi et al., 2011). Comparison with these reports are 
limited, this is because there are a range of migration definitions and assessment techniques 
used. In the majority of cases, migration was only defined where there was a related clinical 
event or where reintervention was required. Based on this 'clinically significant definition 
the reported incidence within the literature ranges from 1% (O'Neill et al., 2006a) to 12% 
(BSET and GLOBALSTAR Collaborators, 2012). Troisi and colleagues reported a higher (24%) 
migration rate, all of which required reintervention (Troisi et al., 2011). The report by Troisi 
et al., was based on a mix of branched, fenestrated and combined branched/fenestrated 
devices and highlighted only cases of migration with a concurrent type I endoleak. In their 
series, there were an additional eight cases of in-stent stenosis or occlusion. It was not clear 
if stent-graft migration could have accounted for any of these events. It was also difficult to 
separate out those cases, which resulted solely from the migration a fenestrated stent-graft. 
There is, however, one advantage of comparisons with the current reports in the literature; 
all refer to the migration of the Zenith fenestrated AAA endograft which was the focus of this 
thesis. If this thesis adopted a similar {clinically significant) classification then the single 
centre migration rate would be 9%; two patients lost a single target vessel loss (both RAs) 
and three patients had stenosis of a target vessel (2 SMAs, 1 RA). Overall, the reported
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incidence of proximal migration, based on the single centre experience reported in this 
chapter, is in keeping with rates published within the literature (Table 2.4).
With respect to the timings of proximal migration, there are very few comparative 
references with the literature. To the author's knowledge there are only three publications 
that have reported the timings of cases of fenestrated stent-graft migration. An efficacy 
series, in 2010, by Verhoeven and colleagues highlighted a single case of migration occurring 
at 24 months following implantation (Verhoeven et aL, 2010). The more recent German 
series by Troisi et aL, reported a series of migration-related reinterventions (n=8) in patients 
with an accompanying type I endoleak (Troisi et aL, 2011). In this report the timings of 
migration ranged from 4 to 68 months, however, interpretation these data must be taken 
with caution. Nicola Trosi and her research group reported only the timings of the 
reintervention and not the time of first diagnosis of migration. Ail cases had an 
accompanying type I endoleak and, therefore, these migrations were clinically significant and 
different from the definition used in this thesis. Troisi also made little comment on their 
migration assessment techniques. Their work is important as it does provide some indication 
of the event times for stent-graft migration. The most recent report documenting timings of 
migration (using Kaplan-Meier methods) was the report from the UK GLOBALSTAR registry. 
Freedom from proximal migration was reported as 99%, 92% and 88% at 12, 24 and 36 
months, respectively (BSET and GLOBALSTAR Collaborators, 2012). Again the assessment 
techniques and definitions were not clearly defined and the overall follow-up of the study 
cohort was short (median 6 months). As such comparisons of proximal migration timings 
against those reported in the literature are difficult. The opinion of this thesis, taking into 
account the two relevant publications (Troisi et al., 2011, Verhoeven et al., 2010), is that
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proximal migration of a fenestrated stent-graft can occur at any point during follow-up. 
There are likely to be various aetiologies which can explain migration at different time points. 
A discussion of these possibilities will be provided in the multicentre migration chapter 
(Chapter 6), where there is greater certainty around the incidence and timings of migration.
One methodological consideration, when considering the timings of migration, were 
the event time definitions used. Migration is a progressive event, if a numerical definition is 
used then the event will typically occur between two adjacent CT scans. Depending on how 
the migration time was defined will impact on the reporting of stent-graft migration. In this 
thesis four migration event time definitions were tested, these spanned across both the 
proximal and distal iliac landing zones. If it can be accepted that a more sophisticated 
interval censoring approach is superior, then the following trends can be observed. Using the 
beginning of the interval as the event time will overestimate the incidence of migration at 
early follow-up times e.g. 12 months. Conversely, using the end of the interval will cause an 
underestimation of the incidence but this trend was reversed for later follow-up times e.g. at 
36 or 48 months. The closest approximation to interval censoring was when using the 
midpoint (the time halfway between the 1st CT scan where the migration was diagnosed and 
the previous CT scan) as the event time definition. It is surprising that the majority of 
research articles cited within this thesis did not contain information on any event time 
definitions used to report migration.
A further consideration within this chapter was the incidence and type of migration-
related sequelae. Only two cases of target vessel loss were identified in patients with
proximal migration. There are numerous reasons for the compromise of a target vessel,
these can include the fabric shuttering from migration but there can be others. It is also
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important to highlight that there were no cases of proximal type I endoleak, rupture or
conversion to open repair in the cohort presented in this chapter. All three of these 
complications have been associated with migration of infrarenal stent-grafts (Wyss et ai, 
2010, Harris et al,, 2000). Questions must arise regarding the absence of these 
complications, especially in view of proximal migration being identified in ten patients (20%). 
Various reasons can be suggested for this and there will be a further more detailed 
discussion within the multicentre chapter. With respect to this single centre cohort, both the 
sample size and duration of follow-up could be attributed to the lack of ruptures and open 
conversions. There are also major differences in the stent-graft design between those used 
in this chapter (fenestrated) and those where migration-related ruptures have been reported 
(infrarenal). The assessment and classification of more subtle levels of migration will also 
affect the relationship with serious sequelae. If the migration definition was more liberal (i.e. 
> 10 mm) then there would have been a lower incidence and fewer patients would have 
been expected to have migration-related sequelae. Excluded patients must also be a 
consideration. Could any exclusions be the result of migration or a migration-related 
sequelae? Within this chapter the bulk of the exclusions were due to a lack of CT data and 
not losses to follow-up. The exception would be cases that were followed up externally. The 
ethical approval process (single centre) did not permit access to external follow-up CT data or 
allow the ascertainment of the follow-up status of patients outside of the treating institution 
(single centre). In the UK, FEVAR practice spans across a small number of centres, as a result 
outcome data and experience is constantly been sought in order to inform practice and 
satisfy funders. If there were ruptures or significant complications at external centres then it 
is likely that they would have been communicated back to the treatment hospital. At the
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time of writing, there have been no such reports made to Hospital A regarding any of the
single centre data presented.
With regard the two cases of renal artery occlusion, both were deemed not to result 
from proximal migration. Patient 6 had widely patent and stenosis free renal arteries on 
both preoperative and 1st postoperative CTA. A left renal artery occlusion was reported at 2 
years, it was a further six months before the device migration reached a detectable threshold 
(>4 mm). Analysis of follow-up imaging (CT and abdominal radiographs) demonstrated no 
evidence of stent crushing or fracture. Following occlusion, the patient's serum creatinine 
levels rose from 94 to 134 pmol/L, without any need for dialysis. Due to the presence of 
significant comorbidities the patient withdrew from follow-up at 5 years and has since died 
from a non-aneurysm related cause. Patient 7 also had a left renal artery occlusion detected 
at 2 years, 12 months after the initial diagnosis of proximal migration. During follow-up, the 
CT and ultrasound examinations continually demonstrated a reduction in left renal artery 
blood flow and associated left renal atrophy. On preoperative imaging the patient had a 
minor stenosis with some calcification of the left renal artery. The occlusion was, therefore, 
felt to be the result of a continuation of the patient's renovascular disease. Renal function 
has remained stable with serum creatinine levels around 100 pmol/L and the patient was 
alive and well at last follow-up, 2 years. Stent-graft migration with resultant shuttering of 
the fabric over the ostium of the vessel is a possible cause of target vessel loss. Other factors 
include the misalignment of a fenestration during deployment, pre-operative quality of the 
target vessel, progression of atherosclerosis, distal embolisation and intimal hyperplasia.
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A further consideration is the magnitude of proximal migrations alongside event 
times. The majority of proximal migrations were caudal movements of less than 6 mm (60%). 
Based on KM survival analysis with interval censoring, review of the time to 1st CT diagnosis 
of proximal migration histogram (Figure 5.6) and the proximal migration outcomes table 
(Table 5.5) it can be reported that proximal migration occurs at around 8% per year. 
Proximal migration also appears to be most frequent within the first 25 months following 
implantation. Both the early peak and size of movements may suggest that the majority of 
movements are the result of barb engagement. This theory of an initial phase of stent-graft 
movement, which was associated with barb engagement, has been reported in a lab based 
study (Zhou et al., 2007). A full and more detailed evaluation of the causative factors for 
proximal migration will form part of the discussion in the next two chapters (multicentre data 
and predictive factors).
With respect to iliac limb migration, 10% of distal iliac limbs migrated during follow­
up and all were cranial in direction. Distal iliac limb migrations appear to be more of a late 
occurring event with a peak between years 3 and 4 with an annual migration rate of 8%. The 
range of distal migrations (-4.3 mm to -21.3 mm) was larger than proximal migration and may 
reflect the absence additional fixation mechanisms (e.g. barbs and target vessel stents). 
Similar to proximal migration, there is also a general absence of published data on the 
incidence and timings of distal stent-graft migration. Three series were identified from the 
literature, two were case reports but all used devices other than a Zenith fenestrated AAA 
stent-graft. In the first, cranial limb migration occurred at around 4 years with an associated 
type I endoieak and aneurysm expansion (Maleux et al., 2001). The migration caused severe 
kinking of the limb, an endovascular solution was not possible and the patient received an
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open conversion. The second was a case of bilateral iliac limb migration at 5 years with an 
accompanying distal type I endoleak (Alerci et al., 2005). This patient was successfully 
treated with an endovascular solution. The third report was from the US Vanguard endograft 
trial investigators (Beebe et al., 2001). Distal iliac limb migration was observed in two 
patients (0.7%); both were at 12 months following repair and were successfully treated using 
an endovascular approach. Comparison with the study by Beebe et al., is limited. The 
Vanguard device is a 1st generation stent-graft and is no longer commercially available. In 
addition, there were no formal mechanisms for assessing distal iliac limb migration within the 
study methods. The report was published in 2001, thin-slice MDCT technology was not 
widely available and most vascular CT examinations relied on > 5 mm CT slices. Such CT data 
would have undoubtedly caused problems if the investigators had attempted to assess subtle 
stent-graft migration.
Data within this chapter suggests that there are no differences in migration rates 
between limb types (ipsi- and contralateral). Migrations were almost equally distributed 
between ipsilateral (n=4) and contralateral (n=6) limbs. Related-sequelae for distal migration 
were also favourable. There were no cases of distal type I endoleaks irrespective of the 
presence of migration within data reported in this chapter. Iliac limb occlusions are also a 
possibility but no late limb losses were reported in this cohort in patients with either 
proximal or distal stent-graft migration.
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Limitations
In reporting data in this chapter it is accepted that there are limitations. Thirty-four per cent 
of the initial cohort were excluded, this was primarily due to a lack of available follow-up CT 
scans. In Hospital A (single centre) PACS was introduced in 2006, prior to this time it was 
difficult to gain retrospective access to CT data. Ten per cent of patients had follow-up at 
another institution and whilst it may have been possible to locate their CT data, this would 
have been outside of the ethics approval. The issue of whether some of these patients were 
excluded because of migration or migration-related sequelae has been previously discussed. 
There are also limitations in the reporting of distal iliac limb migration. There were several 
instances when a CLL migration measurement could not be obtained. This was either due to 
CT image quality issues or the absence of a clearly visible CIA bifurcation due to prior HA 
occlusion or procedural embolization and graft extension into the EIA. It is important to 
understand that in eleven cases, a deployed iliac limb was present and migration assessment 
was not possible. These limbs could have undergone migration and as such interpretation of 
the iliac limb migration rates reported must consider this factor. A sensitivity analysis has 
been undertaken in the multicentre chapter, this will help understand the possible effects of 
missing CLL measurements when reporting iliac limb migration.
It was technically possible to statistically compare the complication and 
reintervention rates between patients with and without stent-graft migration. Due to the 
small number of migrations, complications and reinterventions these have described only 
using summary statistics. All full analysis, including appropriate statistical testing, will form 
part of the next (multicentre) chapter.
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5.5 Conclusion
Migration of a fenestrated stent-graft is potentially catastrophic but can be effectively 
assessed using a CT central luminal line technique. Based on a single centre sample of fifty- 
five patients, migration at the proximal and distal landing zones occurs in around a quarter of 
patients by four years. The bulk of the migrations are less than six millimetres in length but 
movements of greater than ten millimetres are possible at both landing zones. Despite this 
observation, migration appears to take a relatively benign course. In order to have a greater 
understanding of this phenomenon, further analysis of a larger number of patients and 
migration events are required.
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6. Fenestrated Stent-Graft Migration: a multicentre analysis
6.1 Introduction
There have been little multicentre outcome data for patients treated by FEVAR. Data from a 
single systematic review (Sun et ah, 2006), a small (30 patients) US prospective trial 
(Greenberg et a!., 2009a), a retrospective French multicentre (134 patients) series (Amiot et 
al., 2010) and more recently the UK GLOBALSTAR registry (BSET and GLOBALSTAR 
Collaborators, 2012) have been published. Generating multicentre data can bring many 
advantages, these include the ability to recruit a larger numbers of participants, across 
different geographical locations and the ability to compare results between centres (Waldron 
and Cookson, 1993). Such advantages have also been said to increase the generalizability of 
the resultant study findings (Guthrie et al., 2012). Within this context, Hughes and Watkins 
(2012) recently highlighted the need to acquire multicentre data in order to answer 
questions of complex endovascular repair. Endovascular techniques are often considered to 
be a substantial way behind open surgery, when it comes to the reporting of procedural 
outcomes data and trend analysis. As an example, a multicentre analysis of complex open 
aortic aneurysm repair from the National Surgical Quality Improvement Program (NSQIP) 
database analysed data from nearly 600 patients (Khuri et al., 1998). Such large multicentre 
series do not exist for FEVAR. In the UK the GLOBALSTAR registry is the largest collection of 
multicentre FEVAR outcomes and includes retrospective data from over 300 patients across 
14 UK centres (BSET and GLOBALSTAR Collaborators, 2012). For the investigation of 
fenestrated stent-graft migration, there are no directly focused studies, either single or 
multicentre that have reported within the literature.
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The recent report from the UK GLOBALSTAR registry documented proximal 
fenestrated stent-graft migration rates of 8% and 12% at 24 and 36 months, respectively 
(BSET and GLOBALSTAR Collaborators, 2012). It was, however, not stated in the methods 
section how migration was assessed or any reporting standards used to define the 
complication. Further limitations of the GLOBALSTAR report are that median follow-up was 
only six months and that complications were assessed by the treating institution and not a 
core lab or independent review group. Other studies, which have highlighted cases of 
migration, have generally relied on subjective markers e.g. gross positional changes or have 
simply chosen only to report, cases where migration led to a clinical event, e.g. endoleak or 
where reintervention was required. Greenberg and colleagues have previously alerted the 
vascular community to the potential advantages from identifying migration early (Greenberg 
et a!., 2004b). To do this, would require more subtle detection methods and appropriate 
reporting standards.
FEVAR is both a relatively new procedure and technically complex. In the previous 
chapter, the migration rates for FEVAR patients treated at a single institution were reported. 
This provided essential information on the utility of the validated CLL technique when used 
to quantify fenestrated stent-graft migration. Experimental data from this chapter also 
provided early information on the incidences, timings and complications relating to 
fenestrated stent-graft migration. Using a larger sample size has allowed this thesis to 
provide greater certainty around the overall thesis aims.
Within the UK, both device manufacturers and government agencies, recommend
lifelong imaging surveillance following stent-graft AAA repair (National Institute for Health
and Care Excellence, 2006, Medtronic, 2012, Cook Medical, 2013). For a patient with a
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fenestrated stent-graft implanted, the follow-up strategy usually includes contrast-enhanced
CT scanning at 1-month, 6-months and then annually thereafter. As a result, there is a 
growing cohort of FEVAR patients across the UK, from which the position of the stent-graft 
can be tracked using these serial CT scans. The bulk of the FEVAR experience has been 
developed through a small number of specialist centres under the guidance from a single 
manufacturer. It is, therefore, highly likely that both the CT follow-up protocols and the 
implantation procedures will be similar between comparator institutions. Flowever, 
heterogeneity in the migration rates between centres will be considered within this chapter.
6.1.1 Aims
Using multicentre CT data acquired for patients who have undergone fenestrated 
stent-graft repair the research aims for this chapter are to:-
Aim 6.1. Quantify the incidence of proximal and distal (iliac) stent-graft migration of the 
Zenith fenestrated AAA endograft;
Aim 6.2. Investigate the timings of proximal and distal (iliac) stent-graft migration;
Aim 6.3. Report the frequency and type of migration-related complications and secondary 
(reinterventional) procedures encountered in this cohort.
Data generated from this chapter has also been used as the basis for the predictive 
factor analysis which has been presented in Chapter 7.
6.2 Materials and methods
Within this chapter, several of the methods used to assess migration have been previously 
described. These are within previous chapters of this thesis and within the published
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literature (England et al., 2012, England et a!,, 2013). In summary, this was a multicentre 
retrospective review of follow-up CT data in patients who had fenestrated aortic stent-grafts 
implanted within the United Kingdom.
6.2.1 Patients
Patients of both genders, who had a fenestrated aortic aneurysm repair, were considered for 
inclusion. Each patient needed to have had their AAA treated using a fenestrated aortic 
stent-graft (Zenith fenestrated AAA endograft, Cook Medical Inc, Bloomington, IN). Patients 
were identified from local endovascular databases and using the GLOBALSTAR registry. The 
GLOBALSTAR registry is a summary of UK FEVAR experience and recruited data from a total 
of 318 patients (14 centres). Inclusion into GLOBALSTAR was strict and required participating 
centres to have previous experience of both EVAR and FEVAR. Funding and project timescale 
restrictions would not allow a complete set of CT data to be obtained from all centres and for 
all patients included in GLOBALSTAR. Ethics approval (NRES 09/Q1502/43) and local Trust 
R8tD approval permitted the inclusion of data from nine GLOBALSTAR participating hospitals. 
A single study researcher, who was the author of this thesis, was responsible for case 
recruitment, data collection, and follow-up analysis.
6.2.2 Sample size justification
Previous exploratory (pilot) work at Hospital A helped inform a sample size 
calculation. Based on linear regression, a sample of approximately 140 patients would be 
required to detect an annual migration of the stent-graft equal to 2mm/year against the null 
hypothesis "slope = Imm/year" (regarded as the non-migration scenario). A significance 
level equal to 5% was considered together with study power equal to 90%. This calculation
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was based on a sample standard deviation of migration equal to 2.6 mm. The standard 
deviation was based on a sample of 27 patients with fenestrated aortic stent-grafts 
implanted and an interval of follow-up of 24 months. This initial pilot work was undertaken 
prior to the validation experiment (Chapter 4). Data from the validation chapter has since 
highlighted the limitations of treating migration distances as a continuous variable. From the 
validation experiment, it was concluded that the quantification of stent-graft migration equal 
to or greater than 4 mm is possible using current follow-up CT protocols. Stent-graft 
movements of less than 4 mm cannot be accurately quantified and, therefore, linear 
regression using these more subtle movements (0 to 3.99 mm) are likely to be unreliable. 
This issue was not known about during the initial pilot work and could not be accounted for 
in the initial sample size calculation. In order to adjust for this within this this chapter and in 
the subsequent predictive factor analysis, migration will be treated as dichotomous (binary) 
variable using the > 4 mm definition. It should be made clear that the primary reason for the 
sample size calculation was to consider the ability of the dataset to provide information on 
predictive factors. Studies using fewer patients (n=113) have successfully reported predictive 
factors for migration of standard (infrarenal) aortic stent-grafts (Cao et ai, 2002). In the 
study by Cao and colleagues, stent-graft migration was reported in only 15% of patients, this 
is a similar incidence to the single centre FEVAR experience in Chapter five of this thesis 
(18%). The report by Cao et al., also treated migration as a dichotomous variable (definition, 
movement > 10 mm). Bearing in mind both of these factors, it appears appropriate for the 
multicentre data to be analysed for predictive factors and this will be a feature of the next 
chapter. Based on the numbers of possible migration events the hypothesis to be tested will
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be that the frequency of complications and reinterventions is indifferent between patients 
with evidence of proximal migration and those patients without.
6.2.3 Research procedures applied
The primary aims for this chapter are to report the incidence (Aim 6.1), the timings 
(Aim 6.2) and the related sequelae (Aim 6.3) for both proximal and distal migration of 
fenestrated aortic stent-graft. In order to satisfy each of the above aims the following data 
collection and analysis procedures were utilised.
In order to satisfy Aim 6.1 the incidence of stent-graft migration was reported for 
each of the three endograft attachment sites (proximal, ipsilateral and contralateral iliac 
limbs). All FEVAR patients had previously undergone follow-up to a standardised surveillance 
protocol (CTA preoperatively, at 1-month, 6-months and annually thereafter). Electronic 
copies of all available CT scans were collected, transferred and stored anonymously at the 
study institution. The availability of the CT scans varied through the participating centres. 
On the basis of the results in Chapter 4, any CT scan with a significant deviation from the 
protocol used in the validation experiment was excluded from the analysis. Examples are CT 
scans without adequate intraluminal contrast, which were excluded as they could give rise to 
an unreliable CLL Such problems have been reported in a similar study by Wyss and 
colleagues and they also chose to exclude unsuitable CT scans from their analysis (Wyss et 
al., 2011).
A thorough explanation of the precise methods used to quantify stent-graft migration 
has been described in chapters 4 and 5 (England et al., 2012, England et al., 2013). In 
summary, the 1st post-operative CT scan was used as a baseline in order to measure the
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distance between the attachment sites and a vascular reference point. This measurement 
was then repeated on all available subsequent CT scans. Any measurement differences 
between the 1st postoperative CT scan and subsequent scans (of > 4 mm) would be 
considered stent-graft migration. Movement of the stent-graft in a caudal direction was 
indicated by a plus sign (+) and movement in a cranial direction by a minus (-).
For Aim 6.2, the timings of device migration would initially be determined based on 
the date of the first CT scan when stent-graft migration was detected. The date of graft 
implantation would then be subtracted from this in order to give a migration time. For the 
majority of cases early stent-graft migration is likely to be asymptomatic. For these patients 
the exact time of migration (>4 mm of movement) would be at a point between two serial CT 
scans e.g. 1st post-operative and 2nd post-operative. If these CT scans were performed at 
relatively close intervals e.g. monthly then this would generate a more precise estimation of 
the actual migration time. In reality, most patients with migration, the migration would be 
diagnosed between two annual CT scans (e.g Year 3 and Year 4). As previously stated, the 
reporting and estimation of migration rates must also take into account the time interval 
between serial follow-up examinations. Further details on the possible approaches to 
dealing with interval censoring survival data are described in the statistical section of Chapter 
5. For this chapter the event time definitions will be the same, the beginning, the midpoint 
and the end of the interval together with an interval-censoring approach. These definitions 
will again be used to report survival data using Kaplan-Meier methods.
Aim 6.3 of this chapter was to report the association between device migration and
any adverse complications or secondary interventions. The technique for identifying
complications and reintervention was described in the previous chapter and was applied to
151
this multicentre cohort. Follow-up CT data, local endovascular databases and the
GLOBALSTAR registry helped to establish the presence or absence of any complications or 
reinterventions.
6.2.4 Procedural reporting standards
When reporting migration data for the Zenith AAA endovascular stent-graft (Cook Inc, 
Bloomington, IN) it is important to provide key data on the patient sample and specific 
details around individual stent-graft configurations used. Reporting standards for 
endovascular repair do exist. The two most relevant standards are from the Society of 
Vascular Surgery (SVS) / International Cardiovascular Society (ICVS) (Chaikof et al., 2002a) 
and clinical practice guidelines from the Society of Interventional Radiology, which are 
endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the 
Canadian Interventional Radiology Association (Walker et aL, 2010). A more recent UK 
report, by Boyle and colleagues, will be used to assist in the description of the sample (Boyle 
et al., 2011). It is necessary to report such variables, as it allows the generalisability of results 
against other FEVAR cohorts. The reporting of the FEVAR procedure and its outcomes has 
followed a similar structure to that of the previous chapter.
6.2.5 Statistical analysis
As with the previous chapter, all statistical analyses were undertaken using a combination of 
SPSS for Windows Version 21.0 (IBM Corp, Armonk, NY) and the statistical programming 
package R 2.2.1 (R Development Core Team, 2005). The multicentre data generated in this 
chapter were analysed in a similar manner to the data in Chapter 5. For full details of the 
statistical analyses please refer to the previous statistical analysis section. In addition, using
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Kaplan-Meier survival analysis, a log-rank test (Fay and Shaw, 2010) was undertaken in order 
to compare freedom from proximal stent-graft migration in patients with and without 
evidence of complications or reinterventions. The use of a log-rank test was further 
developed to assess the differences between migrations rates for the single centre cohort 
(Hospital A) and the additional multicentre data (Hospitals B - I). Full details of this analysis 
are provided at the end of this chapter.
6.3 Results
6.3.1 Description of dataset
Patients treated by FEVAR from February 2003 through to March 2012 were entered into this 
retrospective review following entry into the GLOBALSTAR registry (n=154). Additional 
patients had undergone FEVAR but either failed to satisfy the study inclusion or satisfied the 
exclusion criteria. The most abundant reason for exclusion was a lack of a baseline (1st) post­
operative CT. Reasons for this included imaging outside of the treating institution, absence 
of CT data on the hospital PACS or an inability to secure approval from the NHS site to 
receive CT data. Details of the study exclusions can be found in Table 6.1. When considering 
the total number of patients available within the GLOBALSTAR registry, this potentially 
included all patients treated by each of the respective institutions. It is, therefore, accepted 
that there may be a learning curve associated with some of the early patients included within 
this chapter. Based on an evaluation of selected parameters from the GLOBALSTAR 
database, there were no significant differences between the two groups (included and 
excluded). The median (1QR) age was 73.0 (68.0 to 78.5) years for included patients and 74.4 
(69.3 to 80.0) years for excluded (P=0.12). Of the 154 patients included, 91% were men
versus 89% in the excluded group (P=0.37). Similarly for AAA diameter, in the included group
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the median (IQR) diameter was 62 (58 to 69) mm versus 60 (58 to 70) mm for the excluded 
group (P=0.92). It should be noted that a full range of preoperative variables (entry 
parameters) were not available for excluded patients and a comparison has been made 
based on those available.
Table 6.1 Summary of inclusions and exclusions from the participating centres (n refers to the number
of patients)
Included
Clinical Site
Total
Cohort n %
A 83 60 72%
D 44 14 32%
B 36 23 64%
F 23 12 52%
E 19 14 74%
C 19 16 84%
1 18 3 17%
G 14 8 57%
H 6 4 67%
Total available
cohort 262
Included, n 154
Included, % 59%
Numbers of patients eligible for inclusion within this study (total available 
cohort) did include each individual centres learning curve (this is a 
requirement of inclusion in the GLOBALSTAR registry.
For the included patients, baseline demographics, comorbidities and American 
Society of Anesthesiologists (ASA) physical status gradings (Dripps, 1963) are described in 
Table 6.2. Variable selection was based on available data available from the UK GLOBALSTAR 
registry (BSET and GLOBALSTAR Collaborators, 2012), parameters routinely recorded in local
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endovascular databases and those suggested by relevant reporting standards. It must be 
noted that this was largely a multicentre retrospective review and that the majority of 
variables were entered through a secure website. Some variables were not submitted for 
several patients and the degree of missingness, where present, has been described within 
each of the relevant results tables.
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Table 6.2 Description of multicentre cohort (baseline demographics, comorbidities and AAA diameter)
Continuous variables
Mean SD Median IQR Min. Max. Normality n Missingness
test
(%)
Age (years) 73.9 6.8 74.0 69.0 to 79.0 54.0 87.0 0.06 151 2%
Maximum aneurysm diameter (mm) 66.4 9.5 65.0 593 to 72.0 52.0 108 <0.001 152 1%
SO, standard deviation. IQR, inter quartile range. Min, minimum. Max, maximum. Normality test, Shapiro-Wilk. Shaded areas indicate the appropriate 
summary statistic when considering the distribution of the data.
Categorical variables (n=154)
n n (%) Missing Missingness (%)
Gender
Male 141 92% 0 0%
Ischaemic heart disease 64 42% 27 18%
Heart failure 9 6% 28 18%
Hypertension 84 55% 27 18%
Chronic renal insufficiency 10 7% 28 18%
ASA physical status grade
1 1 1%
II 32 21%
37 24%
III 76 49%
IV 8 5%
Diabetes mellitus 15 10% 27 18%
ASA, American Society of Anesthesiology. Definitions for categorical variables are provided within the 
appendices, n, number of patients.
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6.3.2 Operative details (procedure)
Cook Zenith fenestrated stent-grafts were successfully implanted into all included patients. A 
variety of target vessel configurations were used (Table 6.3), the most common was an SMA 
scallop and two renal fenestrations. There were a total of 468 target vessels, of which 335 
(72%) were stented (Table 6.3).
Table 6.3 Graft shape and target vessel configuration for the multicentre cohort
Categorical variables (n=154) n % Missingness
(%)
Graft shape
Tube 6 4%
Aorto-uni-iliac (AUI) 5 3% 0%
Bifurcated 143 93%
Target vessel configuration
CA
Scallop (stented) 29(0) 19% (0%)
0%
Fenestration (stented) 6 (6) 4% (4%)
SMA
Scallop (stented) 93 (0) 60% (0%)
0%
Fenestration (stented) 45(44) 29% (29%)
RT renal
Scallop (stented) 7 (2) 5% (1%)
0%
Fenestration (stented) 137 (137) 89% (89%)
LT renal
Scallop (stented) 6 (2) 4% (1%)
0%
Fenestration (stented) 145(144) 94% (94%)
Under the section of target vessel configuration values in the parentheses indicate the number and percentage of stented 
vessels. CA, coeliac axis. SMA, superior mesenteric artery. RT, right. LT, left, n, number of patients.
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All patients were followed-up according to local protocols within the respective study
institution. Patients were followed-up for a median 20.9 (IQR 10.4 to 36.5, range 6 to 109) 
months.
6.S.3 Device migration
Based on the retrospective collection and analysis of 564 follow-up CT scans, the distance 
between the proximal and distal positions of the stent-graft (SMA to proximal stent and CIA 
bifurcation to distal stent) were measured and compared. Using previously acquired 
validation data (Chapter 4) the criteria for stent-graft migration was defined as any 
movement (proximally or distally) > 4 mm. The presence of proximal stent-graft migration 
was assessed in a total of 154 patients and a subsequent assessment of iliac limb migration 
was possible in 259 ClAs. Full details on the landing sites assessed within the study cohort 
are illustrated in Figure 6.1.
Figure 6.1 Inclusions and exclusions within the multicentre cohort
IQ/CLL issue 
n -5
Available for 
assessment 
n * 142
Occluded IIA 
n - 14
IQ/CLL issue 
n - 6
Distal 
(iliac limb)
Patients 
n -154
Excluded 
n * 12
Occluded IIA 
n»6
n -129
Proximal
Excluded 
n * 6
Available for 
assessment 
n- 148
Not assessed 
n-12
Not assessed 
n-19
Sites assessed
Assessed
n = 130
Ipsilateral Contralateral
IIA, internal iliac artery; IQ, image quality; CLL, central luminal line. Reasons for exclusion 
include tube and aorto-uni-iliac device with an absent iliac limb.
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Proximal migration
Thirty-three (21%) patients showed CT evidence of proximal migration (median migration 
+6.0, IQ.R +4.5 to +7.9, range +4.1 to +10.0 mm). The median time to the 1st CT diagnosis of 
proximal migration was 11.8 (IQR 9.0 to 23.4, range, 1.0 to 88.7) months. Based on 329.9 
years of follow-up data, it can be estimated that there will be one proximal migration per 10 
person-years of follow-up. Full details on the frequencies, magnitudes and timings of 
proximal migration are illustrated in Figure 6.2 and Figure 6.3. Kaplan-Meier survival analysis 
for estimating freedom from proximal migration will be discussed later in this chapter.
Figure 6.2 Magnitudes and frequencies of proximal stent-graft migration
4.0 to 4.9 5.0 to 5.9 6.0 to 6.9 7.0 to 7.9 8.0 to 8.9 9.0 to 9.9 >10
Caudal migration distance, mm
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Figure 6.3 Time to 1st CT diagnosis of proximal migration
1-11 12-23 24-35 36-47 48-59 60-71 72-83 >83
Time to 1st CT diagnosis of migration, months
Distal (iliac) limb migration
Using data from 154 patients, a total of 259 iliac limbs were assessed for the presence 
of distal migration. In 36 patients (49 ClAs) a CLL was unable to be constructed or there was 
an absence of a deployed iliac limb (e.g. tube or AUI device) (Figure 6.1). Of the 259 limbs 
assessed 34 (13%) showed CT evidence of cranial migration, median -6.1 mm (IQR -7.8 to - 
5.1, range -21.3 to -4.1) mm. Based on 276 person-years of iliac limb follow-up, it is 
estimated that there will be one iliac limb migration per 9.9 years of follow-up. Details on 
the magnitude and timings for distal migration of both ipsilateral and contralateral limbs are 
illustrated in Figure 6.4 and Figure 6.5.
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Figure 6.4 Magnitudes and frequencies of distal stent-graft migration
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Figure 6.5 Time to 1st CT diagnosis of distal (iliac) limb migration (based on the assessment of 259
limbs)
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Any (proximal or distal) migration
The number of patients experiencing either a proximal or distal (iliac) limb migration was 52 
(34%) and the number of patients with proximal and at least one iliac limb migration was 28 
(24%).
6.3.4 Timing of migration
Kaplan-Meier survival analysis, using interval censoring, estimated that the probability of 
being free from proximal migration at 12, 24 and 36 months were 82% (95% Cl, 75%-89%), 
77% (95% Cl, 70%-85%) and 77% (95% Cl, 70%-85%), respectively. Data using standard 
survival approaches, with event time (T) at the beginning, midpoint and the end of the 
interval are also provided for comparison (Table 6.4 and Figure 6.6).
Table 6.4 Comparison of survival estimation approaches for proximal migration (multicentre 
data). Percentages relate to the proportion of patients free from migration.
Time, mo
Interval censoring Beginning of interval
n. risk survival 95% Cl n. risk survival 95% Cl
12 89 82% 75% to 89% 88 82% 76% to 89%
24 49 77% 70% to 85% 48 79% 72% to 86%
36 31 77% 70% to 85% 29 74% 65% to 84%
48 13 64% 51% to 80% 13 71% 61% to 82%
Midpoint of interval End of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 92 84% 78% to 90% 92 84% 78% to 90%
24 49 77% 70% to 85% 49 77% 70% to 85%
36 30 75% 67% to 84% 30 75% 67% to 84%
48 13 63% 51% to 79% 13 63% 51% to 79%
Mo, months. n, number of patients. Cl, confidence interval.
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Figure 6.6 Kaplan-Meier survival analysis illustrating freedom from proximal stent-graft migration 
using a combination of event time definitions (multicentre data).
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across the y-axis relate to the proportion of patients free from migration.
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As previously stated, a total of 259 iliac limbs were assessed for the presence of distal 
stent-graft migration. Survival analyses were undertaken for ipsilateral and contralateral iliac 
limbs and for evidence of any iliac limb migration. Kapian-Meier survival analysis, using 
interval censoring, estimated that the probability of being free from any iliac limb migration 
at 12, 24 and 36 months were 85% {95%CI 79% to 92%), 82% (95%CI 75% to 90%) and 65% 
(95%CI 52% to 80%), respectively (Table 6.5, Figure 6.7). For separate iliac limbs, the 
ipsilateral migration rate at 12, 24 and 36 months were 94% (95%CI 90%-98%), 87% (95%CI 
80%-95%) and 76% (95%CI 64%-89%), respectively (Table 6.6, Figure 6.8). Contralaterally, 
freedom from migration rates were similar 92% (95%CI 93%-100%), 92% (95%CI 87%-98%) 
and 78% (95% Cl 67%-90%), respectively (Table 6.6, Figure 6.9).
Table 6.5 A comparison of survival estimation approaches for freedom from any iliac limb 
migration. Percentages relate to the proportion of patients free from migration.
Interval censoring Beginning of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 83 85% 79% to 92% 78 83% 77% to 90%
24 45 82% 75% to 90% 41 80% 73% to 88%
36 22 65% 52% to 80% 21 76% 68% to 86%
48 12 65% 52% to 80% 11 76% 68% to 86%
Midpoint of interval End of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 89 91% 86% to 96% 93 93% 89% to 98%
24 44 80% 72% to 88% 50 84% 77% to 93%
36 24 73% 63% to 84% 28 70% 59% to 84%
48 11 62% 49% to 79% 13 62% 49% to 78%
Mo, months. n, number of patients. Cl, confidence interval.
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Figure 6.7 Kaplan-Meier survival analysis illustrating freedom from any iliac limb migration using a 
combination of event time definitions (multicentre data).
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Table 6.6 Comparison of survival estimation approaches for individual iliac limb migration 
(multicentre data). Percentages relate to the proportion of iliac limbs free from 
migration.
Ipsilateral Interval censoring Beginning of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 81 95% 90% to 99% 78 92% 87% to 97%
24 45 89% 82% to 96% 43 85% 77% to 94%
36 26 77% 67% to 90% 26 82% 74% to 92%
48 14 77% 67% to 90% 14 82% 74% to 92%
Midpoint of interval End of interval
Time, mo n. risk Survival 95% Cl n. risk survival 95% Cl
12 81 95% 91% to 99% 82 95% 91% to 99%
24 44 98% 82% to 96% 46 90% 84% to 97%
36 26 79% 68% to 91% 29 80% 70% to 92%
48 14 79% 68% to 91% 14 74% 62% to 89%
Contralateral Interval censoring Beginning of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 86 95% 91% to 99% 83 92% 88% to 97%
24 49 90% 84% to 97% 47 88% 82% to 95%
36 24 76% 65% to 89% 24 82% 73% to 92%
48 15 76% 65% to 89% 15 82% 73% to 92%
Midpoint of interval End of interval
Time, mo n. risk survival 95% Cl n. risk Survival 95% Cl
12 85 94% 90% to 98% 86 94% 90% to 99%
24 48 90% 84% to 96% 49 90% 84% to 97%
36 25 81% 71% to 92% 28 82% 72% to 93%
48 15 77% 67% to 90% 16 75% 63% to 90%
Mo, months, n, number of patients. Cl, confidence interval.
Figure 6.8 Kaplan-Meier survival analysis illustrating freedom from ipsilateral limb migration using a 
combination of event time definitions (multicentre data)
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Figure 6.9 Kaplan-Meier survival analysis illustrating freedom from contralateral limb migration using 
a combination of event time definitions (multicentre data)
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Freedom from any (proximal or distal iliac limb) migration at 12, 24 and 36 months 
were 72% (95%CI 65%-80%), 69% (95%CI 61%-78%) and 50% (95%CI 44%-67%), respectively 
(Figure 6.10 and Table 6.7).
Table 6.7 A comparison of survival estimation approaches for freedom from any
migration (proximal or distal). Percentages relate to the proportion of patients free 
from migration.
Time, mo
Interval censoring Beginning of interval
n. risk survival 95% Cl n. risk survival 95% Cl
12 80 72% 65% to 80% 78 72% 65% to 80%
24 41 69% 61% to 78% 37 63% 54% to 73%
36 21 55% 44% to 67% 18 52% 41% to 65%
48 10 44% 32% to 59% 9 48% 37% to 63%
Midpoint of interval End of interval
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 85 76% 69% to 84% 97 79% 72% to 87%
24 40 66% 58% to 75% 45 66% 58% to 76%
36 20 52% 42% to 65% 28 57% 47% to 69%
48 9 38% 26% to 56% 13 39% 27% to 55%
Mo, months, n, number of patients. Cl, confidence interval.
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Figure 6.10 Kaplan-Meier survival analysis illustrating freedom from any migration (proximal or iliac 
limb) using a combination of event time definitions (multicentre data)
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Consideration must also be made for patients, where an iliac limb had been deployed 
but a CLL analysis was not possible (image quality reasons or occluded IIA). It could be 
theoretically possible that these limbs had undergone migration but because a CLL could not 
be generated, then they could not be accounted for in the analysis. To account for this, two 
exploratory (sensitivity) analyses were undertaken with the following assumptions. 1) any 
deployed iliac limb that could not be assessed would be considered to have migrated by the 
second CT scan (6-months). It was also assumed that the previous CT scan would have been 
performed at 1-month (interval). The results of this analysis are presented in Figure 6.11 and 
Table 6.8. A second set 2) of assumptions were that any iliac limbs not assessed using a CLL 
were assumed to have migrated with a similar incidence (13%) and timings as those in 
assessed patients. The results of the second exploratory analysis are presented in Table 6.9 
and Figure 6.12.
Table 6.8 Comparison between Kaplan Meier survival analysis (original data) and a modified dataset 
assuming migration at six months for missing values (Assumptions 1)
n.risk survival (%) lower 95%CI upper 95%CI
time. Original Modified Original Modified Original Modified Original Modified
mo dataset dataset dataset dataset dataset dataset dataset dataset
■o 12 82 107 94 95 90 92 98 99
5' a) 24 44 47 87 91 80 85 95 96
o" n>
SL
36 36 26 76 74 64 63 89 87
48 15 15 76 74 64 63 89 87
no 12 84 84 92 76 87 69 98 833__ *"+ 24 49 49 92 75 87 68 98 83
3 SLo- U
3
36 24 24 78 64 67 54 90 75
48 13 13 78 64 67 54 90 75
Cl, confidence interval. Mo, months. All survival analyses were constructed using an interval censoring approach. For 
patients with missing iliac migration data the incidence of migration was assumed to be at 6-months with a prior CT scan at 
1 month. Percentages relate to the proportion of iliac limbs free from migration.
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For assumption one, when comparing the original and modified datasets, there were
no changes in the freedom from ipsilateral iliac limb migration rates during follow-up. For 
contralateral limbs, the migration rate increased by between 14% and 16% across all follow­
up times, when switching from the original to the modified dataset. There was a narrowing 
of the 95% Cl when using the modified dataset reflecting the increased sample size. For the 
second assumption, there were little differences in the survival rates when switching 
between datasets (1% to 4%). Again, there was a reduction in the size of the confidence 
intervals when using the larger (modified) datasets. Although the use of a modified dataset 
decreases, the confidence intervals for the survival estimates questions regarding the most 
appropriate scenario exist. With data missing on 31 iliac limbs it is likely that there will have 
been migration in some limbs and, therefore, when interpreting the survival estimates this 
point must be considered.
Table 6.9 Comparison between Kaplan Meier survival analysis (original data) and a dataset 
assuming migration a similar migration rate for missing values (Assumptions 2)
n.risk survival (%) lower 95%CI upper 95%CI
time. Original Modified Original Modified Original Modified Original Modified
mo dataset dataset dataset dataset dataset dataset dataset dataset
T3 12 82 107 94 95 90 92 98 99
1 & 24 44 47 87 91 80 85 95 96cr re 36 36 26 76 74 64 63 89 870)
48 15 15 76 74 64 63 89 87
no
12 84 109 92 94 87 90 98 98
3_ #+ 24 49 52 92 94 87 89 98 98
3 a.
O’ %
(V
36 24 24 78 74 67 63 90 87
s_ 48 13 13 78 74 67 63 90 87
Cl, confidence interval. Mo, months. All survival analyses were constructed using an interval censoring approach. For 
patients with missing iliac migration data the incidence of migration was assumed to mirror that of the original dataset. 
The missing cases were then modeled as either migrated or non-migrated with interval, event time or maximum follow-up 
reflect the mean data from the original dataset. Percentages relate to the proportion of iliac limbs free from migration.
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Figure 6.11 Sensitivity analysis, Kaplan-Meier plot, using interval censoring, of freedom from 
ipsilateral and contralateral limb migration assuming a 6 month migration time for all non-assessed 
iliac limbs(Original data versus Assumption 1)
Ipsilateral (Original) • Interval censoring Ipsilateral (Assumption 1) • Interval censoring
Time Som 1«ro*o*^p CT scon, (norths
r « twn
Tune from 1st lotow ip CT scon.
Contralateral (Original) • Interval censoring Contralateral (Assumption 1) - Interval censoring
Time from 1st Mow ip CT soon, (norths Tene from in fdow4? CT scan, (norths
95% confidence intervals (dotted lines); CT, computed tomography; std. err, standard error. Percentages relate 
to the proportion of iliac limbs free from migration.
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Figure 6.12 Kaplan Meier survival analysis, using interval censoring for a modified dataset assuming a 
similar migration rate to those assessed using a CLL
(ptJUteral (Original) • Interval centering Ip*lateral (Assumption 2) • Interval censoring
m lotoe-te ct scan, morns Tune ton 1st lotCMMjp CT scan, months
Contralateral (Original) • Interval censoring Contralateral (Assumption 2) • Interval censoring
Ttne tern 1« lo!oaM« CT scan, mores Tme ton 1st lotow ip CT scan.
95% confidence intervals (dotted lines); CT, computed tomography; std. err, standard error. Percentages relate 
to the proportion of iliac limbs free from migration.
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6.3.5 Migration-related complications and reintervention
Complications are an accepted part of FEVAR. Endoleak, thrombosis, graft kinking and 
component fracture can all result from stent-graft migration but can also be attributed to 
other causes. In view of the number of participating centres, migration and complication 
definitions and data collected within the GLOBALSTAR registry, it was not always possible to 
ascertain the direct cause a complication or subsequent reintervention. However, it is 
plausible that the incidence of these events would be greater in a cohort of patients 
demonstrating evidence of stent-graft migration.
Forty-five endoleaks were present in 37 (24%) patients during follow-up, they were, 
however, statistically no more or less prevalent in patients with proximal stent-graft 
migration (Fisher's Exact test, P=0.13) (Table 6.10). Graft-related endoleaks (types 1 and 3) 
were present in 16 patients (13%) but only three patients (9%) with a graft-related endoleak 
had CT evidence of proximal stent-graft migration (Fisher's Exact test, P=0.15). Target vessels 
were lost in 10 (8%) patients, three of which had CT evidence of proximal migration (Fisher's 
Exact test, P=0.35) (Table 6.10). The number of cases of kinking and component fractures 
were statistically indifferent between proximal migration and non-migration groups (Fisher's 
Exact test, P=0.12 and P=0.54, respectively). Full details of complications are described in 
Table 6.10.
The iliac-related secondary events that could be related to distal iliac limb migration 
are distal type 1 endoleak and iliac limb occlusion. The distal type 1 endoleak rate has been 
previously reported in only one (0.6%) patient (Table 6.10). Limb occlusions were reported in 
6 (3.9%) patients, the majority (five) were experienced within the first 30-days post-
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implantation and were not considered to be associated with either proximal or distal
fenestrated stent-graft migration. The individual per-limb failure rate was six out of 259 
limbs (2.3%).
Table 6.10 Complications and their potential relationship with proximal migration during follow-up.
Early Late
No proximal Proximal No proximal Proximal
migration migration migration migration
(n=121) (n=33) P value (n=121) (n=33) P value
Target vessel loss* 1 (1%) 2(6%) 0.12 6 (5%) 1 (3%) 0.54
Endoleak
Type 1 proximal 9 (7%) 2(6%) 1(1%) 1 (3%)
Type 1 distal 1 (1%) 0 (0%)
0.85
0 (0%) 0 (0%)
0.39
Type 3 0 (0% 0(0% 2(2%) 0(0%)
Type 2 7 (6%) 3 (9%) 17 (14%) 2 (6%)
Kinking* 8 (7%) 5 (15%) 0.12
Component fracture* 6 (5%) 1 (3%) 0.54
Component separation* 12 (11%) 6 (19%) 0.16
Limb occlusion* 5 (4%) 0(0%) 0.29 1 (1%) 0(0%) 0.79
P values for categorical variables (indicated by an asterisk*) are expressed using Fisher's exact test. All other 
categorical variables are expressed using the Chi-squared test. Component separation was defined as movement 
between the proximal and distal bodies > 4 mm.
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The reintervention rate within this multicentre cohort is likely to reflect the incidence of 
complications. On the whole, there was a relatively low number of complications and this is 
reflected in a low number of reinterventions (n=13, 8%) (Table 6.11). When comparing crude 
reintervention rates between a proximal migration cohort they were not statistically 
different (P=0.50). Interventions for endoleak were undertaken in five patients (3%), four of 
these were in patients without evidence of proximal migration and one in a patient with 
proximal migration (P=0.71). It has not been reflected within this paragraph or the 
accompanying table (Table 6.11) the relationship between the timings of the reinterventions 
and the timings of any migration. It may have been possible, that in some patients the 
migration may have occurred at a time point after the reintervention and, therefore, it would 
not be considered to be connected. This factor must be considered when interpreting these 
results.
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Table 6.11 Reinterventional procedures encountered in the multicentre cohort
Migration P
No Yes Value
(n=121) (n=33)
Reintervention 10 (8%) 3 (9%) 0.50
Endoleak
Balloon dilatation 1 1
Embolisation 2 0
Unspecified 1 0
TV compromise
PTA 1 0
Stenting 3 1
Unspecified 2 1
Total 10 3
Numbers represent the number of patients, no patient had more than a single
reinterventional procedure. PTA, percutaneous transluminal angioplasty, 
expressed using Fisher's exact test.
P values were
Reintervention resulting from the compromise of a target vessel were required in 
eight patients (5%). Again, it was difficult from reviewing the available data to ascertain if 
any cases were the unequivocal result of proximal stent-graft migration. There were six 
procedures for target vessel compromise in patients without evidence of proximal migration 
versus two reinterventions in those patients with proximal migration (P=0.54). Interventions 
favoured an endovascular approach and this may reflect the nature of the complications.
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available treatment options and the physical status of the patients. It must be highlighted 
that other complications were reported (e.g. infection) but were not reported in the 
statistical analysis as they were thought to not be relevant to an investigation of device 
migration. Target vessel compromise was attributed to both occluded and threated 
(stenosed) vessels. For a vessel to be eligible for inclusion in this category, it needed to have 
been assigned a scallop or fenestration on the deployed endograft. By way of a further 
example, if the deployed device had a single renal scallop and the coeliac axis occluded at 24 
months following repair, this could not have been categorised as a target vessel loss.
Survival estimates were generated for patients who experienced complications or 
required a secondary interventional procedure using the subgroup of patients with and 
without proximal migration (Figure 6.13). The Kaplan-Meier survival curves were constructed 
using interval censored data and the resultant survival functions were statistically compared 
using a log-rank test (Zhao and Sun, 2004, Kalbfleisch and Previce, 2002). Within this chapter 
the log-rank test was used to test the null hypothesis that there is no difference in probability 
of an event (complication or reintervention) at any time point for a group with proximal 
migration and a group without. The advantage of this technique is that the analysis is based 
on the times of the event and not just whether the event occurred. A limitation is that the 
log-rank test is purely a test of significance and it cannot provide an estimate of the size 
difference between the groups or a confidence interval (Bland and Altman, 2004). In order 
to understand the size of any effect difference a Cox proportional hazards model must be 
used, this will be focus of the next chapter. Based on the log-rank calculations from the 
survival curves in Figure 6.13, there were no statistical differences in the proximal survival 
functions for complications (P=0.84) and reinterventions (P=0.81).
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Figure 6.13 Kaplan-Meier curves (using interval censoring) showing freedom from proximal migration
in patients with and without a complication. Log-rank test, P=0.84
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Figure 6.14 Kaplan-Meier curves (using interval censoring) showing freedom from proximal migration 
in patients with and without reintervention. Log-rank test, P=0.81
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6.3.6 Migration rate by institution
The primary aim of this research was not to compare migration rates, either proximal or 
distal, between participating centres. However, data from Hospital A has previously been 
presented (Chapter 5) and has been incorporated into the multicentre analysis in this chapter 
(n=154). The data included in the chapter from Hospital A now contains an additional five 
patients and overall follow-up duration is longer. It is, however, important to see the 
differences in migration rates between Hospital A (pilot sample) and Hospitals B - I 
(additional multicentre data). Differences in migration data between the pilot and 
multicentre cohorts will now be presented and followed by an exploratory analysis of 
migration outcomes for individual centres.
Of the 154 patients included in the multicentre analysis 94 (61%) were recruited from 
Hospitals B - I. A comparison of baseline demographics, comorbidities and ASA physical 
status grading are described in Table 6.12. On the whole there were no statistically 
significant differences (P>0.05) in baseline demographics, comorbidities and ASA grades 
between patients from Hospital A and those from Hospitals B-l. The graft shape and target 
vessel configurations were also compared between Hospital A and Hospitals B -1 (Table 6.13 
& Table 6.14). Median (IQR) follow-up duration were 30.7 (14.3 to 49.6) months and 17.2 
(8.4 to 26.1) months for Hospital A and Hospitals B-l, respectively. When assessed using a 
Mann-Whitney U test differences in follow-up duration were statistically significant 
(P<0.001). This difference could have been expected in that Hospital A was the first centre in 
the UK to embark on FEVAR procedures and was responsible for cascading training and 
developing a FEVAR service in hospitals B-l.
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Table 6.12. Differences in demographics and comorbidities between patients 
from Hospital A and Hospitals B-l.
Hospital A Hospitals B -1 P
value
Age, years 74 (SD 7) 74 (SD 7) 0.56
Maximum AAA diameter. 66 (IQR 60-73) 65 (IQR 59- 0.49
mm 70)
Gender, male 53 (88%) 88 (94%) 0.20
Ischaemic heart disease 31 (56%) 33 (46%) 0.16
Fleart failure 3 (6%) 6 (8%) 0.41
Fiypertension 33 (60%) 51 (71%) 0.14
Chronic renal insufficiency 6 (11%) 4 (6%) 0.21
Diabetes mellitus 4 (7%) 11 (15%) 0.13
ASA physical status grade
1 1 (2%) 0 (0%) 0.16
II 16 (29%) 16 (26%) [0.12]
III 37 (67%) 39 (63%)
IV 1 (2%) 7(11%)
SD, standard deviation; IQR, inter-quartile range; ASA, American Society 
for Anesthesiology. For continuous data P values were calculated using 
either a t-test or Mann-Whitney U test. For categorical data either 
Fisher's Exact or Chi-squared test were used. Figures in the parentheses 
of categorical variables indicate the relative proportion for each cohort. 
Figures in the square brackets indicate the linear-by-linear association 
test.
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Table 6.13. Differences in stent-graft configurations implanted in patients 
from Hospital A and Hospitals B-l.
Hospital A Hospitals B-l P value
Bifurcated 60(100%) 83 (88%) 0.02
AUI 0(0%) 5(5%) [0.01]
Tube 0 (0%) 6 (6%)
Numbers within the parentheses indicate the relative proportions for 
each cohort. P values were generated using the Chi-squared test 
[linear-by-linear association].
Table 6.14. Target vessel configuration used, comparison between patients 
from Hospital A and Hospitals B-l.
Hospital A Hospitals B-l P value
CA
Scallop 13 (22%) 16 (17%) 0.75
Fenestration 2 (3%) 4 (4%)
SMA
Scallop 34 (57%) 59 (63%) 0.59
Fenestration 18 (30%) 27 (29%)
RT renal
Scallop 3 (5%) 4 (4%) 0.74
Fenestration 52 (87%) 85 (90%)
LT renal
Scallop 4 (7%) 2 (2%) 0.03
Fenestration 53 (88%) 92 (98%) [0.008]
No statistically significant differences were identified between the number of target vessels
stented between Hospital A and Hospitals B-l (P>0.05). CA, coeliac axis. SMA, superior.
mesenteric artery. RT, right. LT, left. Numbers within the parentheses indicate the relative
proportions for each cohort. P values were generated using the Chi-squared test [linear-by-
linear association].
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Proximal migration
Proximal migration rates have been previously described for the pilot data and the full 
multicentre cohort. Proximal migration data will now be presented stratified for cohort 
(Hospital A versus Hospitals B - I). For Hospital A there were ten (17%) cases of proximal 
migration whereas for Hospitals B - I there were 23 (24%) cases according to thesis 
definitions. Median (IQR) proximal migration distances were +6.9 (+4.9 to +9.1) mm and +5.1 
(+4.3 to +7.7) mm for Hospital A and Hospitals B - I, respectively. When assessed using a 
Mann-Whitney U there were no statistically significant differences between the two groups 
(P=0.167). Full details on the frequencies, magnitudes and times of proximal migration are 
illustrated in Figure 6.15 & Figure 6.16.
Figure 6.15. Magnitudes and frequencies of proximal stent-graft migration (comparison between 
Hospital A and Hospitals B-1)
ii
10
9
Hospital A
Hospitals B -1
3
2
1
0
4.0 to 4.9 5.0 to 5.9 6.0 to 6.9 7.0 to 7.9 8.0 to 8.9 9.0 to 9.9
Caudal migration distance, mm
>10.0
184
Figure 6.16 Time to 1st CT diagnosis of proximal migration (comparison between Hospital A 
and Hospitals B-1)
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Kaplan-Meier survival analysis, using interval censoring, estimated that the 
probability of being free from proximal migration, at Hospital A, at 12, 24 and 36 months 
were 92% (95% Cl, 86%-100%), 85% (95% Cl, 75%-96%) and 85% (95% Cl, 75%-96%), 
respectively. For Hospitals B - I the probability of being free from proximal migration at 12, 
24 and 36 months were lower, 75% (95% Cl, 65%-85%), 70% (95% Cl, 59%-82%) and 70% 
(95% Cl, 59%-82%), respectively. Comparison of the two survival curves (Figure 6.17) visually 
and using the log rank test (P=0.01) confirmed that the proximal migration hazards were 
statistically different between cohorts.
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Figure 6.17. Kaplan-Meier survival analysis illustrating freedom from proximal stent-graft migration 
using interval-censoring (comparison between Hospital A and Hospitals B -1).
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Distal (iliac) limb migration
Using data from the two cohorts, a total of 110 iliac limbs were assessed for the presence of 
distal migration from Hospital A and 151 from Hospitals B -1. Of the 110 limbs assessed from 
Hospital A, 22 (20%) showed CT evidence of cranial migration. Median (IQR) migration was - 
7.0 (-8.0 to -4.5) mm and -6.1 (-7.4 to -5.2) mm for ipsi- and contralateral limbs, respectively. 
Of the 151 limbs assessed from Hospitals B - I 13 (9%) showed evidence of cranial migration. 
Median (IQR) migration was -5.8 (-6.6 to -5.1) mm and -9.6 (-15.0 to -5.1) mm for ipsi and 
contralateral limbs, respectively. Details on the magnitude and timings for distal migration of 
both ipsilateral and contralateral limbs are illustrated in Figure 6.4 and Figure 6.5.
Figure 6.18. Magnitudes and frequencies of ipsilateral limb migration (comparison between Hospital 
A and Hospitals B-l)
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Figure 6.19. Time to 1st CT diagnosis of ipsilateral limb migration (comparison between Hospital A and 
Hospitals B-l)
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Figure 6.20. Magnitudes and frequencies of contralateral limb migration (comparison between 
Hospital A and Hospitals B-l)
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Figure 6.21 Time to 1st CT diagnosis of contralateral limb migration (comparison between Hospital A 
and Hospitals B-l)
m Hospital A 
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Kaplan-Meier survival analysis, using interval censoring, estimated that the probability of 
being free from any iliac limb migration, at Hospital A, at 12, 24 and 36 months were 89% 
(95% Cl, 81%-98%), 81% (95% Cl, 71%-92%) and 57% (95% Cl, 42%-76%), respectively. For 
Hospitals B - I the probability of being free from proximal migration at 12, 24 and 36 months 
were similar at 90% (95% Cl, 84%-97%), 77% (95% Cl, 65%-92%) and 62% (95% Cl, 44%-88%), 
respectively. Visual inspection of the two survival curves (Figure 6.22) and analysis of the log 
rank test (P=0.53) suggested, based on the available evidence, that the any iliac limb 
migration hazards were indifferent between cohorts. Data breakdowns by iliac limb type are 
present in Figure 6.23 & Figure 6.24.
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Figure 6.22 Kaplan-Meier survival analysis illustrating freedom from any iliac limb migration using 
interval-censoring (comparison between Hospital A and Hospitals B -1).
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Figure 6.23. Kaplan-Meier survival analysis illustrating freedom from any ipsilateral iliac limb 
migration using interval-censoring (comparison between Hospital A and Hospitals B -1).
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Figure 6.24. Kaplan-Meier survival analysis illustrating freedom from any contralateral iliac limb 
migration using interval-censoring (comparison between Hospital A and Hospitals B -1).
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Any migration
The number of patients experiencing either a proximal or distal (iliac) limb migration was 26 
(43%) for Hospital A and 31 (33%) for Hospitals B -1 (P=0.232). The number of patients with 
proximal migration and at least one iliac limb migration was two (3%) in Hospital A and five 
(5%) Hospital B-1 (P=0.705). Kaplan-Meier survival analysis, using interval censoring, 
estimated that the probability of being free from any device migration, at Hospital A, at 12,
24 and 36 months were 69% (95% Cl, 57%-82%), 69% (95% Cl, 57%-82%) and 69% (95% Cl, 
57%-82%), respectively. For Hospitals B -1 the probability of being free from any migration 
at 12, 24 and 36 months were 69% (95% Cl, 59%-80%), 63% (95% Cl, 52%-77%) and 47% (95% 
Cl, 29%-76%), respectively. Visual inspection of the two survival curves (Figure 6.25) and 
analysis of the log rank test (P=0.75) suggested, based on the available evidence, that the any 
migration rates were indifferent between cohorts.
193
Figure 6.25. Kaplan-Meier survival analysis illustrating freedom from any device migration using 
interval-censoring (comparison between Hospital A and Hospitals B -1).
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The primary aim of this research was not to compare migration rates, either proximal or 
distal, between participating centres. These data are available but must be treated with 
caution, since there is a wide range in the number of patients included by each of the 
participating centres (Table 6.15 and Table 6.16). Between centres, the proximal migration 
rate ranged from 0 to 44%. Based on the evidence available and when using a Chi-squared 
test these differences between centres did not reach statistical significance (P=0.05). 
Distally, the range was narrower (0 to 29%) but again when using a Chi-squared test, there 
was no statistical significant (P=0.34). In both of these situations the Chi-square test must be 
used with some caution as there were lower frequencies for some participating centres. As 
Frankfort-Nachmias and Leon-Guerrero report, Chi-square is sensitive to small expected 
frequencies in the cells and caution needs to be taken when in interpreting Chi-square if one 
or more cells have frequencies less than 5 (Frankfort-Nachmias and Leon-Guerrero, 2010). 
All institutions participating in this study are high volume UK vascular centres. Training for 
FEVAR was supervised by a single manufacturer (Cook Medical Inc), proctoring was provided 
clinicians from Hospital A, who were first to undertake FEVAR within the UK.
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Table 6.15 Migration distances and event timings for proximal migration for individual 
participating centres.
Centre A B C D E F G H 1
Patient n=60 n=22 n=16 n=14 n=14 n=12 n=9 n=4 n=3
1 9.6 mm 4.1 mm 6,7 mm 5.3 mm 4.3 mm 6.8 mm 4.3 mm
[24.2 mo] [9.0 mo] [11.8 mo] [7.4 mo] [13.6 mo] [9.0 mo] [9.3 mo]
Z 4.6 mm 4.8 mm 4.1 mm 4.8 mm 7.7 mm
[54.9 mo] [6.0 mo] [17.9 mo] [4.4 mo] [2.0 mo]
3 S.5 mm 10.0 mm 5.0 mm 4.4 mm 5.1 mm
[37.2 mo] [7.0 mo] 22.6 mo] [6.0 mo] [48.1 mo]
4 9.5 mm 8.0 mm 8.6 mm 7.0 mm 7.5 mm
[44.6 mo] [12.8 mo] 11.0 mo] [18.5 mo] [10.8 mo]
7.8 mm 4.6 mm 9.8 mm
o
[11.7 mo] [9.9 mo] 16.2 mo]
5 9.0 mm 6.6 mm 4.2 mm
[9.2 mo] [21.5 mo] [6.0 mo]
7 6.0 mm 4.3 mm
[12.0 mo] [11.5 mo]
5.0 mm
o
[52.9 mo]
4.3 mm
[88.7 mo]
6.0 mm
JLU
[24.5 mo]
Total 10 (17%) 4 (18%) 7 (44%) 6 (43%) 1 (7%) 4 (33%) 0 (0%) 1 (25%) 0 (0%)
Values presented are the caudal migration distance in millimetres. values within the parentheses indicate the
migration event time (1il CT diagnosis). Pearson Chi-Square test P=0.05. Mo, months.
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Table 6.16 Migration distances and timings for distal (iliac limb) migration for individual 
participating centres.
Centre A B C D E F G
Limb(s) n=110 n=33 n=28 n=22 n=27 n=16 n=13
Contra Ipsi Ipsi Contra Contra Ipsi
1 -7.2 mm -4.7 mm -11.9 mm -13.2 mm -4.6 mm -5.4 mm
[38.0 mo] [6.0 mo] [11.0 mo] [6.0 mo] [23.0 mo] [12.0 mo]
Contra Contra Ipsi Ipsi
2 -5.5 mm -6.5 mm -6.0 mm -6.0 mm
[89.0 mo] [7.0 mo] [23.0 mo] [38.0 mo]
Contra Ipsi Contra Ipsi
3 -6.0 mm -7.2 mm -15.6 mm -5.0 mm
[12.0 mo] [25.0 mo] [24.2 mo] [6.0 mo]
Ipsi Ipsi
4 -21.3 mm -5.2 mm
[37.0 mo] [12.0 mo]
Ipsi Ipsi
5 -7.4 mm -5.8 mm
[10.0 mo] [20.0 mo]
Ipsi
6 -8.6 mm 
[5.0 mo]
Ipsi
7 -4.3 mm 
[14.0 mo]
Contra
8 -6.4 mm
[23.0 mo]
Contra
9 -17.8 mm
[49.0 mo]
Contra
10 -11.2 mm
[5.0 mo]
Contra
11 -5.0 mm
[35.0 mo]
Contra
12 -6.4 mm
[36.0 mo]
Contra
13 -5.5 mm 
[13.0 mo]
Contra
14 -6.0 mm 
[6.0 mo]
Ipsi
15 -6.6 mm 
[63.0 mo]
Ipsi
16 -7.8 mm 
[27.0 mo]
Ipsi
17 -4.4 mm 
[41.0 mo]
Total 17(15%) 5(15%) 3(11%) 3(14%) 1(4%) 0(0%) 1(18%) 0(0%) 0(0%)
Values presented are the cranial migration distance in millimetres, values within the parentheses indicate the migration 
event time (1st CT diagnosis). Pearson Chi-Square test P=0.39. Mo, months.
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6.3.7 Progression of migration
The issue of the stability of a device following migration is often raised within the 
vascular community. Do migrated stent-grafts continue to migrate or do they migrate into a 
more stable position and no further movement is seen? For proximal migration there is 
much discussion around the issue of barb engagement. Is some initial (minor) movement 
expected whilst the anchoring barbs engage into the aortic wall? Based on data included in 
this chapter, fifteen patients (45%) with proximal migration were diagnosed at the last 
follow-up CT scan. Of the remaining 18 (55%) patients, there was a small amount of further 
movement (mean +1.0, SD 1.8, range -2.4 to +4.6 mm) over a median 21 (IQR 10.6 to 28.5, 
range 1 to 80) months of remaining follow-up.
For patients with distal (iliac) limb migration 41 limbs demonstrated CT evidence of 
migration. Nineteen (46%) limbs were diagnosed as migrated on the last follow-up CT scan. 
Of the remaining 22 (54%) limbs there was further movement (mean -2.0, SD 1.9, range -6.1 
to +0.7 mm) over a median 16.5 (IQR 12.0 to 28.3, range 4 to 64) months of further follow­
up. Full details of the progression of distal iliac limb migration (between limb types) are 
described in Table 6.17.
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Table 6.17 Progression of iliac limb migration after reaching criterion (> 4 mm)
All limbs Ipsilateral Contralateral
Migrated limbs, n 41 19 22
Migrated at last follow-up, n 19 {46%) 9 (47%) 10 (45%)
Limbs with additional movement, n 22 (54%) 10 (53%) 12 (55%)
Mean -2.0 -2.8 -L4
Additional SD 1.9 1.9 1.7
migration.
mm Minimum -6.1 -6.1 -5.1
Maximum +0.7 +0.1 +0.7
Median 16.5 16.5 16.5
Further IQR, 1st quartile 12.0 12.3 12.0
follow-up
time.
IQR, 3rd quartile 28.3 28.8 26.8
months Minimum 4.0 4.0 7.0
Maximum 64.0 63.0 64.0
SD, standard deviation. IQR, inter-quartile range. Percentages, indicated by
parentheses, are based on the total number of migrated iliac limbs per column.
6.4 Discussion
Aortic stent-graft technology is dynamic and ever-changing. The constant challenge for the 
endovascular community is to develop devices which lead to a decrease in complications and 
whilst allowing the safe treatment of more complex aneurysms (Stokmans et ai., 2012). Just 
over a decade ago, fenestrated aortic stent-grafts were such a development and have 
extended the role of EVAR to include complex AAA. Many patients, who previously would 
have been excluded from open repair or standard EVAR, now have the option of treatment.
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Early enthusiasm for a technology does not necessarily translate into to improved outcomes. 
There are continual pressures amongst clinicians to continue to widen inclusion criteria and 
treat more complex aortic disease. This approach must be taken with caution, Schanzer et 
al., in 2011 identified a link between the treatment of infrarenal AAA outside of the 
manufacturers IFU (more complex disease) and post-EVAR aneurysm expansion. FEVAR is 
now a well-established technique, more than 3000 patients have been treated and this trend 
is growing at an exponential rate (Amiot et al., 2010). Concerns still exist that endovascular 
techniques have unacceptably high complication and reintervention rates (BSET and 
GLOBALSTAR Collaborators, 2012). There have also been reports of the occasional late 
rupture following EVAR (Harris et al., 2000, Wyss et al., 2010, Schlosser et al., 2009). With 
FEVAR devices, stent-graft migration has been associated with serious complications 
including target vessel loss (Verhoeven et al., 2010) and type 1 endoleak (Troisi et al., 2011). 
There is also growing speculation regarding its role in post-FEVAR rupture.
Based on multicentre data presented in this chapter, proximal migration was 
identified in 33 of out 154 patients (21%). Kaplan-Meier survival analysis, using interval 
censoring, estimated the incidence of proximal fenestrated stent-graft migration to be 18%, 
23% and 36% at 12, 24 and 48 months, respectively. According to KM methods, the greatest 
incidence of proximal migration was during the first 12 months following implantation. 
Unlike the single centre series within the previous chapter, there were only small differences 
in migration estimations between the four event time definitions used. The greatest 
difference was at 48 months and between the interval censoring and beginning of the 
interval event times. In this situation using the beginning of the interval caused an 
underestimation of migration by 7%. When compared to the single centre data (Chapter 5),
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the migration rate was initially higher for the multicentre cohort at 12 months (18% versus 
9%), this equalised by 36 months (23% versus 22%) but then again increased in the 
multicentre cohort by 48 months (36% versus 22%). By using data from the larger cohort it 
can be concluded that proximal migration occurs in around one third of patients by 4 years. 
There appears to be an initial peak in migration, which occurs during the first year, this could 
be explained by movement associated with engagement of the anchoring barbs in the aortic 
wall. This theory was discussed by Zhou et al.t in their lab based experiment (Zhou et oL, 
2007). Zhou and colleagues, investigated the forces required to cause migration in standard 
and a stent-graft with a single fenestration. Their report identified an initial phase of 
movement (barb engagement) following by a period of stability and then a second phase of 
movement. The 13% rise in migration from 36 to 48 months may correlate with this second 
phase of migration, it is, however, clear from both multicentre data and reports within the 
literature that proximal migration can occur at any time point during follow-up.
Distally (iliac) limb migration occurred in 34 out 259 limbs (13%) and was seen in 15%, 
18% and 35% of patients by 12, 24 and 48 months, respectively. When compared with the 
single centre analysis (Chapter 5), migration rates were lower 5%, 14% and 30%, respectively. 
The greatest difference in migration rates (10%) was at 12 months. Differences in sample 
size could explain this. An alternative explanation could be that more individual limbs were 
available for assessment in the multicentre cohort thus increasing the probability of 
migration. However, arguing against this were the relatively equal ratios of iliac limbs 
assessed in the single centre report (98 out of a possible 110 limbs, 89%) and the multicentre 
cohort (259/290, 89%). Limb-by-limb analysis demonstrated similar instances of migration 
regardless of limb type in the multicentre cohort. At 12 months, iliac migration was
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experienced in 5% of individual limbs and this increased to 24% by 48 months. For both limb
types the greatest incidence of migration was between 24 and 56 months (12% to 14%). 
There are two explanations to explain this trend, firstly, there are a lack of fixation 
mechanisms for iliac limbs when compared to the proximal device (target vessel stents, 
anchoring barbs). There are also smaller forces acting on the iliac limbs when compared to 
the proximal main body. Migration of the iliac limbs is, therefore, likely to be a slower 
process. Adding to this is the possibility that iliac limb fixation may deteriorate (radial force) 
over time in some patients if there is progressive iliac limb dilatation. This is likely to be a 
relatively slow process and this may be a reason for seeing a later spike in iliac limb 
migration.
Data presented within this chapter sought to briefly compare migration outcome data 
between the single (pilot) centre (Hospital A) and the multicentre cohort (Hospitals B - I). 
Broadly patients from Hospital A and B-l were comparable in terms of baseline criteria. 
There was, however, a significantly longer follow-up duration for patients from Hospital A. 
This difference has been previously explained in that Hospital A was the first UK centre to 
embark on FEVAR procedures. As a result the overall follow-up duration for this cohort was 
longer as procedures had started earlier. It is also likely that some of the initial patients 
treated at Hospital A may have been treated with less complex AAA morphologies (e.g. a 
single unstented renal fenestration). This may provide some explanation as to the 
differences in the stent-graft configurations and proximal migration rates between the two 
cohorts. By way of an example by 24 months an additional 15% of patients were free from 
proximal migration at Hospital A when compared with Hospitals B - I (Figure 6.17). When
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comparing the actual proximal migration distances between the two cohorts they were 
similar [P=0.167).
Iliac limb migration distances were also similar between the two cohorts (Figure 6.18 
& Figure 6.20). Time to 1st CT diagnosis of migration had a tendency to be longer for patients 
at Hospital A. This latter point may again reflect the longer median follow-up duration for 
patients within this cohort. When comparing Kaplan-Meier estimates, freedom from any iliac 
limb migration was similar between the two cohorts (P=0.53). Breakdown of migration 
events by limb type (ipsi- versus contralateral) revealed, based on the available evidence, no 
statistically differences between the two cohorts (P>0.05). Further analyses revealed no 
statistically significant differences in the incidences of a proximal and at least one distal iliac 
migration (P=0.23) or any proximal or distal migration event (P=0.71). Visual inspection of 
the survival curves for all analyses was undertaken, findings were again consistent with the 
reported p values. Comparison between the two cohorts (Hospital A versus Hospitals B - I) 
relied heavily on the use of survival analyses with an interval censoring approach. The choice 
of event time definition and survival analysis approach has been the subject of further 
analysis and discussion. It is fair to acknowledge that if different event time definitions were 
used then there could be some differences in the estimations of freedom from migration 
when comparing cohorts. A full analysis of this issue for each cohort was beyond the project 
time frame.
When consider the overall multicentre cohort (n=154) the magnitude of migrations
was similar to those experienced in the single centre cohort (n=55), proximal migration
median +6 mm, distal/iliac limb migration -6 mm). Of all the cases of migration which
reached criteria (n=67, both proximal and distal), 42% were < 6 mm. Maximum proximal
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migration was +10 mm in a caudal direction whereas the maximum iliac limb migration was -
21 mm cranially. If referring to the stent-graft force diagram by Mohan et al., in Chapter 3 
(Mohan et ah, 2002), forces acting on the proximal device operate in the caudal direction 
whereas forces on the iliac limbs cause the device to migrate cranially. It is for this reason 
that within the literature several iliac limbs were reported to have migrated back into the 
aneurysm sac with an accompanying distal type 1 endoleak (Alerci et al., 2005). In order to 
minimise distal type 1 endoleaks, iliac limbs should be deployed in a reasonably length of CIA 
or the device must be extended into the EIA. In this full multicentre cohort, the median (IQR) 
distance between the CIA bifurcation and the distal iliac limb were 16 (10 to 23) mm and 18 
(9 to 25) mm for the ipsilateral and contralateral sides, respectively (data reported within the 
appendix). In addition, data from this chapter reporting the consistent deployment of the 
iliac limbs close to the CIA bifurcation may explain the low distal type I endoleak rate.
In the previous chapter it was identified that comparison of migration rates against 
those published in the literature is difficult. This is also the case for the multicentre data and 
the broad conclusion is that both the incidence and timings are in keeping with the limited 
information published within the literature. It must be highlighted that this study focused on 
identifying stent-graft migration using robust assessment methods and strict definitions. It is 
the first quantitative account of fenestrated stent-graft migration within the literature. 
There have been several discussions about prospective trials and the need to evaluate the 
newly available fenestrated devices (e.g. Ventana). Methods and data within this thesis will 
provide essential data for those comparisons.
The resultant effects of any fenestrated stent-graft migration must be considered.
Three principle complications, which are potentially associated with migration, include graft-
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related endoleaks, target vessel loss and rupture (Resch et ai, 2010). Causes of all of these 
complications are likely to be multifactoriai. With regard target vessel loss, the preoperative 
quality of vessels, stent-graft selection, graft deployment and disease progression can all play 
a part (Scurr and McWilliams, 2007). For endoleaks, these can also depend on adverse aortic 
neck features, stent-graft design and deployment issues (Wain et ol., 1998). In order to make 
an informed decision as to whether a complication is related to migration would require 
carefully review of each individual case, often as part of a multidisciplinary team. When 
considering the cause of ruptures this is more complicated. For infrarenal EVAR devices, 
there are patients with untreated proximal type 1 endoleaks which who progressed on to 
rupture. There are also patients without any prior complications whose aneurysms 
proceeded to rupture (Wyss et ai, 2010). The report by Wyss et al., was based on data from 
the UK EVAR trials, five (18.5%) patients had a late rupture despite no adverse events during 
follow-up. All three of the FEVAR ruptures reported within the literature have been 
attributed either to type 1 or 3 (graft-related) endoleaks.
Using data from this chapter, if it was assumed that all type 1 and 3 endoleaks and 
target vessel losses in the proximal migration group resulted from migration then the clinical 
significant migration rate was 4.5%. This fits within the reported ranges (around 3%) of 
proximal fenestrated stent-graft migration within the literature (Table 2.4). With the regards 
the assessment of complications and reinterventions, the resultant log-rank tests 
demonstrated no differences in migration-related sequelae in patients with and without 
proximal migration. There are two further points to consider from the complications and 
reinterventions summary statistics (Table 6.10 and Table 6.11). Despite no apparent 
statistical significance (P=0.39), there were fewer late (> 6 weeks) type 2 endoleaks in the
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proximal migration group (6%), when compared to patients without evidence of migration 
(14%). There is an in vitro study within the literature that has suggested that the downward 
displacement force on a stent-graft is lower in the presence of an endoleak (Li and 
Kleinstreuer, 2006b). If this theory is true, then the trend from this multicentre cohort 
provided some clinical evidence of low migration rates in the presence of endoleak. There 
was also a non-statistically significant difference (P=0.12) in endograft kinking rates between 
patients with (15%) and without (7%) proximal migration. This is perhaps unsurprising, if a 
device moves caudally and there is an absence of space for it to move into, then it will buckle 
or kink. For infrarenal stent-grafts the EUROSTAR report, by Fransen and colleagues, 
demonstrated an association between kinking and stent-graft migration (Fransen et a!., 
2003a).
With the low rates of iliac limb occlusion and distal type 1 endoleaks, iliac limb 
sequelae was not investigated in further detail. This fits in with the literature, where there is 
a lack of detailed reports investigating associated complications from the migration of an iliac 
limb. Reasons for this could be similar, there could be a lack of complications relating to iliac 
limb migration or there could be a lack of awareness that iliac limbs can migrate. It is worth 
noting that the follow-up duration in the cohort reported in this chapter, at best, may only be 
considered to cover the medium term. It is possible that there could be a spike in the 
incidence of iliac migration and related events when patients are subjected to more long­
term follow-up. It is for this reason that patients should be followed up over the long-term 
(up to 10 years) and events reported as part of a prospectively designed trial or submitted 
through a registry. The UK EVAR trial has studied patients out to 10 years and although did
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not provided specific details of individual complications did report that new complications 
were still be reported after 8 years (Greenhalgh et ai, 2010).
Low incidences of fenestrated stent-graft migration and minimal related sequelae 
could be attributed to the design of the fenestrated stent-graft. Standard (infrarenal) stent- 
grafts achieve a seal using a section of normal aorta below the most caudal renal artery. 
Device fixation varies by manufacturer, but is often a combination of radial force, 
longitudinal columnar support and barbs which embed into the aortic wall. Fenestrated 
stent-grafts are similar but have the addition of fabric coverage above the caudal renal 
artery. In many instances, the fabric will extend up to or above the origin of the SMA. 
Nowadays, the majority of fenestrated stent-grafts also have target vessel stents which 
provide further fixation within the aorta. Further resistance to proximal migration may be 
achieved using a separate distal bifurcated component. The aim of a separate proximal and 
distal component is to focus the displacement forces that act on the aortic bifurcation on to 
the distal component, thereby preventing proximal movement (Dowdall et ai, 2008). 
Dowdall and colleagues investigated the separation of the modular components of the Zenith 
fenestrated AAA stent-graft. In their series of 106 patients, 14 (13%) had evidence of 
movement between the proximal and distal bodies (> 10 mm). This indicates that the distal 
bifurcated body does directing some of the downward displacement force away from the 
proximal component. The significance of inter-modular component separation in preventing 
migration will be considered in the next chapter. The Zenith fenestrated AAA endograft also 
uses the same barb fixation system used in the conventional infrarenal Zenith device. In a US 
multicentre trial (n=739), spanning over 5 years only 19 (2.6%) patients showed evidence of
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stent-graft migration (5 -10 mm) and this was largely attributed to the barb fixation system 
(Greenberg et aL, 2008).
With the data reported in this chapter, there are cases of proximal and distal 
migration where the displacement force on the stent-graft exceeded its fixation. Within 
Chapter 2 of this thesis, the factors affecting the displacement force were discussed and the 
resistive mechanisms of a stent-graft against migration identified. Of the 33 patients with 
proximal migration the individual circumstances surrounding each case could be evaluated 
and compared against a subgroup without any migration. It is perhaps more sensible to use 
the incidence of migration together with data from the available preoperative and 
postoperative variables in order to produce a more scientific and rigorous evaluation of the 
causative factors of migration. This work has been presented in the next chapter.
Limitations
When considering the reported incidence of migration in this chapter the impact of any 
missing patients must be considered. Out of the possible 262 patients 154 (59%) were 
included in this analysis. Questions must arise as to whether there is stent-graft migration 
and or its associated complications within the 108 patients unavailable for analysis. If so, the 
inclusion of these patients may have contributed to a different migration rate than has 
currently been reported within this chapter. With standard infrarenal stent-grafts device 
migration has been associated with post-EVAR rupture (Wyss et aL, 2010, Harris et aL, 2000) 
and the need for open conversion (Harris et aL, 2000). Some commentators would expect to 
see an incidence of post-FEVAR rupture and possibly a similar relationship to stent-graft 
migration. Whether there could be incidences of post-FEVAR migration-related rupture in
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the excluded patient group must also be considered. The lack of any post-FEVAR ruptures in
the included cohort is highly encouraging and there are possible reasons to explain this. For 
standard infrarenal EVAR post-treatment rupture has been experienced in approximately 
0.6% (Harris et al., 2000) to 3.2% of patients (Wyss et al., 2010). From the current 
publications reporting FEVAR outcomes (patients, n=819), there have been post-treatment 
ruptures in only 3 (0,4%). In each case, rupture was attributed to either a type 1 or type 3 
endoleak with timings at 5 days, 10 months and 18 months (Bicknell et al} 2009, Metcalfe et 
aL, 2012, Ziegler et al., 2007). These reports confirm that there is a low risk of post-FEVAR 
rupture and this can occur early or late during follow-up. With 154 patients included in this 
analysis, rupture rates of 0.4% rate would suggest that approximately one case could be 
expected within this multicentre cohort. Further detail on the three reported cases would be 
needed in order to confirm that they had similar characteristics to the multicentre cohort 
reported in this chapter (e.g. AAA diameter, follow-up, management of complications etc). 
With specific regard to excluded patients, this was due to an inability to access the necessary 
imaging data. These patients had been included in the GLOBALSTAR registry and its resultant 
publication in 2012 (BSET and GLOBALSTAR Collaborators, 2012). This was, however, the first 
publication from the GLOBALSTAR registry and median follow-up was only short (6 months). 
This core lab review of FEVAR migration followed initial the GLOBALSTAR report and, 
therefore, contained more long-term follow-up data (median 20.9, IQR 10.4 to 36.5 months). 
The possibility of migration and or a low incidence of post-FEVAR rupture in excluded 
patients must be considered when interpreting these results.
Other considerations within this chapter are any differences in the baseline 
characteristics between the included and excluded patients. Theoretically, it is possible that
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there could be differences in the incidence of migration between included and excluded 
patients. With an absence of any risk factors for fenestrated stent-graft migration, it was 
difficult to compare and conclude that both groups were similar. In view of the number of 
exclusions, attempts have been made to compare groups based on the available baseline 
characteristics. Age, gender and maximum preoperative AAA diameter were not found to be 
statistically different between groups. Questions may arise as to whether these three 
variables are sufficient to state that both groups are comparable. Age and gender are 
typically described for vascular surgical cohorts and there are also reports documenting a 
relationship between AAA diameter and neck angle and length (Zhang et al., 2001). Based 
on this publication AAA diameter could be used as a surrogate marker aortic neck 
complexity. If AAA diameters were relatively similar then it could be suggested, based on the 
report by Zhang et al., that the morphologies of the aortic neck are likely to be similar. Such 
an assumption is important since several risk factors for infrarenal stent-graft migration are 
based on preoperative aortic neck morphology (Chapter 3).
There are further limitations regarding the retrospective use of multicentre data. 
Firstly, there are likely to be some variations in preoperative imaging, patient selection, 
implantation procedure and aftercare between institutions. Such variation is likely to be 
minimal as all centres fall under a single healthcare system (UK National Health Service), 
procedures are performed under the supervision of a single manufacture (Cook Medical Inc) 
and training and mentorship was provided by the first centre to start this procedure in the 
UK (Hospital A). If this were an international multicentre study, then there could be 
geographical variations in the incidence of comorbidities (e.g smoking or hypertension). 
Surgical techniques could have slight differences and so could postoperative care. In these
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situations it is desirable to undertake any analyses using clustering methods. The assumption 
of any cluster analysis is that the objects within a cluster are in some sense more similar to 
each other than objects in other subgroups (Shannon, 2008) and that observations in a 
cluster tend to be correlated (Petrie and Sabin, 2009). Failure to acknowledge this 
correlation may result in the underestimation of standard errors. The majority of work 
within this thesis is based on an assessment of CT data at the study institution by a single 
observer. The use of a single observer in a centralised location will remove some of the 
issues surrounding clustering. Also, from a statistical point of view, cluster analysis requires a 
minimum number of individuals (or objects) per cluster, and in this study there were centres 
with insufficient samples sizes to fit a meaningful model which would take into account 
correlations within centres.
There were several missing iliac limb migration measurements when there was a CT 
image quality issue or a non-patent IIA. In these ClAs there were iliac limbs present which 
could have migrated. The majority of KM data presented refers to a subgroup of patients, 
where missing iliac limb assessments have been excluded from the analysis. To explore the 
impact of excluding these data, two sensitivity analyses have been undertaken. The first 
analysis assumed that all of the originally non-assessed limbs had migrated by the 6-month 
CT scan and that there was a 1-month interval CT scan present. The second scenario, 
assumed that any non-assessed limbs had migrated with a similar incidence/timing to those 
observer in the multicentre cohort, where a full CLL assessment was possible. For the 1st 
scenario modifying the dataset had little effect on migration rates for the ipsilateral limb but 
increased the incidence of contralateral limb migration by between 12% and 16% across each 
of the time points. For the second scenario, the incidence of migration between the original
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and the modified datasets were almost equal. When interpreting the iliac limb migration
data, it is important to consider that some of non-assessed limbs may have migrated. It is 
also important to consider that one of the main reasons for not assessing an iliac limb was 
occlusion of the HA. it is not clear how an occluded HA would affect the overall flow 
dynamics and whether this could have an effect on the incidence of iliac limb migration. If 
alternative migration measurement techniques were available and validated then this could 
be researched.
6.5 Conclusion
Migration at the proximal landing zones occurs in around a third of patients by four years. 
The incidence of proximal migration peaks twice, once during the first year after repair and a 
second between years 3 and 4. Proximal migrations were all caudal in direction and the 
majority (60%) were less 6.9 mm in length. Clinical sequelae were infrequent with no 
statistically significant differences between complications and reinterventions were 
identified in patients with and without proximal migration. Freedom from any iliac limb 
migration showed a similar incidence to proximal migration. The incidence peaked between 
years 2 and 3 and a third of patients had at least one iliac limb migration by 4 years. Overall, 
iliac related complications and reinterventions were rare. Proximal migration does not 
appear to be significantly associated with proximal type 1 endoleak or target vessel loss. 
Concerns still exist regarding any post-EVAR rupture and any association with migration. 
Ruptures have been reported for FEVAR and since migration can occur at any time point 
routine follow-up imaging still is recommended.
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7. Predictive factors for proximal migration
7.1 Introduction
Previous reports have identified anatomical, procedural and device-specific factors that have 
been associated with stent-graft migration (Cao et a!., 2002, Arko et al., 2005, England et ai, 
2004, Mohan et al., 2002), Such reports are, however, predominantly limited to 
investigations involving standard (infrarenal) aortic stent-grafts. It is accepted that any 
attempts to identify predictive factors for fenestrated stent-grafts, would also be 
advantageous. If there are associations between fenestrated stent-graft migration and pre- 
or post-operative variables then 1) high risks patients could be excluded from treatment, or 
2) for those who are treated and at high risk they could be followed-up more closely or have 
follow-up tailored to their individual risk profile. There could also be benefits for device 
manufacturers, a greater understanding of risks factors could help direct future modifications 
to stent-grafts.
Movement of a fenestrated stent-graft at the proximal landing zone is potentially 
disastrous and could result in a significant target vessel loss or reperfusion of the aneurysm, 
with the possibility of rupture. All three cases of post-FEVAR rupture reported in the 
literature had a graft-related endoleak (Bicknell et al., 2009, Metcalfe et al., 2012, Ziegler et 
al., 2007). There is a general consensus within the literature that the potential consequences 
of proximal migration of both fenestrated and convention (infrarenal) stent-grafts are 
considered to be more serious that distal (iliac) limb migration. It is for this reason that the 
investigation of predictive or risk factors for fenestrated stent-graft migration will focus on 
proximal landing zone.
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7.1.1 Aims
Within the last chapter, multicentre data were presented outlining the incidence, timings and 
related sequelae for migration of the Zenith fenestrated AAA stent-graft. As part of this 
retrospective data collection process, a series of pre-, intra- and post-operative variables 
were collected from the GLOBALSTAR registry, locally available databases and from direct 
measurements from CT scans. These variables formed the basis of the predictive factor 
analysis. Using these variables the aims of this chapter are as followed:-
Aim 7.1. To establish the risk factors for proximal migration of a Zenith fenestrated 
aortic stent-graft.
Aim 7.2. To identify any protective factors for proximal migration of a Zenith 
fenestrated aortic stent-graft.
Aim 7.3. To investigate and report the magnitude of effect for any identified risk or 
protective factors that are associated with proximal fenestrated stent-graft 
migration.
In order to undertake a successful predictive factor analysis, a review of the literature 
was essential. All variables that have been investigated for possible association with stent- 
graft migration were identified. Many of these have been identified and discussed within the 
introductory chapters (2 & 3). For simplicity, these have also been summarised in the table 
below (Table 7.1). When considering these factors there are some limitations since, almost 
all were acquired either using lab-based experiments or clinical data from patients with 
conventional (infrarenal) stent-grafts implanted. To the author's knowledge, only two 
studies, have explored the relationship between potential risk factors and the migration of a
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fenestrated stent-graft (Scurr et al.t 2008b, Zhou et ai, 2007). Both of these studies were
lab-based experiments and undertaken more than five years ago. The study by Zhou and 
colleagues investigated the additional distraction force needed to displace fenestrated graft 
incorporating a single target vessel stent, when compared to a standard infrarenal device 
(Zhou et al., 2007). In their report Zhou et ai, confirmed that a device with a single stented 
fenestration does offer higher ultimate fixation. The publication by Scurr and colleagues, 
from the same institution, compared the forces needed to crush different types of target 
vessel stents when subjected to distraction forces (Scurr et al., 2008b). Scurr's report 
evaluated three target vessel stents (Jostent, Advanta V12 and Palmaz Genesis) and 
concluded that there were no significant differences in the ability of either stent to withstand 
a crushing force when deployed within an endograft fenestration.
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Table 7.1 Previously investigated risk factors for aortic stent-graft migration (n represents the 
sample size)
Risk factor Author(s) Year n P value
Increase in aortic neck diameter Cao et al. 2002 148 0.01
England etal. 2004 38 NS
Preoperative AAA diameter Cao et al. 2002 113 0.02
Mohan et al. 2002 2862 0.01
England et al. 2004 38 NS
Proximal graft diameter Mohan etal. 2002 2862 0.01
Cao et al. 2002 113 NS
Cao et al. 2002 113 NS
Aortic neck angulation. England et al. 2004 38 NS
Wyss et al* 2011 217 0.08
Aortic neck length. Cao et al. 2002 113 NS
England etal. 2004 38 NS
Waasdrop et al. 2009 154 0.001
Aortic neck thrombus. Cao et al. 2002 113 NS
Wyss et al* 2011 217 0.02
Aortic neck calcification. Wyss et al* 2011 217 0.04
Distal transverse aortic neck diameter Mohan et al. 2002 2862 0.02
Renal artery to stent-graft distance Zarins et al. 2003 1119 <0.01
Waasdorp et al. 2009 154 <0.001
Heikkinen et al. 2006 173 <0.01
Endoleak at 30-days. Cao et al. 2002 113 NS
Graft oversizing Cao et al. 2002 113 NS
Mohan etal. 2002 2862 NS
Device type, bifurcated versus AUI Waasdrop et al. 2009 154 0.01
Mohan et al. 2002 2862 NS
Smoking Mohan et al. 2002 2862 0.02
Hypertension Mohan et al. 2002 2862 0.04
Heart rate England et al. 2004 38 0.03
Stiff body device Cao et al. 2002 113 NS
Arko et al. 2005 8 <0.001
Iliac artery engagement distance Heikkinen etal. 2006 173 <0.001
Waasdorp et al. 2009 154 <0.001
Presence of proximal barbs Malina etal. 1998 137 <0.001
Pulsatile aortic neck distension Van Keulen et al. 2010 26 0.03
*the paper by Wyss et a!., covered generic EVAR complications and not specifically 
migration. NS: not significant.
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7.2 Materials and methods
7.2.1 Patient Data
The inclusion criteria have been previously discussed in Chapter 6. A total of 262 patients 
were potentially available and of these 154 (59%) satisfied the inclusion criteria and received 
a subsequent CT CLL assessment of proximal migration. Differences in study entry 
parameters, between the included (n=154) and excluded (n=108) groups have been 
previously compared (see Section 6.3.1). Limited data were available from the excluded 
patients and essentially there were no statistically significant differences in the age, gender 
and preoperative AAA diameters between the two groups (P>0.05).
To summarise, key data from the previous chapter, based on an analysis of 154 
patients with a median 20.9 (IQ.R 10.4 to 36.5, range 6 to 109) months follow-up, proximal 
migration was experienced in 33 (21%) patients. Kaplan-Meier survival analysis, using an 
interval censoring approach, estimated freedom from proximal migration (where proximal 
migration is defined as movement > 4 mm) of 82%, 77% and 77% at 12, 24 and 36 months, 
respectively.
A series of preoperative, intra- and postoperative variables were collected from CT 
scans, local endovascular databases and the GLOBALSTAR registry. A list of collected 
variables and their relevant definitions have been provided (Table 7.2) (Appendix). 
Definitions were taken from the relevant reporting standard, previous journal articles or 
consensus opinion within the research team. All direct CT measurements were undertaken 
by the author following appropriate training, using a departmental PACS workstation, which 
had an in-built vessel analysis module (Kodak Carestream PACS, 10.2, Kodak, Rochester, NY).
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The author has been previously involved in several research studies which have used CT
based measurements to evaluate outcomes and complications following EVAR and FEVAR 
(England et al., 2004, Wyss et al., 2009, England et al., 2010b, England et al., 2008, England et 
al., 2010a, Oshin et al., 2010). Part of these studies involved the assessment of intra- and 
inter-observer variability.
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Table 7.2 Variables collected within this retrospective multicentre review.
Baseline (preoperative) variables
Continuous variables Categorical variables
Age, years Gender Chronic renal insufficiency
Body mass index, kg/m2 Smoking status Diabetes mellitus
Heart rate, b.p.m Ischaemic heart disease ASA physical grade
Systolic blood pressure, mmHg Heart failure
Serum haemoglobin, g/dL Hypertension
Graft-related variables
Continuous variables Categorical variables
Stent-graft diameter, mm (proximal) Graft shape (bifurcated, AUI or tube)
Stent-graft length, mm (proximal body) Target vessel configuration (number, type, stented or 
unstented).
MDCT CTA variables CT time point
Continuous variables (mm unless 
otherwise statedj
Preoperative 1st postoperative Subsequent
follow-up
Aortic diameter at the middle of the:
CA, SMA, CrRA, CaRA & BN S
Maximum diameter of the:
AAA, CIA S
Vessel length from:
CA to SMA; SMA to CrRA; CrRA to 
CaRA; CaRA to BN; BN to aortic 
bifurcation; Aortic bifurcation to 
CIA bifurcation.
S
Angulation of:-
Maximum coronal aortic neck (°) V V V
Maximum sagittal aortic neck (°) S
Graft-related measurements
SMA to proximal stent-graft >7 V
CIA to ipsi- & contralateral limb S
CA to distal bifurcated
component
>7 >7
Ipsilateral limb diameter (stent) >7 >7
Contralateral limb diameter 
(stent)
>7 S
Categorical variables
Vessel patency S S
Endoleak S >7
Kinking S
Component fracture S
In order to investigate the risk factors for proximal migration of fenestrated stent- 
grafts a series of statistical analyses were undertaken.
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7.2.2 Statistical analysis plan
In order to satisfy the aims of this chapter (Aims 1.1, 1.2 and 7.3) the demographic, 
clinical, anatomical and graft-related features of patients with CT evidence of proximal stent- 
graft migration were compared to those without any evidence of migration. Analysis then 
comprised of a series of univariate and multivariate statistical techniques.
Describing the study cohort
Firstly, a selection of appropriate summary statistics were presented for all variables. At this 
point there were no subgroupings according to proximal migration status. The majority of 
variables were captured from the GLOBALSTAR registry or using direct measurements from 
CT scans. Within the summary statistics there were brief descriptions of any missing values. 
For continuous variables, the distribution of the data was first assessed using the Shapiro- 
Wilk normality test (Shapiro and Wilk, 1965). Next, appropriate summary statistics were 
presented, for data that were approximately normally distributed, the mean plus or minus its 
standard deviation were reported. For those variables that had a non-normal distribution, 
the median values with their respective inter-quartile ranges were stated.
Analysis of missing values
The second phase of the statistical analysis was to compare the frequencies of missing values 
between those patients with and without evidence of proximal fenestrated stent-graft 
migration. In order to do this, proximal migration was considered as a dichotomous variable 
(migration > 4 mm). Included variables were coded as present or missing, differences in the 
frequencies of missing values for patients with and without proximal migration were then
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described using absolute values and percentages. Differences were further assessed for 
statistical significance using Fisher's exact test.
Further consideration to the missing data was also given. According to Rubin, missing 
data can be classified as either missing completely at random (MCAR), missing at random 
(MAR) or missing not at random (MNAR)(Rubin, 1976). Missing data are an important issue, 
the absence of data can be informative, and as Fielding et aL, stated, ignoring patterns of 
missingness may bias the results obtained (Fielding et a!., 2009). Understanding the precise 
mechanism regarding the missing values is useful as it can direct the most appropriate form 
of analysis. According to Fielding and colleagues complete-case analysis will only be 
unbiased if the data are MCAR (Fielding et al., 2009). A number of hypothesis tests have 
been suggested that can be carried out to test for MCAR. Little, in 1988, developed a test 
that has become extremely popular and is based on the means under the different missing 
data patterns (Little, 1988). Other authors have also proposed an MCAR test based on mean 
values (Listing and Schlittgen, 1998). One of the first procedures to be undertaken when 
assessing missing values is to compare the distributions of the fully observed values for 
respondents and nonrespondents (Little, 1988). This test was described in the first 
paragraph of this section and was completed for all data variables analysed within this 
chapter. Little's MCAR test was also undertaken on all of the variables collected within this 
chapter. Little's MCAR test is based on the premise that under MCAR at each assessment the 
calculated means of the observed data should be the same irrespective of the pattern of 
missingness. The null hypothesis is that the data are MCAR.
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Exploratory (univariate) analyses
Following the assessment of missing values, the next phase of the statistical analysis was the 
identification of risk factors using univariate analyses. The purpose of the univariate analyses 
were two-fold, 1) it can provide an indication of risk factors in its own right but 2) it can help 
guide which variables should be included in the multivariate analysis. For the univariate 
analysis proximal migration was treated as a binary variable (No migration = 0, proximal 
migration > 4 mm = 1). All variables identified in Table 7.2 were grouped into their respective 
proximal migration and no migration subgroup. The type of the variable (continuous or 
categorical) and the distribution of the data informed the appropriate univariate statistical 
test to be applied (Table 7.3).
Table 7.3 Methods of univariate statistical analysis
Data distribution
Variable type Normal Not normal
Continuous t test Mann Whitney U test
Categorical (binary) Fisher's exact test/ Chi-squared test
Categorical (ordinal) Chi-square test (including linear trend test)
For the purposes of the univariate data analysis P values <0.05 were considered 
statistically significant, however, P values <0.1 were highlighted as they would be considered 
for inclusion in the subsequent multivariate analysis.
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Multivariate analyses
For the multivariate analysis a Cox proportional hazards model was used. Time-to- 
event curves analysed by Cox proportional hazards regression are commonly used to 
describe outcomes in clinical studies. This methodology, as reported for example by 
Spruance et oi, has the advantage of using all available information, including whether the 
event has occurred, in addition to the timing of the event (Spruance et al.t 2004). Within this 
chapter, the survival data were modelled for all four event time definitions. As a reminder, 
these definitions included the beginning, the midpoint, the end of the interval (or time of 1st 
CT diagnosis of migration) and the interval censoring approach (See section 5.2.5). Variables 
achieving a PcO.lO in the univariate analysis were considered for entry into the multivariate 
analysis. The Cox proportional hazards model, a regression method for survival data, 
provides an estimate of the hazard ratio (HR) and its confidence interval for each of the 
factors included in the model (Spruance et aL, 2004). The hazard ratio as an estimate of the 
ratio of the hazard rates between two levels of explanatory variable (e.g. males versus 
females, 70-years old versus 80-years old). The hazard ratio is the probability that, given the 
event in question (migration) has not already occurred, it will occur in the next time interval, 
divided by the length of that interval. The time interval is made very short, so that in effect 
the hazard rate represents the probability (in this case migration) at a given time point. In 
this chapter the HR will be assessed to satisfy Aims 7.1, 7.2 and 7.3 and provide a statistical 
indication of risk/protective factors for proximal migration and an estimation of the strength 
of any association. A further consideration must by for any adjustments when dealing with 
missing data; these adjustments will be described later in the chapter.
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Multivariate analysis requires carefully planning in order to achieve a robust analysis.
Based on the experience of migration in this thesis (n=33) and a total cohort of 154 patients, 
consideration must be made on how many variables can be entered into a model. Several 
rules of thumb exist and some would argue that the analysis of risk factors associated with 
migration (where migration is treated as a continuous variable) should be limited to no more 
than eight covariates (20 patients per covariate). In logistic analysis, for example, when the 
outcome variable is binary (migration/no migration) the rule of thumb suggests that the 
number of explanatory variables in the model should be such that the number of events per 
variable is not lower than 10. There have been arguments made within the literature that 
this rule is too conservative and that fewer events per predictor can be used (Vittinghoff and 
McCulloch, 2007). The work by Vittinghoff and McCulloch (2007) is important in that for 
logistic and Cox regression they found situations where 5-10 events per variable were 
adequate to ensure validity of the analysis. For the analysis of data within this chapter, 
initially parameters were included in the multivariate model if they achieved a P<0.10 in the 
univariate analysis. A separate analysis will be conducted for those univariate variables with 
P<0.05. This method is considered to be a well-recognised statistical approach, it must 
always be clearly stated that the model was generated using stepwise regression and not 
specified in advance (Chatfield, 1995). In reality it is likely that different multivariate 
approaches, using Cox proportional hazards, will generate a series of models which must 
then be discussed and a decision on which was is likely to be most plausible made.
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7.3 Results
7.3.1 Description of the cohort
Summary statistics were generated for a total of 154 patients without any subgrouping for 
proximal migration status. These summary statistics presented represent a cohort of 
patients in their later years of life (mean age 74 SD 7 years). The cohort also had the typical 
range of comorbidities, which is expected from those undergoing vascular surgery. Two- 
thirds of all patients had hypertension (84/127), a similar frequency were previous or current 
smokers (84/123). Overall ASA physical grading was 3 or more in 72% of patients (84/117). 
Aneurysm morphology typically reflected a group of patients with complex AAA. 
Preoperative CT scans were available in 95/154 (62%) patients. Reasons for fenestrated 
repair were not simply the absence of an infrarenal aortic neck, median (IQ.R) length of 7 (0 - 
13) mm. Aortic neck angulation ranged from 0° to 85°, 8% of patients (8/95) had moderate 
or severe aortic neck calcification and 48% of patients (46/95) had moderate or severe aortic 
neck thrombus. Repair was predominantly using a bifurcated device, 143/154 (93%) and 
target vessel stents were present in at least one fenestration in 137/154 (89%) of patients. 
Of those patients where data was available, the mean proximal stent-graft diameter (n=83) 
was 29 (SD 4.5) mm. Median proximal component length (n=68) was 123 (IQR 109 to 137) 
mm. The table below provides detail on the summary statistics that are available, together 
with their respective location within the appendix (Table 7.4).
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Table 7.4 Description of tables provided in the appendices summarising the full cohort of
patients included in this chapter.
Appendix Variables Time point Data type
APPJL Demographic Continuous
Clinical Preoperative /
APP_2 CT AAA morphology Intraoperative Categorical
Graft details
APP„3
1st postoperative CT scan
<6 weeks following Categorical
APP„4 implantation Continuous
APP„5 Remaining follow-up CT >6 months following Categorical
APP_6 scans implantation Continuous
The degree of missingness for each of reported variable varies depends on the 
parameter type and the data source e.g. registry or CT scan. A full analysis of missing values 
follows this section and carries an accompanying explanation as to the causes of any 
missingness.
7.3.2 Missing values analysis
Several of the variables collected within this study had values missing. Figure 7.1 shows the 
frequency of missing values across each of the variables collected for this chapter. 
Missingness varied from 0% to 56% (median 7%, IQR 2% to 32%). There are three dominant 
reasons for missing values. Firstly, for data entry into the GLOBALSTAR registry, the majority 
of the fields within this web-based database were not compulsory. A study researcher made
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every effort to make the database as complete as possible, but since this was primarily an 
efficacy registry, some variables were not completed. Secondly, for several institutions 
research ethics approval did not allow access to patient identifiers, it was, therefore, 
impossible to contact specific sites with regard to missing database entries. Thirdly, there 
were several instances when preoperative CT scans could not be transferred to the study 
institution. Reasons for this included that the respective scan was not on PACS or that the 
local data transfer agreement prohibited transfer of any foreign CT scans. To clarify this last 
point, there were several instances where FEVAR was performed following a referral from 
another secondary care institution. The preoperative CT scan had been undertaken at the 
referring institution but the treating institution was not permitted to transfer imported CT 
data. Although it would have been advantageous, it was beyond time restrictions of this 
thesis to seek individual Trust approval for preoperative CT scans acquired outside of the 
nine participating institutions.
As previously stated data can be classified as missing completely at random (MCAR), 
missing at random (MAR) or missing not at random (MNAR)(Rubin, 1976). For our data 
Little's MCAR test returned a test statistic of 5030 (P=0.11). There was not enough evidence 
to suggest that the missing data were not MCAR. Further missing value analyses were 
conducted where the cohort had been split on the basis of the proximal migration status (no 
or yes). The frequencies of present and missing values were compared between subgroups. 
Statistical testing was undertaken using Fisher's exact test, P values <0.05 were considered 
statistically significant. The following table provides an overview of the overall missing value 
analysis that have been presented in the appendix (Table 7.5).
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Table 7.5 Summary of missing value tables presented in the appendices
Appendix Covariates
APP„7 Baseline demographics and clinical
APP_8 Preoperative CT
APP_9 Graft design
APPJLO 1st post-operative CT/database
APPJLl Follow-up changes CT/database
In some variables missing values were present in up to 56% of cases. Several 
variables had statistically significant differences in the number of missing values when 
comparing proximal migration status. These variables were those predominantly captured 
from the preoperative CT scan and the reasons for this have already been alluded to. 
Consideration of the effect of these missing values on the resultant assessment of predictive 
factors will be made in the discussion. A histogram summarising (Figure 7.1) the missing 
values together with a table (Table 7.6) describing those variables that have statistically 
significant differences in missing values are provided below.
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Table 7.6 Covariates with statistically significant differences in the numbers of missing values for 
proximal migration and non-migration groups.
Covariate (n
Present,
n(%)
Proxima
No
=121)
Missing,
n(%)
migration
Yes 
(n=33) 
Present, 
n (%)
Missing, 
n (%)
P Value
Coeliac axis (CA) 81 (67%) 40 (33%) 13(39%) 20(61%) 0.004
sQj‘ Superior mesenteric artery (SMA) 82 (68%) 39 (32%) 13(39%) 20 (61%) 0.003
3rc
f?
Cranial renal artery (CrRA) 82 (68%) 39 (32%) 13(39%) 20 (61%) 0.003
cn Caudal renal artery (CaRA) 81 (67%) 40 (33%) 13(39%) 20 (61%) 0.004
3
3 Bottom aortic neck {BN) 82 (68%) 39 (32%) 13(39%) 20 (61%) 0.003
Maximum common iliac artery (maxCIA) 81 (67%) 40 (33%) 13(39%) 20 (61%) 0.004
CA to SMA 80 (66%) 41 (34%) 13(39%) 20 (61%) 0.024
ro SMA to CrRA 81 (67%) 40 (33%) 13(39%) 20 (61%) 0.016
ZT
CrRA to CaRA 80 (66%) 41 (34%) 13(39%) 20 (61%) 0.021
3 CaRA to BN 81 (67%) 40 (33%) 13(39%) 20 (61%) 0.016
3 CaRA to aortic bifurcation 81 (67%) 40 (33%) 13(39%) 20 (61%) 0.016
Common Iliac Artery (mean) 80 (66%) 41 (34%) 13(39%) 20 (61%) 0.005
>13TO
C
Maximum coronal neck 82 (68%) 39 (32%) 13(39%) 20 (61%) 0.003
o‘p
o Maximum sagittal neck 82 (68%) 39 (32%) 13(39%) 20 (61%) 0.003
Aortic neck calcification 82 (68%) 39 (32%) 13(39%) 20 (61%) 0.003
Q
Aortic neck thrombus 80 (66%) 41 (34%) 13(39%) 20 (61%) 0.005
n>TOO Visceral artery patency 82 (68%) 39 (32%) 13(39%) 20 (61%) 0.003
Oto. CIA calcification 80 (66%) 41 (34%) 13 (39%) 20 (61%) 0.005
CIA thrombus 80 (66%) 41 (34%) 13 (39%) 20 (61%) 0.005
P values were derived using Fisher's exact test. Diameters refer to aortic diameters unless otherwise specified.
7.3.3 Univariate (exploratory) analyses
The first phase of the formal analysis of risk factors was based exploratory univariate 
analyses. Initially, all available variables were included {continuous and categorical) and 
inferential statistical tests were conducted, when separating the groups according to 
proximal migration status. In order to assist with variable selection for the multivariate
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analysis, any variable which produced a P value <0.1 was considered for possible inclusion. A
further subgroup, who had P values <0.05, were subjected to a separate multivariate 
analysis. In view of the large dataset within this chapter, the summary statistics for each of 
the univariate analyses are provided within the appendices and their locations are detailed in 
the table below {Table 7.7).
Table 7.7 Tables outlining univariate analyses presented in the 
appendices
Appendix Type of variables investigated
APPJL2 Baseline demographic and clinical
APPJL3 Preoperative CT morphology
APP_14 Graft-related
APP_15 Follow-up complications
APP_16 1st post-operative CT morphology
APP_17 Changes in morphology during follow-up
Those variables that have generated P values <0.1 are summarised in Table 7.9. With 
respect to clinical variables, heart rate, serum haemoglobin and smoking status were all 
identified as potential univariate risk factors for proximal migration. Review of the data 
showed that there were no clinical differences in heart rate between patients with and 
without evidence of proximal migration. Median (IQR) heart rate was 70 (64 to 82) beats per 
minute in the non-migration group whereas those with proximal migration the median (IQR) 
heart rate was 70 (57 to 74) beats per minute (P=0.07). Serum haemoglobin levels were 
higher in patients with proximal migration (median 14.4, IQR, 13.0 to 15.8 g/dL) compared to
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the non-migration group (median 13.8, IQR, 13.0 to 14.8 g/dl; P=0.09). There were more 
past or current smokers in the proximal migration group (63/97, 65%) when compared with 
those without migration (21/26, 81%; P=0.09).
With regard to preoperative CT variables, proximal migration was more likely in 
patients with larger aortic necks. For patients with CT evidence of migration, median (IQ.R) 
aortic neck diameter was 24 (22 to 30) mm, whereas those patients without migration, the 
median (IQR) diameter was 23 (20 to 25) mm (P=0.07). Maximum coronal neck angle was 
lower in patients with proximal migration (median 17°, IQR 9° to 26°) when compared with 
those without migration (median 25°, IQR 13° to 38°; P-0.06). Moderate or severe CIA 
thrombus was more prevalent (22, 28%) in patients without proximal migration than those 
with (2,15%; P=0.1).
There were three graft-related factors that were possible risk factors when subject to 
univariate analysis. Patients with two or more target vessel stents were greater in frequency, 
than the non-migration group (35/121, 29%) when compared patients to similar patients 
with proximal migration (5/33, 15%; P=0.08). Deployment of the ipsilateral limb in close 
proximity to the CIA bifurcation was found to be potentially protective of proximal migration. 
Patients with proximal migration had a median (IQR) ipsilateral limb deployment distance 
from the CIA of 20 (16 to 27) mm. This was greater than the median (IQR) length 15 (9-22) 
mm for the non-migration group (P=0.02). Larger diameter contralateral limbs were also 
suggested as being potentially protective of proximal migration. However, the clinical 
significance of this is questionable as the differences in limb diameters between the 
migration (median 13, IQR 11 to 13 mm) and non-migration groups (median 13, IQR 12 to 15
mm) were small (P=0.02).
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Based on the 1st post-operative CT scan, proximal migration was greater in patients 
with larger aortic neck diameters (P=0.07), shorter aortic neck lengths (P=0.02), smaller 
contralateral CIA diameters (P=0.09) and smaller caudal renal artery to aortic bifurcation 
lengths (P=0.09). There were also some potential risk factors identifiable from changes in 
aortic morphology during follow-up. The incidence of proximal migration was greater in 
patients with expanding aortas, in these situations aortic diameters were measured at the 
coeliac axis (P=0.03), cranial (P=0.06) and caudal (P=0.03) renal arteries. Migration was also 
greater when the length of the SMA to crania! renal artery was shown to increase during 
follow-up (P=0.03) and when there was an increase in the inter-renal artery distance 
(P=0.08). Conversely, proximal migration appeared to be more prevalent in situations when 
the caudal renal artery to bifurcation length was decreasing (P=0.07). For follow-up 
complications, migration appeared to be more prevalent in cases where there was evidence 
of device kinking. By way of further clarification, in the non-migration group there was one 
case of stent-graft kinking (1/121, 1%) whereas there were three (3/33, 9%) in the proximal 
migration group (P=0.03). Further details on each of these factors are provided in Table 7.9 
(P values <0.1) and Table 7.10 (P values <0.05). A tabulated summary of these results follows 
this paragraph (Table 7.8) and a further explanation with regarding these factors will form 
part of the discussion section.
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Table 7.8 Summary of the covariates that achieved a statistically significant (P<0.05) association 
with proximai migration.
Covariate
No proximal migration
(n=121)
Proximal migration
(n=33) P Value
Median IQR Median IQR
Ipsilateral CIA deployment distance, mm 15.0 9 to 22 20.0 16 to 17 0.02
Contralateral limb diameter, mm 13.0 12 to 15 13.0 11 to 13 0.02
1st postop CT neck length, mm 5.0 Oto 11 0.0 Oto 7 0.02
Change in aortic diameter at CA, mm 1.0 0.0 to 2.0 2.0 0.5 to 4.0 0.03
Change in aortic diameter at CaRA, mm 2.0 1.0 to 4.0 4.0 2.0 to 7.0 0.03
Change in SMA to CrRA aortic length, mm 1.0 -2.0 to 2.0 2.0 -0.8 to 4.0 0.03
Graft kinking 1(1%} 3 (9%) 0.03
IQR, inter-quartile range. CA, coeliac axis. CaRA, caudal renal artery. CrRA, cranial renal artery.
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7.3.4 Multivariate analyses
Univariate analyses have identified several risk factors that were associated with proximal 
migration of a Zenith fenestrated stent-graft (Table 7.8). The focus for this thesis now turns 
to the evaluation of multiple factors within a single statistical model. Ideally, results from the 
model will allow the prediction of proximal migration of a fenestrated stent-graft from one or 
more independent variables. Proximal migration is measured in a continuous scale, but from 
previous validation experiments, there is uncertainty regarding the accuracy of any migration 
measurements that are less than four millimetres. Due to this limitation migration is 
considered as a binary event (movement > 4 mm) and modelled as a categorical (binary) 
variable. Various methods exist for investigating the effect of multiple variables on an event. 
The event migration is not the only concern within this project but also the time to the event. 
In order to use the time data within the model, a multiple regression analysis using a Cox 
proportion hazards model has been constructed. The Cox model has several available 
options in order to consider multiple variables and can also model the time to event when 
the data is interval censored. Modelling using interval censored data has previously proven 
to be difficult and the majority of commercially available computer programmes require a 
precise event time (i.e. SPSS Statistics for Windows).
The first stage in the multivariate analysis will utilise the statistical software package 
R. This package provides the option of a Cox regression analysis using pre-specified event 
times (beginning of the interval, midpoint and end of the interval) together with the option 
of an interval censoring approach. In order to construct a Cox model using interval censored
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data the R package requires the add-on package 'Intcox' (Wei, 1999). Although the original 
paper by Wei was published in 1999, the integration of this function (Cox proportional 
hazards model using interval censored data) has only been available in R from February 2013. 
The output from this package provides a hazard ratio (exponential regression coefficient) but 
no indication of 95% confidence intervals or resultant P values. 95% confidence intervals can 
be generated using the Intcox package and a separate bootstrapping technique.
In statistics, bootstrapping is a method of assigning measures of accuracy to sample 
estimates (Efron and Tibshirani, 1993). This computer sampling technique allows the 
generation of an estimate of the sampling distribution of almost any statistic using very 
simple methods (Varian, 2005). The theory behind bootstrapping is to repeatedly sample 
(with replacement) from a single sample. Using these new "samples" to compute the 
sampling distribution for the statistics related to the problem. With respect to regression, 
bootstrapping can be used to generate related confidence intervals (Campbell and 
Torgerson, 1999). Simply, the Intcox function was run repeatedly with removal of a single 
case each time in order to generate a series of regression coefficients. The bootstrapping 
method was asked to generate 100 regression coefficients for the same variable and then 
rank them in order. Values in positions 3 and 97 provide approximate 95% confidence 
intervals. This procedure was completed for all hazard ratio calculations that used interval 
censored data. If the confidence interval did not cross 1 then the hazard ratio was 
considered to be statistical significant i.e P<0.05. R codes for the calculation of survival data, 
Cox proportional hazards models and bootstrapping techniques are provided within the 
appendices.
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Within the statistical programming language R, there are limited options for how 
selected variables are entered within the Cox model. The default option is the 'enter' 
method where all selected variables are entered at the same time. SPSS Statistics for 
Windows 20.0 has a greater range of options, in addition to the enter method there is the 
further option of step-wise regression. Step-wise regression allows the software to 
determine the order of entry of a variable. There are two stepwise options, forward and 
backward, a forward method is where the variable that causes the greatest increase R2 is 
selected first. There is also the option of starting with a full model of all selected variables 
and then eliminating variables that do not significantly enter the regression equation and a 
partial model is found. This is described as a backward variable entry procedure. Both 
forward and backward regression options are readily available using SPSS, however, a 
forward and backward model cannot be generated in SPSS using interval censored data. The 
impact of this will be considered within the discussion section.
When using covariates which generated a univariate P value (<0.1), there were no 
statistically significant variables identified using a multivariate Cox proportional hazards 
model. These findings were consistent across the two statistical packages and for all event 
time definitions. This absence of any statistically significant variables was also seen for the 
different variable entry methods (Enter, Forward and Backward). A series of tables providing 
summary statistics are presented in the appendices, the locations of which are described in 
the table below (Table 7.11).
239
Table 7.11 Description of the Cox proportional hazards models that
are resented in the appendices
Appendix Cox Proportional Hazards Model
APP_18 R, beginning of interval (P<0.1)
APP_19 R, midpoint of interval (P<0.1)
APP_20 R, end of interval (P<0.1)
APP_21 SPSS, beginning of interval (P<0.1)
APP_22 SPSS, midpoint of interval (P<0.1)
APP_23 SPSS, end of interval (P<0.1)
With regard to those variables that produce a P Value <0.05. Results from this 
multivariate analysis are first described using the R programme (Table 7.12). Results using 
the computer programme SPSS Statistics for Windows 20.0 are summarised in Table 7.13, 
these included results from the forward and backward stepwise regression models.
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Table 7.12 Multivariate analysis of risk factors for proximal migration using R and the four 
event time definitions
Event time definition
Univariate Multivariate
95%CI 95%CI
Beginning of interval
HR Lower Upper P Value HR Lower Upper P Value
Ipsilateral CIA deployment distance, mm 1.02 0.99 1.05 0.17 1.02 0.98 1.06 0.26
Contralateral limb diameter, mm 0.85 0.75 0.97 0.02 0.88 0.74 1.05 0.16
1st aortic neck length, mm 0.91 0.84 0.97 0.01 0.91 0.84 0.99 0.02
Diameter change - coeliac axis, mm 1.08 0.97 1.20 0.18 1.03 0.89 1.19 0.71
Diameter change - caudal renal artery, mm 1.11 0.98 1.25 0.09 1.22 1.03 1.44 0.02
Length change, SMA to caudal renal artery, mm 1.07 1.01 1.14 0.03 1.16 1.04 1.28 0.01
Graft kinking 1.70 0.65 4.42 0.28 0.42 0.05 3.21 0.40
Midpoint of interval
Ipsilateral CIA deployment distance, mm 1.02 0.99 1.05 0.29 1.02 0.99 1.06 0.25
Contralateral limb diameter, mm 0.85 0.75 0.97 0.02 0.86 0.72 1.04 0.12
1st aortic neck length, mm 0.90 0.83 0.97 0.00 0.90 0.83 0.97 0.01
Diameter change - coeliac axis, mm 1.08 0.97 1.21 0.14 1.02 0.88 1.19 0.75
Diameter change - caudal renal artery, mm 1.10 0.97 1.24 0.15 1.18 1.00 1.39 0.06
Length change, SMA to caudal renal artery, mm 1.06 1.00 1.13 0.07 1.12 1.01 1.24 0.02
Graft kinking 1.84 0.71 4.79 0.21 0.52 0.07 3.98 0.53
Endpoint of interval
Ipsilateral CIA deployment distance, mm 1.01 0.98 1.04 0.48 1.02 0.98 1.05 0.38
Contralateral limb diameter, mm 0.84 0.73 0.95 0.01 0.84 0.70 1.02 0.09
1st aortic neck length, mm 0.89 0.83 0.96 0.00 0.90 0.83 0.97 0.01
Diameter change - coeliac axis, mm 1.08 0.97 1.20 0.17 1.01 0.87 1.18 0.87
Diameter change - caudal renal artery, mm 1.07 0.94 1.22 0.29 1.12 0.95 1.33 0.18
Length change, SMA to caudal renal artery, mm 1.05 0.98 1.12 0.14 1.10 0.99 1.21 0.07
Graft kinking 1.79 0.69 4.65 0.23 0.61 0.08 4.78 0.64
Interval censoring
Ipsilateral CIA deployment distance, mm 1.01 0.98 1.05 >0.05 1.02 0.97 1.06 >0.05
Contralateral limb diameter, mm 0.85 0.72 0.94 <0.05 0.84 0.57 0.95 <0.05
Aortic neck length, mm 0.91 0.86 0.97 <0.05 0.90 0.78 0.97 <0.05
Diameter change - coeliac axis, mm 1.07 0.97 1.25 >0.05 1.01 0.81 1.21 >0.05
Diameter change - caudal renal artery, mm 1.10 0.97 1.24 >0.05 1.12 0.91 1.48 >0.05
Length change, SMA to caudal renal artery, mm 1.09 1.02 1.16 <0.05 1.10 0.96 1.28 >0.05
Graft kinking 0.53 0.00 1.78 >0.05 0.61 0.00 3.40 >0.05
Variables were selected from univariate analysis (P<0.05) and entry into the R package used the ENTRY method. Values in red
indicate those variables that were statistically significant (P<0.05) when using multivariate analysis. Univariate HR were provided for 
additional information.
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Multivariate analysis based on the Cox proportional hazard model using the R 
statistical package (interval censoring) revealed that 1st postoperative aortic neck length 
measurement is a risk factor for proximal migration (HR 0.9, 95%CI 0.78 to 0.97, P<0.05). 
This covariate was statistically significant across all three other event time definitions and the 
effect occurred in a negative direction. For every unit increase (mm) in 1st postoperative 
neck length there is a 9-10% decrease in the proximal migration hazard. Taking into 
consideration the 95% confidence intervals this decrease in hazard can vary between 1% and 
22%.
When using the beginning of the interval as the event time definition, follow-up 
changes in aortic diameter at the most caudal renal artery (HR 1.22, 95%CI 1.03 to 1.44, 
P=0.02) and changes in the SMA to cranial renal artery distance were also found to be risk 
factors (HR 1.16, 95%CI 1.04 to 1.28, P=0.01). For every mm increase in aortic diameter at 
the most caudal renal artery during follow-up there was a 22% (95%CI 3% - 44%) increase in 
proximal migration hazard. For changes in the SMA to the cranial renal artery length, every 
mm increase during follow-up will cause an estimated 16% (95%CI 4% - 28%) rise in proximal 
migration hazard. This last covariate was also found to be statistically significant when using 
the midpoint of the interval as the event time (HR 1.12, 95% Cl 1.01 to 1.24, P=0.02). Using 
an interval censoring event time definition, contralateral iliac limb diameter was found to 
have a negative effect on the risk of proximal migration (HR 0.84, 95%CI 0.57 to 0.95, 
P<0.05). For every unit increase (mm) in contralateral limb diameter, there was an estimated 
16% (95% 5% to 43%) reduction in the proximal migration hazard.
There were many similarities when using the SPSS 'enter' method. For all three
specific event time definitions the 1st postoperative aortic neck length was found to be a risk
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factor for proximal migration. Hazard rates were similar showing around a 10% reduction for 
every additional mm in aortic neck length. When using the beginning of interval event time 
definition there were further consistencies. Follow-up aortic diameter changes at the caudal 
renal artery and an increase in SMA to cranial renal artery length were also found to be risk 
factors, with similar hazard ratios. Follow-up aortic diameter changes at the most caudal 
renal artery escaped statistical significant (P=0.06) when using the midpoint event time 
definition. However, postoperative changes in the SMA to cranial renal artery length were 
associated with proximal migration, when using this event time (HR 1.12, 95%CI 1.01 to 1.24, 
P=0.02). When using the end of the interval, the 1st postoperative aortic neck length was the 
only statistically significant variable, producing similar hazard ratios to the R package (HR 0.9, 
95%CI 0.83 to 0.97, P=0.01).
When using the SPSS stepwise forward and backward variable entry methods, the 
following results were observed. Using forward selection, 1st postoperative CT aortic neck 
length, postoperative aortic diameter changes at the most caudal renal artery and length 
changes between the SMA and caudal renal artery were found to be statistically significant. 
This was only when using the beginning and midpoints of the interval as event times. When 
using the endpoint of the interval, follow-up length changes were not included in the model 
and the contralateral limb diameter was included (HR 0.83, 95%CI 0.70 to 0.98, P=0.03). 
Using a backward selection process produced almost identical results to forward selection for 
the beginning and midpoints of the interval (event times). When using the end of the 
interval, the 1st postoperative CT aortic neck length measurement was the only statistically 
significant risk factor (HR 0.91, 95% Cl 0.84 to 0.98, P=0.01). A summary of possible changes 
to covariates and their resultant effects on the migration hazards are described in Table 7.14.
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Table 7.14 Effect of possible variable changes on the proximal migration hazards.
Variable Model Event time 
definition
Migration Hazard 
(1 unit rise)
Beginning 9% decrease
R (Enter) Midpoint
Endpoint
10% decrease
10% decrease
Interval censoring 10% decrease
Postoprative 1st
Beginning 9% decrease
SPSS (Enter) Midpoint 10% decrease
CT aortic neck Endpoint 10% decrease
length, mm Beginning 8% decrease
SPSS (Forward) Midpoint 9% decrease
Endpoint 9% decrease
Beginning 8% decrease
SPSS (Backward) Midpoint 9% decrease
Endpoint 9% decrease
R (Enter) Beginning
Midpoint
22% increase
12% increase
Aortic diameter 
changes at most SPSS (Enter)
Beginning
Midpoint
20% increase
18% increase
caudal renal
artery, mm SPSS (Forward)
Beginning
Midpoint
22% increase
19% increase
SPSS (Backward) Beginning
Midpoint
21% increase
18% increase
Length changes 
from SMA to R (Enter)
Beginning
Midpoint
16% increase
12% increase
cranial renal
artery, mm SPSS (Enter)
Beginning
Midpoint
14% increase
12% increase
Contralateral R (Enter) Interval censoring 16% decrease
limb diameter, SPSS (Forward) Endpoint 17% decrease
mm
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7.3.5 Multiple imputations (Ml) and missing data recovery
Missing data are a common problem in all types of medical research. As Donders and 
colleagues reported there are various methods available to handle missing data (Donders et 
al., 2006). Simple and commonly used methods include complete or available case analysis, 
the missing-indicator method (Miettinen, 1985), hot deck imputation (Andridge and Little, 
2010) and overall mean imputation (Shrive et a/., 2006). Reports have argued that these 
methods can lead to an inefficient analysis and more seriously can produce severely biased 
estimates of any associations (Greenland and Finkle, 1995, Vach, 1994, Rubin, 1987, Schafer, 
1997, Little, 1992). With improvements in statistical programming and computer technology, 
there are now more sophisticated imputation techniques to handle missing data. One of 
these techniques replaces missing values for any given subject based on a computer 
prediction from known characteristics. This technique is termed multiple imputations (Ml). 
Ml is a Monte Carlo technique in which missing values are replaced by m>l simulated 
versions, where m is typically small (e.g. 3-10). Commonly available statistical programmes 
provide the option for Ml (e.g. SAS, R and SPSS).
One of the limitations of the multicentre cohort was the presence of missing values 
for some variables. The accuracy of the Cox proportional hazards model may be improved by 
modelling for missing values using a technique such as Ml. The computer programme IBM 
SPSS Statistics for Windows 20.0 (IBM Corp, Armonk, NY) provides an option for Ml. Within 
this thesis, the original multicentre dataset (with missing values, see previous section) was 
subject to an Ml procedure. This resulted in the generation of 5 additional Ml datasets (MI-1, 
MI-2, MI-3, MI-4 and MI-5) with no missing values. Descriptive statistics for the seven
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covariates tested within the original P<0.05 Cox proportional hazards model and the new Ml
datasets are summarised below (Table 7.14).
Table 7.15 Summary statistics for original and alternative (multiple imputation) datasets (MI-1 
to MI-5)
Missingness Normality test.
Variable Dataset n (%)Rvalue Mean SD Median IQR Min, Max
Original 4(3%) <0.001 5.6 6.3 4.0 0.0 to 10.0 0.0, 25.0
MI-1 0(0%) <0.001 5.6 6.3 4.0 0.0 to 10.0 0.0, 25.0
1st postoperative CT MI-2 0 (0%) <0.001 5.5 6.3 4.0 0.0 to 10.0 0.0, 25.0
neck length, mm MI-3 0 (0%) <0.001 5.7 6.3 4.0 0.0 to 10.0 0.0, 25.0
MI-4 0(%) <0.001 5.6 6.3 4.0 0.0 to 10.0 0.0, 25.0
MI-5 0 (0%) <0.001 5.7 6.3 4.0 0.0 to 10.0 0.0, 25.0
Original 5(3%) <0.001 1.4 2.4 1.0 0.0 to 2.0 -3.0,14.0
Follow-up aortic MI-1 0 (0%) <0.001 1.4 3.4 1.0 0.0 to 2.0 -4.0,14.0
neck diameter MI-2 0 (0%) <0.001 1.3 2.4 1.0 0.0 to 2.0 -4.0,14.0
change-coeliac MI-3 0 (0%) <0.001 1.4 2.4 1.0 0.0 to 2.0 -4.0,14.0
axis, mm MI-4 0 (0%) <0.001 1.4 2.4 1.0 0.0 to 2.0 -4.0,14.0
MI-5 0(0%) <0.001 1.4 2.4 1.0 0.0 to 2.0 -4.0,14.0
Original 6(4%) <0.001 3.3 2.4 3.0 2.0 to 5.0 -1.0,10.0
Follow-up aortic MI-1 0(0%) <0.001 3.2 2.6 3.0 1.0 to 5.0 -1.0,12.0
neck diameter MI-2 0(0%) <0.001 3.2 2.6 3.0 1.0 to 5.0 -1.0,12.0
change - caudal MI-3 0 (0%) <0.001 3.2 2.6 3.0 1.0 to 5.0 -1.0,12.0
renal artery, mm MI-4 0(0%) <0.001 3.2 2.6 3.0 1.0 to 5.0 -1.0,12.0
MI-5 0(0%) <0.001 3.2 2.6 3.0 1.0 to 5.0 -1.0,12.0
Original 15 (10%) <0.001 13.7 3.2 13.0 12.0 to 15.0 8.0, 28.0
MI-1 0 (0%) <0.001 13.6 3.2 13.0 11.8 to 15.0 7.0, 28.0
Contralateral limb MI-2 0 (0%) <0.001 13.6 3.1 13.0 12.0 to 15.0 7.0, 28.0
diameter, mm MI-3 0 (0%) <0.001 13.6 3.2 13.0 11.8 to 15.0 7.0, 28.0
MI-4 0(0%) <0.001 13.6 3.2 13.0 11.9 to 15.0 7.0, 28.0
MI-5 0 (0%) <0.001 13.6 3.2 13.0 12.0 to 15.0 7.0, 28.0
Original 27(18%) <0.001 17.0 12.2 16.6 9.8 to 23.9 -46.8, 53.6
Ipsilateral limb
MI-1 0 (0%) <0.001 16.7 10.8 16.5 10.3 to 21.8 -46.8, 53.6
deployment MI-2 0 (0%) <0.001 16.7 10.8 16.3 10.3 to 21.8 -46.8, 53.6
distance, mm MI-3 0 (0%) <0.001 16.7 10.9 16.5 10.1 to 21.9 -46.8,53.6
MI-4 0 (0%) <0.001 16.8 10.9 16.3 10.6 to 21.8 -46.8,53.6
MI-5 0 (0%) <0.001 16.6 10.8 16.0 10.6 to 21.1 -46.8, 53.6
Original 5(3%) <0.001 -0.7 3.9 -1.0 -2.0 to 1.8 17.0,11.0
Follow-up change
MI-1 0 (0%) <0.001 -0.6 5.0 -1.0 -3.0 to 2.0 -18.0, 22.0
SMAto cranial renal MI-2 0 (0%) <0.001 -0.6 4.9 -1.0 -3.0 to 2.0 18.0, 22.0
artery length, mm MI-3 0 (0%) <0.001 -0.6 5.0 -1.0 -3.0 to 2.0 -18.0, 22.0
MI-4 0 (0%) <0.001 -0.6 5.0 -1.0 -3.0 to 2.0 18.0, 22.0
MI-5 0 (0%) <0.001 -0.5 5.0 -1.0 -3.0 to 2.0 -18.0, 22.0
SD, standard deviation. IQR, inter-quartile range. Ml-missing imputation dataset. Min, minimum. Max, maximum. Base on the 
distribution of the data the shaded area highlights the appropriate descriptive statistics.
The multiple imputation technique recovered a total of 63 missing values across the 
seven variables. Comparison of the datasets generated using the Ml process (Mil to MIS) 
demonstrated very little difference in the summary statistics (Table 7.15). The Cox 
proportional hazards model was then reapplied to each of the five alternative datasets (MI-1
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to MI-5). The original seven included covariates remained the same as did the four event 
time definitions. Generating the Cox proportional hazards model using five additional Ml 
datasets produced a significant amount of data. These have been summarised within the 
appendices, the full detail on the locations of these results are provided in the table below 
(Table 7.16).
Table 7.16 Location of Cox proportional hazards models for the Ml 
datasets within the appendices.
Appendix Cox Proportional Hazards Models for Ml datasets
APP_24 1st postoperative CT aortic neck length
APP_25 Postop aortic diameter change - coeliac axis
APP_26 Postop aortic diameter change - caudal renal artery
APP_27 Contralateral limb diameter
APP_28 Ipsilateral iliac limb deployment distance
APP_29 Graft kinking
APP_30 Postop change in length, SMA to cranial renal artery
For the 1st postoperative CT aortic length measurement, this was identified as a 
statistically significant risk factor across all Ml datasets, for all event time definitions and with 
all modelling techniques. There was additional consistently, a 10% hazard reduction from 
every unit increase in 1st postoperative CT aortic neck length was similar to the Cox HR 
estimates using the original dataset. 95% Cl were also consistent across all event time 
definitions and between datasets.
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Follow-up changes in aortic diameter, at the level of the coeliac axis, were not found 
to be a statistically significant risk factor for proximal migration with any of the Ml datasets. 
This feature was consistent with the original dataset and was not affected by event time 
definition or modelling process e.g. SPSS or R. Follow-up changes in aortic diameter at the 
level of the most caudal renal artery did, however, provide some further evidence that this 
may be a risk factor. Using the original data this variable was found to be significant when 
using the beginning and midpoint of the interval. Introduction of the Ml datasets produced 
similar results and also identified this as a risk factor when using the end of the interval 
(forward and backward stepwise selection on SPSS, 2 out of 5 Ml datasets only). When using 
the original dataset the contralateral iliac limb diameter was found to be a risk factor, when 
using R and an interval censoring approach. For each of the five new MI datasets, statistically 
significant differences, for all event times and using all approaches, were demonstrated for 
the contralateral limb diameter. Originally, the contralateral limb diameter was missing in 
10% of patients, compensating using an Ml technique is a possible reason for the more 
widespread statistical significance. For the Ml datasets hazard ratios ranged from 0.79 (95% 
Cl 0.67 to 0.93, P=0.01) to 0.87 (95% Cl 0.77 to 0.99, P=0.04).
Ipsilateral iliac limb deployment distance was not found to be a risk factor on 
multivariate analysis (FIR 1.02, 95%CI 0.98 to 1.06; P-0.26). This was a consistent feature 
across all five of the Ml datasets and a similar trend can be reported for graft kinking (FIR 
0.42, 95%CI 0.1 to 3.2; P=0.4). Postoperative changes to the SMA to cranial renal artery 
distance were shown to be a risk factor when using the original dataset for the beginning and 
midpoint of the interval event times. This observation included both the R and SPSS 
statistical programmes and forward and backward stepwise entry approaches (SPSS only).
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These findings were consistent across the Ml datasets, however, there were several
situations where this variable was also found to be statistically significant (e.g. endpoint of 
the interval). There was, however, an opposite trend for this variable, in that the direction of 
effect was negative for the Ml datasets and positive with the original data. This raises 
questions on the reliability of the Ml processes in this instance and further commentary on 
the Ml process will form part of the discussion.
Stepwise regression is a semi-automated process for building a model by successively 
adding or removing variables. Depending on the dataset there could be differences in the 
resultant models. The 1st post-operative neck length measurement was included in all 
stepwise models. When using the original dataset, the second and third commonest 
variables to be included were postoperative changes in aortic diameter (caudal renal artery) 
and changes in the SMA to cranial renal artery length. These were both selected when using 
the beginning of the interval and midpoint and for both forward and backward selection 
processes. Contralateral limb diameter was included in the original data model when using 
interval censoring, together with 1st postoperative aortic neck length (not a stepwise 
approach). This was at the expense of any changes in aortic morphology during follow-up. 
The addition of the Ml datasets included the contralateral limb diameter for all situations all 
of the Ml datasets. Changes in aortic diameter were included in 2 out of 5 Ml datasets for 
both the beginning and midpoints of the interval (forward stepwise). In general, there was 
consistency between the forward and backward stepwise selection processes. There were 
some slight differences between Ml datasets and event time definitions used. Full details on 
the comparison between datasets are provided in Table 7.17 and Table 7.18.
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Table 7.17 Comparison between the original and Ml datasets with regard to variables selected in a 
forward SPSS stepwise model.
Dataset/Variable Original MI-1 MI-2 Ml-3 MI-4 MI-5
1st postoperative
neck length, mm B M E B M E B M E B M E B M E B M E
Aortic diameter 
change -caudal 
renal artery, mm
BM B M B M B M B M
Contralateral iliac 
limb diameter, E B M E B M E B E B M E B M E
mm
Post-operative
length change - 
SMAto cranial 
renal artery, mm
B M B B B M B
Event time - B, beginning of interval; M, middle of interval; E, end of interval. All variables identified in the first 
column generated P values <0.05 using Cox regression.
Table 7.18 Comparison between the original and Ml datasets with regard to variables selected in a 
backward SPSS stepwise model.
Dataset/variable Original MI-1 MI-2 MI-3 MI-4 MI-5
1st postoperative
aortic neck length. B M E B M E B M E B M E B M E B M E
mm
Aortic diameter
change-caudal 
renal artery, mm
BM B M B M B M E B M B M
Contralateral iliac 
limb diameter, mm E B M E B M E B M E B M E B M E
Post-operative 
length change- 
SMAto cranial B M B M B M B M B M B
renal artery, mm_______________________________
Event time - B, beginning of interval; M, middle of interval; E, end of interval. All variables identified in the first 
column generated P values <0.05 using Cox regression.
7.4 Discussion
Fenestrated stent-grafts are expensive, aneurysm morphology is complex and migration- 
related complications are potentially catastrophic. For manufacturers, clinicians and patients 
the identification of risk factors for proximal migration is likely to bring benefit. Using data 
from the previous chapter, it is estimated that a third of patients will experience proximal 
migration by 4 years. With this incidence, it is appropriate to consider causative factors and 
whether migration can be predicted in the future. To date, this is the first in man study to
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quantify fenestrated stent-graft migration using a previously validated technique (Chapter 4). 
Several clinical, anatomical, graft-related and follow-up variables have been previously linked 
with the migration of a conventional (infrarenal) stent-graft. For fenestrated stent-grafts, no 
such reports exist, any speculation regarding risks factors are based on a small number of lab 
experiments, comparisons with conventional devices and personal opinion. Within the 
multicentre cohort report in this thesis, there were 33 cases of proximal migration. To 
identify risk factors for proximal migration a series of univariate analyses were first 
undertaken. Based on the univariate work, several possible risk factors were identified and 
these were entered into a multivariate predictive factor model.
Multivariate analysis is a statistical tool for determining the relative contributions of 
different causes to a single event or outcome. Within in this thesis, the contribution of 
multiple variables on proximal migration was considered. For all multivariate Cox 
proportional hazards models the 1st postoperative CT aortic neck length was found to be a 
risk factor for proximal migration. For every mm increase in 1st postoperative CT aortic neck 
length, the proximal migration hazard decreased by 10% (HR 0.90, 95% Cl 0.78 to 0.98, 
P<0.05). Other variables were shown to be statistically significant risk factors for proximal 
migration, but had some dependence on the event time and statistical approach. These 
variables were postoperative aortic diameter changes at the caudal renal artery (HR 1.19, 
95% Cl 1.02 to 1.38, P=0.02), postoperative vessel length changes between the SMA and the 
cranial renal artery (HR 1.14, 95% Cl 1.04 to 1.25, P=0.01) and the contralateral iliac limb 
diameter (HR 0.84, 95%CI 0.57 to 0.95, P<0.05).
Regarding, the 1st post-operative CT aortic neck length (caudal renal artery to the
start of the aneurysm or changes in aortic diameter). This dominated the multivariate
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analysis, being present across all event times regardless of statistical approach (e.g. SPSS 
versus R). The Cox proportional hazards model estimated that for every mm increase in 
aortic neck length, there is a 10% reduction in proximal migration hazard. This variable was 
also identified as being statistically significant when using univariate analysis (P=0.02). The 
median (IQR) aortic neck length was smaller 0 (0 to 7) mm in the proximal migration group 
when compared to 5 (0 to 11) mm in the non-migration group (P=0.02). Aortic neck length 
has been previously identified as a risk factor when using infrarenal stent-grafts (Waasdorp 
et aL, 2009). Differences in migration rates may result from the differences in the amount of 
apposition (area in contact) between the fabric portion of the device and the aortic wall. This 
may have had an effect on the overall resistance to migration by the device. For fenestrated 
devices, there are further considerations with regard to the aortic neck, as a risk factor. One 
theory surrounding aortic neck length is that it provides an indication of stent-graft to aortic 
wall apposition. However, if the neck length was longer for one particular group (e.g. non­
migration), then this does not, necessarily prove that the device would have more contact 
against the aortic wall. There is the possibility that there could be a long infrarenal neck, 
which was highly conical and as a result, there would only be a small amount of apposition 
between the infrarenal aorta and the stent-graft. Another consideration would be the 
amount of fabric coverage directly above the caudal renal artery. If a fenestrated stent-graft 
was planned with four stented fenestrations, then there would be a big difference in the 
suprarenal fabric coverage, when compared to a device with a single unstented renal scallop. 
A device using a single unstented fenestration is likely to have more infrarenal aortic neck 
than one with four stented fenestrations and this shows that there multiple factors 
influencing fixation. It is important to highlight that the suprarenal fabric coverage was not
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directly measured within this study. It must also be questioned why 1st postoperative neck 
length was a risk factor and not preoperative aortic neck length. One theory is the relatively 
high numbers of missing preoperative CT scans in the proximal migration group (20 out of 
33). It is, however, thought unlikely that there would be a significant difference in aortic 
neck length between the preoperative and postoperative CT scans. As such, there may be 
some transferability of risk factor across to preoperative measurements. To confirm this 
latter point, would require additional study.
The diameter of the distal contralateral iliac limb was suggested as a further 
multivariate risk factor for proximal migration. A Cox proportion hazards model, using 
interval censoring, estimated a 16% decrease in proximal migration hazard for every mm 
increase in contralateral limb diameter. There are computer generated flow models, which 
have confirmed that the forces on a stent-graft are greater in the presence of smaller 
diameter ClAs (Li and Kleinstreuer, 2006a). The reason for this is that blood needs to 
converge suddenly into smaller iliac limbs, resulting in a significant net momentum change. 
Multivariate analysis did not take into consideration the proximal inlet diameter directly, this 
would be important in calculating the proximal/iliac ratio and any differences in 
displacement forces. It is also important to consider that other factors such as the type of 
device type (e.g. aorto-uni-iliac or tube) and whether the limbs were flared could influence 
the proximal/iliac ratio. The contralateral limb is likely to be the smaller diameter of the two 
limbs, this will have the greatest effect on the proximal/iliac diameter ratio and the resultant 
stent-graft drag force. This may be a reason why the contralateral side was identified as risk 
factor and not the ipsilateral side. When using univariate analysis, although statistically 
significant (P=0.02), the median (IQR) limb diameter for the proximal migration and non-
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migration groups were relatively similar, 13 (12 to 15) mm versus 13 (11 to 13) mm, 
respectively. Although multivariate analysis suggested that patients with smaller diameter 
contralateral iliac limbs are more at risk of proximal migration. Clinically, there was little 
difference between the two groups. Further interrogation of the data revealed that the 
maximum contralateral limb diameter was greater in the non-migration group (28 mm) when 
compared with the proximal migration group (20 mm).
There can be changes in aortic morphology during follow-up, which can place a 
patient more at risk for proximal migration. Changes in the diameter of the aorta at the level 
of caudal renal artery were identified as a multivariate risk factor. For every mm increase in 
aortic neck diameter at the caudal renal artery during follow-up, there was an estimated 18% 
increase in proximal migration hazard. Similar trends can be seen in the univariate analysis, 
where aortic neck growth was greater in patients with proximal migration when compared to 
those without. There are two possible explanations for this, firstly, the inlet diameter. 
Unless the stent-graft is a tube with an equal inlet and outlet diameter, there will be a net 
displacement force acting on the stent-graft. Steady state studies have showed that the 
forces acting on a stent-graft increase when increasing the inlet area (diameter) (Mohan et 
a!., 2002). Patients with changes in aortic neck diameter during follow-up, therefore, are 
more at risk from migration, which could be the result of device oversizing or disease 
progression. A study by Lipski et al., showed than non-stented aortic necks can increase by 
at least 5 mm in diameter during follow-up, in a significant number of patients (Lipski and 
Ernst, 1998). Regardless of aetiology, postoperative aortic neck expansion increases the 
stent-graft displacement force. This has also been proven for infrarenal EVAR, Cao and
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colleagues used multivariate Cox regression and reported AAA neck enlargement of 10% or
more as a risk factor (HR 7.3, 95% Cl 1.8 to 29.2; P=0.004) (Cao et ai.t 2002).
An increase in the postoperative SMA to cranial renal artery length was shown 
increase the risk of proximal migration. For every mm increase in SMA to renal artery length 
during follow-up there was a 14% increase in proximal migration hazard. Similar evidence 
was presented in the univariate analysis where length growth was shown to be significantly 
larger in patients with proximal migration (P=0.03). The median (IQR) increase in SMA to 
cranial renal artery length was 1.0 (-2.0 to 2.0) in patients without migration and 2.0 (-0.8 to 
4.0) in patients with proximal migration. Around half of the changes within each group were 
between -2.0 and +2.0. The clinical usefulness of this variable is likely to be the subject of 
debate. For patients with proximal migration, it is hard to explain the apparent increase in 
SMA to cranial renal artery length during follow-up. Non-stented aortas have also been 
shown to have some aortic neck length growth during follow-up. The study by Lipski and 
colleagues reported aortic neck length growth of more than 10 mm in a significant number of 
patients (Lipski and Ernst, 1998). Their report was limited in that it used radiopaque surgical 
clips and AP and lateral abdominal radiographs to track movements. Nowadays, with the 
widespread available of MDCT, many would question this approach and also its lack of 
validation, especially surrounding with the issue of radiographic magnification. Aortic 
elongation has been previously suggested by Litwinski and colleagues, in their study they 
failed to unequivocally prove, that for some patients, the distance between the caudal renal 
artery and the aortic bifurcation increased (Litwinski et al.t 2006). Aortic elongation has been 
reported in in the thoracic aorta (Redheuil et ol., 2011) and it is, therefore, possible that focal 
growth could have occurred across the SMA to cranial renal artery segment. If this was the
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case, then this could have resulted in an increase in distraction force on the proximal 
component and subsequent migration.
There were other univariate (P<0.05) variables tested within the multivariate Cox 
proportional hazards models, which did not show statistical significance. On the basis of the 
univariate analysis, the distance between the distal portion of the ipsilateral iliac limb and 
the CIA bifurcation was found to be associated with migration (P=0.02). The median [IQR] 
distance between the distal limb and the CIA bifurcation was smaller in patients without 
proximal migration when compared to those with evidence of migration (15 [9 to 22] versus 
20 [16 to 27] mm), respectively. This link has been reported for conventional infrarenal 
devices (Waasdorp et al., 2009, Arko et ai, 2005, Heikkinen et al., 2006). There are, 
however, distinct differences with fenestrated devices in that they have separate proximal 
and distal bodies. Forces acting on the bifurcation are theoretically supposed to cause 
movement of the distal body and not the proximal fenestrated section. Observations from 
the study by Waasdorp et al, using conventional (infrarenal) devices, identified that good 
iliac fixation is especially important in patients with short proximal necks (Waasdorp et al., 
2009). This would be even more applicable for a fenestrated series; however, none of the 
previously mentioned iliac fixation studies used a three part fenestrated stent-graft.
Stent-graft kinking was entered into the multivariate model (univariate P=0.03), but
was not identified as a multivariate risk factor. For the univariate analysis stent-graft kinking,
occurred at a greater rate in the proximal migration group (3 patients, 9%) compared to the
non-migration group (1 patient, 1%). There were relatively low numbers of events, in both
the migration and non-migration groups. Stent-graft kinking refers to stent-graft, which
displayed a localised angulation of the graft or graft limb during follow-up. A similar
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definition was used in the EUROSTAR report by Fransen and co-researchers (Fransen et al.,
2003a). It is well accepted that over the course of follow-up the configuration of a stent- 
graft may change. The reported incidence within the literature will depend on the type of 
the device, but also the relevant reporting standards used. Umscheid et al., in a series of 291 
patients treated with various stent-grafts over a four year period, reported kinking in 56.7% 
of patients. Harris et al., reported on mild, significant or severe endograft kinks, reporting 
the latter in 10 (38%) out of 26 stent-grafts (Harris et al., 1999). In the report by Fransen et 
al., they assumed that stent-graft migration resulted in device kinking in a significant portion 
of patients. They also concluded that kinks are potential damaging events and that they may 
lead to delayed type I and III endoleaks, graft stenosis, thrombosis and conversion to open 
repair. The cohort within this thesis represent a series of patients with a fenestrated stent- 
graft implanted, it is therefore, not clear what the long term effects of fenestrated stent-graft 
kinking will be.
Postoperative dilatation at the level of coeliac axis was also suggested as a risk factor 
with univariate analysis (P=0.03). Post-FEVAR aortic neck expansion was smaller at the level 
of the coeliac axis (median 2.0, IQR 0.5 to 4.0 mm), when compared to the caudal renal 
artery (median 4.0, IQR 2.0 to 7.0 mm), in patients with proximal migration. This may explain 
why this variable did not reach statistical significant in the multivariate model. A biological 
explanation could be different levels of radial force between the two locations. This may be 
further explained by the general absence of graft fabric at the level of the coeliac axis. 
Conversely, at the renal arteries, all patients will have had the renal portion of abdominal 
aorta covered by fabric and a self-expanding stent-graft. These results may add to the 
growing body of evidence that any oversizing of the stent-graft should be used with caution.
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Benjamin Howell and colleagues also argued this, confirming that the degree of oversizing 
determines the inlet diameter, which is subsequently the principle determinant of 
displacement force and can massively impact on the risk of migration (Howell et al., 2005).
There were other variables that achieved univariate P values of 0.5 to 0.9. These 
were entered to a multivariation model and no risk factors were identified. Several of the 
morphological parameters have been shown to be risk factors for infrarenal stent-grafts. 
Questions may arise regarding their absence within this thesis. A discussion of these 
variables will now follow, it must be highlighted that missing values could be one explanation 
why some variables did not make it into a multivariate model. Zhou et al., compared a 
standard infrarenal device to a single stented fenestrated device (Zhou et al., 2007). The 
addition of a stented fenestration increased the force needed for initial displacement from 
4.3 to 11.5 N, with a 10% device oversizing. A further, final phase of displacement then 
required an extra 6.4 and 16.8 N, for standard and fenestrated devices respectively. From 
Zhou's work, it is clear that fenestrated stent-grafts offer higher fixation when compared 
with standard devices. It is, however, not clear whether the fixation increases with a greater 
number of target vessel stents. In the cohort reported in this chapter there was a trend of 
less proximal migrations in patients with > 2 target vessels. Out of 121 patients without 
migration, 35 (29%) had more than 2 target vessel stents. When compared with the group 
of patients with proximal migration, less, 5 (15%) had more than 2 target vessel stents 
(P=0.08). When considering that almost all patients had at least a single target vessel stent, 
this suggests that there is some additional benefit from multiple TV stents. There is the 
possibly that the specific design of a target vessel stent could also influence the incidence of 
migration. This would have been difficult to test statistically, as these were a wide range of
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target vessel stents deployed, these varied by anatomical location e.g. CA, SMA or renal and
there were some trends relating to those used by individual institutions. Due to the nature 
of the GLOBALSTAR registry, the exact stent type was not defined in a significant number of 
patients. Confirming that the type of target vessel stent may not be a factor, Scurr and 
colleagues, in a lab experiment failed to identify any differences in the forces required to 
crush a Jostent, Advanta V12 or Palmaz Genesis deployed within an endograft fenestration 
(Scurr et ai, 2008b).
Zhou et aL, also examined the effect of oversizing on the fixation of a device. For 
standard devices increasing the oversizing from 5 to 10% and 5 to 20% required an extra 0.9 
(27%) and 4.3 N (127%) of force for initial displacement. For a fenestrated device the extra 
force needed was less, 1 (9%) and 1.6 N (16%). Final displacement of a fenestrated device 
required an increase of 5.7 and 10.5 N, for 10 and 20% respective oversizing. For a standard 
device this extra force was 2.7 and 8.7 N. From Zhou's work it can been seen that the 
protective benefits of oversizing a fenestrated device (over 10%) are reduced in comparison 
with a standard device. The likely explanation for this is that most of the fixation is provided 
by the target vessel stent and not the interaction between the aortic wall and the stent-graft. 
Zhou et al/s in vitro work used bovine aortas from which they investigated the relationship 
between endograft type, oversizing and the forces needed to cause displacement. The in 
vivo quantification of stent-graft oversizing in a fenestrated device is likely to be more 
challenging. The sealing stent is likely to oppose aortic wall over a range of aortic diameters. 
What may be a 20% oversizing at the SMA may reduce to 15% at the level of the renal 
arteries or vice versa. Device selection, therefore, requires careful consideration of these
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issues, taking into account what is likely to give the best chance of a seal whilst allowing the 
fenestrations to align correctly.
For standard infrarenal devices morphological parameters, such as excessive neck 
angulation (Ghouri and Krajcer, 2010) have been associated with migration. In the cohort 
reported in this chapter, preoperative aortic neck diameter and coronal neck angulation 
demonstrated non-significant trends within the proximal migration and non-migration 
groups. The relationship between inlet diameter and the displacement force acting on a 
stent-graft has previously been discussed. The median (IQR) preoperative aortic neck 
diameter for patients without evidence of proximal migration was 23 (20 to 26) mm, whereas 
in those patients with migration the median diameter was 24 (22 to 30) mm (P=0.07). A lack 
of statistical significance may have resulted from the high numbers of missing preoperative 
CT scans, which prevented measurement of preoperative aortic neck diameter in a significant 
number of patients. According to the report by Howell et al,, the postoperative inlet 
diameter is likely to be more important and will be influenced by the degree of stent-graft 
oversizing (Howell et al., 2005). This was also shown to be larger in patients with proximal 
migration (median 24, IQ.R 22 to 30 mm) when compared to those without (median 23, IQR 
20 to 26 mm; P=0.07). Preoperative coronal aortic neck angulation was smaller in patients 
with proximal migration (median 17°, IQR 9° to 26°) when compared to a non-migration 
group (median 25°, IQR 13° to 38°). This factor did not reach statistical significance (P=0.06) 
and it is difficult to suggest a theory why migration may have been influenced in this way. 
Reports in the literature suggests the drag force on a stent-graft is increased in the presence 
of severe angulation (Li and Kleinstreuer, 2006a). The work by Li and Kleinstreuer considered 
a standard infrarenal device and was based on computer modelling. It is not clear how
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raising the inlet into the suprarenal aorta would affect the resultant force/angulation 
calculations. When calculating the drag force on a stent-graft, the angle at the inlet (fabric 
junction) must be measured and recorded. Angulation of a fenestrated stent-graft could 
result in a crimping effect and this is the mechanism from which additional fixation is 
provided. Within the proximal migration group there was an absence of CT data in 20 out 33 
patients, it is accepted that this has generated problems when forming conclusions based on 
these types of data.
Stent-graft design has also been linked with migration, this includes the utilisation of 
proximal barbs and hooks (Malina et a!., 1998) and stiff body devices (Litwinski et al., 2006). 
Only a single device (Zenith fenestrated AAA stent-graft, Cook Medical) was evaluated in this 
thesis and, therefore, its performance against comparators remains unknown. Follow-up 
complications have also been shown to potentially reduce the rate of migration, Li and 
Kleinstreuer reported that the presence of an endoleak may mitigate the risk of stent-graft 
migration (Li and Kleinstreuer, 2006b). This factor has been discussed within the previous 
chapter, but there are further considerations to be made. Endoleaks are typically classified 
according to their aetiology (Chaikof et oL, 2002b), when referring to migration further 
studies may need to report the duration of the endoleak and at the same time, indicate the 
scale and duration of sac repressurisation, as this is likely to indicate the overall reduction in 
stent-graft displacement force.
Hypertension has also been reported from clinical studies as a factor (Mohan et al.,
2002). A computer based force displacement model by Li and Kleinstreuer (2006) clearly
shows a linear relationship between systolic blood pressure and stent-graft displacement
force. Understanding the clinical effects of changes in blood pressure may be difficult. It is
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often difficult to categorising a patient as hypertensive, numerous definitions exist 
(MacMahon et aL, 2005) and measurements can vary depending on the circumstances in 
which they were acquired {Marshall, 2004). During follow-up some patients may have 
undiagnosed hypertension or will vary in their response to treatment (Blood Pressure 
Lowering Treatment Trialists et aL, 2008). All of these considerations would need to be 
factored into any formal investigation into the effects of blood pressure on endograft 
fixation.
The separate proximal component of the Zenith fenestrated stent-graft should 
theoretically help reduce the effects of the caudally directed forces experienced at the aortic 
bifurcation. This should help reduce the likelihood of migration to the proximal component. 
Agreeing with this Ziegler et a/.,(2007) stated that the lower rate of fenestrated stent-graft 
migration with the Zenith device is a result of a separate proximal and bifurcation 
components. Although potentially helpful in opposing proximal migration, this design brings 
the added risk of component separation between the proximal fenestrated and distal 
bifurcated pieces. With the additional fixation from target vessel stents, it is likely that there 
would be a greater incidence of component separation instead of proximal stent-graft 
migration. Although not a primary focus of this study, inter-component (proximal and distal 
bodies) separation did occur in several patients in this series. If a 10 mm definition was used 
then there was a single (3%) component separation in the proximal migration group and two 
(2%) in the non-migration group (P=0.40). All clinical component separations were 
successfully managed with either the implantation of a bridging stent or using follow-up 
imaging. Conservative management was used if the movement had ceased and there was 
still good overlap between components.
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There are several methodological considerations when reporting risk factors. Choice
of event time definition was shown to generate some differences within the multivariate 
models presented. Using a numerical definition, migration will undoubtedly occur in 
between two adjacent CT examinations. By selecting the beginning of the interval as the 
event time, this is likely to be over conservative, especially if this is the first postoperative CT 
scan. It is thought unlikely that directly following a CT scan, the device immediately migrated 
4 mm. By selecting the end of the interval (i.e. 1st CT scan when the diagnosis was made), 
this may be more accurate since it is guaranteed that the event had definitely occurred, even 
if only immediately prior to the CT scan. An alternative view is that the migration occurred 
between the two time points; this may be best reflected by the midpoint of the interval. It is 
for this reason, that interval censoring approaches have been proposed as being superior 
since they account for the time interval between adjacent CT examinations. When using the 
smaller single centre cohort data, using the midpoint most closely reflected the incidence of 
migration reported by an interval censoring approach. With Cox proportional hazard models, 
the effect of choosing a later time point e.g. midpoint or end of the interval removed several 
variables from the predictive factor model. This is important as the beginning of the interval 
is unlikely to represent the actual migration time for early points during follow-up (e.g. 1st 
post-operative CT scan).
The choice of statistical software is also important. There were smaller differences in 
the hazard ratios between the two platforms. By way of an example, there was a 2% 
difference in HR when using the beginning of the interval (enter technique), when switching 
between R and SPSS. The conclusion of this is that there must be minor differences in the 
approach to modelling between the two packages. When using the stepwise forward and
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backward approaches, the 1st postoperative CT aortic neck length, follow-up aortic diameter 
changes at the caudal renal artery and length changes between the SMA and cranial renal 
artery are likely to be most plausible risk factors for proximal migration. Forward and 
backward processes cannot be undertaken with the statistical programme R, so conclusions 
using these techniques will have some dependence on precise migration times. If it is 
accepted that a Cox proportional hazards model that uses interval censored data is superior, 
then the two multivariate risk factors for proximal migration are 1st postoperative aortic neck 
length and contralateral iliac limb diameter. This would also be the case for a forward 
stepwise approach using the end of the interval as the event time.
As previously identified missing values are likely to influence some of the results 
within this chapter. The use of Ml methods to compensate for missing values is a well- 
documented approach within the literature. The accuracy in which the Ml process replaces 
missing values must be a primary consideration. If it can be assumed that the Ml datasets 
provide an accurate reflection of the multicentre FEVAR cohort then the following point can 
be highlighted from the results. The 1st postoperative CT neck length is still a dominant risk 
factor for proximal migration. Aortic neck diameter change at the coeliac axis was not 
identified as risk factor for any of the Ml datasets. Changes at the level of caudal renal artery 
was identified as a risk factor, this was not consistent across all Ml datasets, unless an SPSS 
backwards approach was used (beginning or midpoint of interval as event times). 
Contralateral iliac limb diameter was consistent identified as risk factor across all Ml 
datasets. There will have been situations when a contralateral limb was not deployed (tube 
or AU1 device) and the Ml process for these cases must be considered. Ipsilateral iliac limb 
deployment distance and graft kinking were not found to be statistically significant risk
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factors for any of the Ml datasets. Changes in aortic length {SMA to cranial renal artery) 
during follow-up, was found to be a risk factor. This was not for all Ml datasets and 
concentrated around the beginning/midpoint of interval event times and when using an SPSS 
backward approach.
The bootstrapping procedure was needed to generate 95% confidence intervals for 
hazard ratios generated using interval censored data. Bootstrapping is a sophisticated 
computer processing technique that will have some dependency on the size of the sample. 
When generating the range of regression coefficients needed to provide an estimate of the 
95% confidence intervals, the number of repetitions in the bootstrapping sequence can be 
specified. Too large a number of repetitions can make generation of confidence intervals 
impossible and too few may render them not useable. Confidence intervals generated using 
bootstrapping methods in this thesis used 100 repetitions. It may be possible that the 95%CI 
could change slightly if a different number of repetitions were selected.
Limitations
It is acknowledged that there are limitations within this chapter. One of the major limitations 
to this work is the number of missing values for the included cohort. This unfortunately 
reflects the nature of a retrospective study and difficulties in gaining access to CT data. In 
the UK EVAR trials, a similar core lab analysis of predictive factors for the time to first graft- 
related complication was made (Wyss et al.t 2011). Out of the 640 patients randomised to 
EVAR the preoperative CT scans were available and fit for purpose in 217 (34%) cases. This 
confirms that the retrospective access to CT data is difficult, even within a single healthcare 
system and with the widespread role out of PACS. There were also problems with the
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completeness of data entry into the GLOBALSTAR registry. In a number of cases, clinical and 
device-specific variables were missing and this will impact on the overall robustness of the 
predictive factor analysis. It should be highlighted that missing value data were provided at 
regular points throughout this thesis and where possible the potential impact on outcomes 
discussed. It must be highlighted that any conclusions from the analysis of predictive factors 
must consider that this was a retrospective review of patients treated by FEVAR. This is a 
real-life clinical study and there were instances where preoperative CT scans, clinical and 
graft-related variables were not present. With respect to the preoperative CT data, there 
were a significant number of patients with proximal migration (20/33) that did not have a 
preoperative CT scan available for analysis. It is possible that there could have been more 
risk factors identified from this examination, if all values were present.
The effect of reporting migration as a dichotomous variable must also be considered. 
Migration measurements are changes in the position of the stent-graft over time. It could 
have been possible to investigate predictive factors by treating proximal migration as a 
continuous variable. This may have provided further data on the effects of different 
variables on the magnitude of migration. A decision was made not to treat migration as a 
continuous variable, this was because of the uncertainty surrounding the accuracy of 
migration measurements below 4 mm.
There are a number of publications, which have discussed the number of variables that
can be assessing in a multivariate model (Peduzzi et aL, 1996, Yuan and Lin, 2006). Different
theories exist regarding the overall size of the cohort and the number of outcome events
needed per included variable. There were a total of 33 proximal migrations in the
multicentre cohort. This will have generated some issues with regard accuracy of the
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multivariate analysis and the reliability of the resultant regression coefficients and 
confidence intervals. The multivariate analysis of proximal migration of infrarenal stent-graft 
has been previously conducted with fewer patients and fewer events (Cao et ai, 2002). This 
does not imply that the methods used by Cao et al., are correct, but data presented in this 
thesis are the first if its kind and will help move forward the investigation of fenestrated 
stent-graft migration.
7.5 Conclusions
Using a multivariate analysis, 1st postoperative CT aortic neck length has been consistently 
identified as a risk factor for proximal fenestrated stent-graft migration. Other risk factors, 
which must be considered, include the contralateral iliac limb diameter, postoperative 
changes in the aortic diameter at the level of the caudal renal artery and changes in the SMA 
to cranial renal artery length. The inclusion of risk factors other than 1st postoperative neck 
length will have some dependence of the event time definitions used and individual Cox 
regression modelling processes. Other variables were suggested from the univariate 
analysis, but were not included in the resultant multivariate model. This may be, in part, 
explained by a large number of missing values, especially those that would have been 
obtained from preoperative CT scans. Based on data reported in this chapter, there are 
identifiable risks factors for proximal migration and the clinical utility of these must be 
carefully considered. Fenestrated repair is a complex process, up until now the majority of 
devices were custom made. As such there is a significant amount of variation within each 
individual stent-graft; this has also made identifying clinical significant parameters more 
difficult. Lessons can be learnt from the data presented within this chapter, the 
identification of risk factors is complex, especially when using retrospective imaging data. It
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is important than further work is undertaken is order to better understand the migration of
fenestrated aortic stent-grafts.
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8. Discussion, further research and conclusions
8.1. Summary of results
This thesis has four aims. The first aim was to validate a CT central luminal line (CLL) 
measurement technique for the quantification of aortic stent-graft migration. Using this 
validated CT CLL technique the second aim of the thesis was to report the incidence and 
timings for the migration of fenestrated stent-grafts, both at the proximal and distal landing 
zones. The third aim was to report any related sequelae (complications and reinterventions) 
for cases of proximal and distal migration. The forth aim was to investigate the predictive 
factors for proximal migration of fenestrated aortic stent-grafts. A tabulated summary of the 
main results are presented below in Table 8.1 and Table 8.2. The multicentre incidence and 
timings for migration of the Zenith fenestrated AAA stent-graft are presented in Table 8.1. 
The predictive factors for fenestrated stent-graft migration are presented in Table 8.2.
Table 8.1 A summary of the freedom from proximal and distal (iliac) limb migration
Proximal migration Any iliac limb migration
Time, mo n. risk survival 95% Cl n. risk survival 95% Cl
12 89 82% 75% to 89% 83 85% 79% to 92%
24 49 77% 70% to 85% 45 82% 75% to 90%
36 31 77% 70% to 85% 22 65% 52% to 80%
48 13 64% 51% to 80% 12 65% 52% to 80%
Survival estimates using interval censored data. Cl, confidence interval. Mo, months.
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Table 8.2 A summary of multivariate risk factors identified using a Cox proportional hazards model.
Entry into the model require a univariate P value <0.05.
Covariate HR 95% Cl
SPSS
Forward Stepwise
SPSS
Backward Stepwise
m3
£L
T3o_
5”
m
3
a.
T3
Ipsilateral CIA 1.02 0.97 to 1.06
deployment
distance, mm,f
Contralateral iliac 0.84 0.57 to 0.95
limb diameter, mm*
1 postop CT aortic 0.90 0.78 to 0.97
v v v v v v
neck length, mm*
Postop aortic 1.01 0.81 to 1.21
diameter change,
coeliac axis, mmw
Postop aortic i.18 1.02 to 1.38
diameter change,
V
caudal renal artery, 
mm
Postop length 1.14 1.04 to 1.25 ~
change, SMA to
cranial renal artery, 
mm
Graft kinking* 0.61 0.0 to 3.40
HR, hazard ratio. Cl, confidence interval. HR were reported using the R programme and interval 
censored data where statistically significant*. If not statistically significant in R, HR were reported for 
the any other approaches, where P <0.05 with the HR closest to 1 reported. Variables not statistical 
significant risk factors for any approached were highlighted with#.
Aim 1: Validation of CT CLL migration measurement technique (Chapter 4)
Using aortic phantoms the mean difference in the CT CLL migration between the actual and
observed measurements (estimate of bias) was +0.4 mm (95% limits of agreement: -2.5 mm
to + 3.3 mm). The 95% limits of agreement for measurements both within and between
observers were -2.1 mm to + 2.1 mm and -2.4 mm to + 3.3 mm, respectively. Data from the
phantom study generated a Coefficient of Repeatability (RC) of 2 mm for the within-observer
271
measurements. This is the value below which the difference between repeat measurements 
are expected to lie with a 95% confidence. When using clinical CT data from patients with a 
selection of aortic stent-grafts implanted, 95% limits of agreement, within and between 
observers was -2.6 mm to +3.1 mm (RC = 3 mm) and -3.5 to +3.9 mm, respectively.
Overall the results from the validation experiment demonstrated that the bias from 
CT CLL migration measurements is small and insignificant from a practical point of view. A 
small amount of measurement variability, both within and between observers does exist. It 
should, however, be feasible to detect changes in stent-graft position during following which 
are > 4 mm. On this basis, stent-graft migration (both proximal and distally) was defined as 
movement during follow-up > 4 mm.
Validation of the CT CLL measurement was undertaken using a commonly performed 
vascular CT protocol. If when using a CT CLL technique, the CT protocol was significantly 
different to that used in the validation experiment, then the subsequent bias, variability and 
migration definition would need to be reconsidered.
Aim 2: Incidence and timings of proximal and distal (iliac) migration of the Zenith
fenestrated AAA stent-graft (Chapters 5 & 6)
Using retrospective CT data from nine UK centres migration of a Zenith fenestrated AAA 
stent-graft was assessed in 154 patients. Median follow-up for the study cohort was 20.9 
(IQR 10.4 to 26.5) months. Estimations of freedom from proximal migration, using Kaplan- 
Meier survival analysis with interval censoring, at 12, 24, 36 and 48 months were 82% (95% 
Cl 75 to 89), 77% (95% Cl 70 to 85), 77% (95% Cl 70 to 85) and 64% (95% Cl 51 to 80), 
respectively. Distally, estimations of iliac migration free survival were 85% (95% Cl 79 to 92),
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82% (95% Cl 75 to 90); 65% (95% Cl 52 to 80) and 65% (95% Cl 52 to 80) at 12, 24, 36 and 48 
months, respectively. All migrations at the proximal landing zone were caudal in direction; 
median migration was +6.0 mm (range, +4.1 to +10.0 mm). Migrations at the distal landings 
zones were all in a cranial direction, median migration was -6.1 mm (range, -21.3 to -4.1 
mm).
Aim 3: Complications and reinterventions in patients with proximal and distal migration of
the Zenith fenestrated AAA stent-graft (Chapters 5 & 6)
A variety of FEVAR-related complications were present in patients with and without CT 
evidence of migration. With regards to the muiticentre cohort within this thesis, there were 
no statistically significant differences in graft-related endoleaks, between the migration and 
non-migration group (P-0.15). Although non-significant, there was a doubling in the 
incidence of type II endoleak in the non-migration group (14%) when compared to the 
proximal migration group (6%). Target vessel losses were relatively evenly distributed 
between patients with (9%) and without (8%) evidence of proximal migration (P=0.35). At 
the distal (iliac) landing zones, there was a general lack of iliac-related secondary events. 
There were six limb occlusions, five were in the first 30-days and not attributed to any device 
migration. Distal type I endoleaks occurred in one (0.6%) patient without any evidence of 
migration.
Also in the multicentre cohort, there were 13 reinterventions in 13 (8%) patients for 
either endoleak or target vessel compromise. There were no statistically differences in the 
reintervention rates between patients with and without CT evidence of proximal migration 
(P=0.50).
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Using a log-rank test and interval censored data, there were no statistically significant 
differences in the incidence of proximal migration, in patients with and without 
complications (P=0.84} and reinterventions (P=0.81).
Aim 4: Predictive frisk) factors for proximal migration of the Zenith fenestrated AAA stent-
graft (Chapter 7)
A predictive factor analysis was undertaken using data on the incidence and timings of 
proximal migration together with a selection of pre-, intra- and postoperative variables. The 
resultant analysis consisted of univariate and multivariate methods (see Section 7.3).
Multivariate analysis, using a Cox proportional hazards model identified the 1st 
postoperative CT aortic neck length as a risk factor for proximal migration (HR 0.90, 95% Cl 
0.78 to 0.97; P<0.05). The identification of other risk factors for proximal migration were 
dependent on the choice of event time definition and statistical approaches. The 1st 
postoperative CT aortic neck length was found to be a risk factor in all of these scenarios. 
Hazard ratios estimated that there was around a 10% decrease in the proximal migration 
hazard for every mm increase in aortic neck length. If different event time definitions and 
modelling approaches were used, then postoperative changes in aortic diameter, at the level 
of the caudal renal artery (HR 1.22, 95% Cl 1.03 to 1.44; P=0,02), was the second most likely 
predictive factor to be included in the model. Other predictive factors identified include 
contralateral iliac diameter (HR 0.84, 95% Cl 0.57 to 0.95, P<0.05) and postoperative changes 
in SMA to cranial renal artery length (HR 1.12, 95% Cl 1.01 to 1.24, P=0.02).
Univariate analysis did suggest further, possible, risk factors (P<0.05), but following 
multivariate analysis these were not found to be statistically associated with proximal
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migration. These additional variables, identified in the exploratory (univariate) analyses, 
were ipsilateral iliac limb deployment distance from the CIA (P=0.02), postoperative change 
in aortic diameter at the coeliac axis (P=0.03), postoperative changes in the length between 
the SMA and the cranial renal artery (P=0.03) as well as stent graft kinking (P=0.03). A study 
with a larger sample size and fewer missing values will increase the certainty about the role 
of these factors in proximal migration of fenestrated aortic stent-grafts.
Within the risk factor analysis, there were a series of missing values for some 
variables. These were highlighted within the thesis and multiple imputations methods used 
to account for missing values. The additional modelling of missing data, made only minor 
changes to the multivariate predictive factors model. One exception was that the 
contralateral limb diameter had more of a significant role in models generated using Ml. For 
this to be considered a valid risk factor, a detailed understanding of the missingness 
mechanisms and decisions within the multiple imputation process are needed.
8.2. Methodology and limitations
CT CLL quantification of aortic stent-graft migration (Chapter 4)
Up until now, there have been no robust techniques for measuring stent-graft migration in 
the abdominal aorta. For conventional (infrarenal) stent-grafts, there are well recognised 
definitions for stent-graft migration and these are contained within the relevant reporting 
standards (Chaikof et al., 2002a). These definitions are not appropriate for fenestrated stent- 
grafts, where smaller movements could be catastrophic. Over recent years, concerns about 
the migration of fenestrated stent-grafts had arisen within the vascular community. Despite 
this concern, to date no validated measurement techniques have been developed or suitable
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definitions proposed. Studies investigating stent-graft migration are generally retrospective
in design. Rather than to propose a new definition for fenestrated stent-graft migrations, it 
was important to understand what definitions could be achieved using current CT 
technology. The first phase of this thesis was to investigate the accuracy of a CT CLL 
technique in quantifying stent-graft migration. It was thought likely that this technique 
would the most precise migration measurement option. Some would consider this 
questionable, as there are other techniques available for undertaking length measurements 
using CT images. A broader study would have been to quantify stent-graft migration, using a 
series of different CT measurement techniques, and then compare the results. The decision 
to evaluate a single technique (CT CLL), within Chapter 4, was guided by evidence from the 
literature {O'Neill et a!., 2006b) and the resources needed to complete this part of the thesis 
(Ghatwary et at., 2012). CT CLL techniques have been used previously to quantify stent-graft 
migration in the thoracic aorta, these techniques and also commonly used to measure the 
length of tortuous and angulated vessels within the abdomen (Ota etal., 2005, Rengier et o/., 
2009).
Currently, there is no gold standard for reporting the position of a stent-graft within a 
patient. Medical imaging examinations can provide an estimation of the position but, there 
are no safe methods for confirming the exact position of a device. With this in mind, two 
commercially available stent-grafts were deployed in a series of plastic aortic phantoms and 
subject to CT examinations. The phantoms were then displaced and subject to a second CT 
scan. Visual differences between the two positions of stent-graft were considered to be 
actual migration, differences between the two CT scans were considered to be an estimate of 
the CT migration. The use of a plastic phantom has raised several methodological issues.
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There was an absence of diameter and angulation changes within the plastic aortic 
phantoms/ this prohibited the testing of the CLL technique across a range of morphologies. 
Phantom CT images also differed from in vivo images in that there were no other organs, 
normal variants, vascular calcification or thrombus within the images. This may have 
generated difficulties with fidelity and when undertaking migration measurements. 
Alternatives could have been to use animal or cadaveric models. The funding source 
prohibited the use of animals within this thesis. Cadavers would have created logistical 
difficulties, including the access to body parts and their transfer to a CT scanner. In 
retrospect, the process for producing the plastic models could have included models with 
varying levels of angulation and diameters. A step further would be phantoms designed from 
individual CT data. This would be in the realms of further research as this would have 
increased the number of measurements needed and the overall length of the study.
The variability for stent-graft migration measurements both between and within 
observers was also a concern. For the CLL validation study observers were required to have 
previous experience in assessing migration. In additional, each observer was provided with 
study specific training and had practice attempts, using the CT CLL technique, on a separate 
of test datasets. A key step in the measurement process was the identification of vascular 
and device-specific landmarks. Some landmarks may be more easily visualised on CT than 
others, the choice of which, could influence measurement accuracy and variability. Studies 
have shown improvements in measurement variability when precise definitions are used 
(Oshin et ol., 2010). Further improvements have been demonstrated when automated 
computer techniques are used to acquire measurements from CT data (Wyss et a!., 2009).
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Within this thesis, landmarks tested as part of a validation experiment were consistently
applied throughout subsequent chapters.
In addition to the phantoms, the CT CLL technique was also tested on clinical follow­
up CT datasets. Methodological considerations now relate to the choice of device, number 
of patients evaluated, range of migrations encountered and the quantity and experience of 
the observers. Talent and Zenith stent-grafts were selected for the evaluation of the CT CLL 
technique. At the time of the study they were the two most common aortic stent-grafts 
implanted (Brown et a/., 2007). Over recent years, the Talent has been replaced by the 
Endurant and there have been some modifications to the structure of the Zenith stent-graft. 
Other devices, such as the Anaconda and Excluder, are now more frequently used within 
clinical practice. Each device has variations in metallic composition, structure of the proximal 
and distal landing zones, all of which could affect the visibility of key landmarks and 
subsequent migration measurements.
Measurement from CT scans can be a lengthy process. Clinical observers will only have 
a limited amount of time available and the study must be achievable within a reasonable 
time frame. These factors help form the basis for the sample size used in the validation 
experiment. There was also the risk that patients selected for inclusion in the clinical phase 
of the validation study may have no (or only very small) levels of migration. This situation 
would affect the overall range of migrations that the CLL technique was tested across. This 
was not a problem within this thesis where a range of migrations both in the phantom and 
clinical CT scans were tested.
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Assessment of the incidence, timings and related sequelae for migration of a fenestrated
stent-graft (Chapter 5 & 6)
Using definitions from the validation experiment (Chapter 4), follow-up CT scans of patients 
treated with a Zenith fenestrated AAA stent-graft were evaluated for the presence of 
proximal or distal (iliac) stent-graft migration, using a CT CLL technique. To the author's 
knowledge, this was the first study to evaluate stent-graft migration using clearly stated 
definitions, event times and a validated technique. There were further advantages to the 
study design. 1) methods were initially piloted using a single centre cohort, 2) all patients 
had the same stent-graft implanted (Cook Zenith fenestrated) 3) treatment criteria, 
implantation procedures and follow-up were relatively similar 4) evaluation of migration was 
by a single centralised centre 5) further analysis used mid-sized multicentre cohort of 
patients who had CT scans available in DICOM format. There were additional advantages to 
the overall analytical approach used within the key outcomes. Survival analyses used an 
interval-censoring approach to account for the lack of certainty regarding precise timing of 
migration (between two adjacent CT scans). In order to report complications the study had 
access to imaging data and records submitted to a UK fenestrated stent-graft (GLOBALSTAR) 
registry.
There were several possible limitations to the study design. Identification of
migration was, following validation, by a single observer in a centralised image analysis
laboratory. It would have been useful for each site to independently assess migration on its
own patients. These figures could then have been compared against migration rates
reported by the core lab. This would provide an indication of the generalizability of the CT
CLL technique for routine migration reporting. A further limitation may also be the structure
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of the core lab itself. Currently, there are attempts by industry and academic leaders to 
demand the reporting of core lab quality-control measures (Brinjikji and Kallmes, 2012). 
More and more trials are being conducted using a core lab, it is likely that fenestrated stent- 
grafts will be subject to further scrutiny, possibility using core lab facilities. If a core lab is 
used then it should be clearly stated what role the core lab will play and the quality control 
standards that will be in place. The issue of missing patients and data {iliac CLL assessments) 
have been discussed at length within this thesis. The limitations of a retrospective study 
design are also well cited within the literature {Hess, 2004). One major limitation of any 
retrospective study is the quality of data reporting and managing those patients who are lost 
to follow-up. With the widespread role out of PACS and the electronic patient record, one 
may think that we are at a point when retrospective data collection would be easier. 
Registries now provide an option for data capture, but they too are subject to data quantity 
and completeness issues. Prospective trials may be the solution, ethics and institutional 
approvals will then be sought prior to the commencement of the study. Financial measures 
are also usually in place to order to support any additional data collection mechanisms {e.g. 
CT scan transfers). The internet also provides options for the collection of imaging data. 
Successful retrospective studies have been conducted, using a medical imaging repository, at 
M2S, Inc. (West Lebanon, NH). At this facility, using standard algorithms, M2S has created 
three-dimensional computer models from CT images of AAA pre- and post-repair. Images 
were sent by secure link, directly following acquisition on the CT scanner, they were then 
mass post-processed. By way of an example, Schanzer et ai, reviewed CT scans submitted to 
M2S from 1999 to 2008 and this included data from 10,228 patients (Schanzer et al.t 2011).
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Further review of outcomes using fenestrated stent-graft may be best served using a central
image repository.
The 1st postoperative CT scan was considered as the baseline in order to track the 
position of the stent-graft over time. In many instances, this was performed within the first 
30-days following implantation. The cut off point for patients included in this thesis was a 
scan within the first 6-weeks. Questions may arise regarding any migration, which may have 
occurred before the 1st postoperative CT scan. For infrarenal AAA, there have been cases of 
migration either intra-operatively or within the first few days following repair. These devices, 
however, do not have additional fixation from target vessel stents and fabric deployed in the 
suprarenal aorta. It is possible that some early migration may have occurred and that a more 
accurate understanding of migration may have been gain using post-discharge CT scan. In 
some centres, flat-panel fluoroscopy systems can acquire CT images at the end of the 
implantation procedure. These are usually limited in quality but may provide a more reliable 
indication of the implantation position of the stent-graft, it is worth highlighting that all of 
these applications require the use of ionising radiation. Data collected in this study was part 
of the standard care of the patient and did not expose them to any additional risks from 
ionising radiation or nephrotoxic iodinated contrast.
The follow-up period of patients included within this thesis must be also considered.
Many believe that migration is a relatively late occurring complication and that a minimum
follow-up period must elapse before reporting outcomes. A report by Cao and colleagues,
who investigated migration of the Medtronic AneuRx device, stipulated in their methods
section that a minimum follow-up period of 2 years was required (Cao et al., 2002).
Consideration must be given to those patients who may have had stent-graft migration but
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did not achieve 24-months follow-up (e.g. lost to follow-up, died or converted to open 
repair). Within this thesis, 62 (42%) of patients had follow-up greater or equal to 2 years. 
Any interpretation of migration or complications, must take into consideration the follow-up 
data available. There is the option of designing a further study that would recruit, based on a 
minimum number of events. Data from this thesis will provide an indication on the time 
requirements for such a study. Such an approach may increase the power of any analysis of 
risk factors.
There was some heterogeneity in the stent-graft devices implanted in the thesis 
cohort. Zenith fenestrated stent-grafts are custom-made devices and there can be variation 
in the number and types of fenestrations, number of sealing stents and the types of target 
vessel stent used to secure fenestrations. There are further options of bifurcated, AUI or 
tube devices and there may have adjuvant procedures during deployment (e.g. balloon 
moulding that may influence overall outcome). There is now the option of 'off-the-shelf 
fenestrated devices and these may make comparisons simpler. The results in this thesis are 
based on a single device, the Zenith fenestrated AAA stent-graft (Cook Medical Inc, 
Bloomington, IN). Vital performance data is now available for the commonest fenestrated 
stent-graft to be implanted. There are, however, several new devices, which are 
commercially available (i.e. Ventana, Anaconda fenestrated) and have significant design 
variations, the results of this thesis will not be generalizable to these devices but will provide 
data from which to compare future performance.
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Predictive factors for fenestrated stent-graft migration (Chapter 7)
From this thesis, multicentre data are now available reporting migration of fenestrated aortic 
stent-grafts. The focus now turns to the identification of predictive factors for migration, 
which are also novel. There are several reasons for this gap in the literature, there have been 
no previous clinical studies investigating predictive factors for the proximal migration of 
fenestrated stent-grafts. Studies that have investigated the migration of infrarenal stent- 
grafts are case-matched single centre series. The analysis of risk factors in this thesis, unlike 
reports from the EUROSTAR registry, is focused on a single device and a relatively 
homogeneous cohort of patients. A further advantage of this predictive factor work is that 
modelling for risk factors included, whether the event had taken place in addition to the 
event time. Further attempts were made to model uncertainties, regarding the precise event 
time, by using interval censored data. Variables collected within the predictive factor 
analysis were also wide, there was no pre-specification of only a small set of risk factors prior 
to the start of the study. By contrast, the UK EVAR trial examined a limited set of variables, 
relating to the attachment sites and the time to first graft-related complication (Wyss et aL, 
2011). The influence of thrombus, calcification, angulation and tortuosity were investigated 
but it was not clear why morphological factors (e.g. aortic neck diameter and length) were 
not included in their multivariate analysis. A further strength of this thesis was that 
statistical modelling used a multivariate approach, in order to ascertain the contribution of 
multiple risk factors on the risk of migration.
There are, however, a series of methodological limitations to this chapter of thesis.
Firstly, the sample size and number of migration events. This is one of the few multicentre
cohorts, with more than 100 patients, to report any FEVAR outcomes. However, when
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compared to standard EVAR series and other open vascular surgery publications, this is a 
relatively small sample size. The number of migration events are also important, whilst it is 
encouraging that the number of proximal migration events are small, this generates 
difficulties when investigating risk factors, especially when using multivariate analysis. Two 
similar predictive factor studies (using standard EVAR device), both by Thomas Wyss and 
colleagues, were analogous in design. One study investigated six covariates, when there 
were 53 complications (Wyss et al., 2011) and four covariates, when there were 27 events 
(Wyss et al., 2010).
Missing patients and risk factor data were also a problem, the extent of which could 
not be known when planning this thesis. Difficulties stemmed from missing values in the 
GLOBALSTAR registry and missing preoperative CT scans for some patients. To overcome 
this, an option could have been for each participating centre to provide an assessment of 
preoperative AAA morphology, on all submitted patients. At the same time, study data entry 
sheets could be completed for all eligible patients, by the participating centre. There could, 
however, have been problems with these two approaches. A constant theme amongst Trust 
research offices were any costs associated with research. If a participating centre was asked 
undertake additional work, the lead site would be approached for reimbursement. By way of 
an example, the transfer costs for a CT scan, ranged from £10 to £150. If a local researcher 
was required to undertake CT measurements or obtain data from case notes, then this would 
have required additional reimbursement. These problems were not initially perceived when 
designing data collection methods within this thesis, as such there was no funding allocated 
within the N1HR research grant. Even if monies were available, there would be training 
requirements for observers to undertaking CT measurements. It may also have been
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possible that some variables were missing from case notes. If this were the case, then there 
would still have been missing data. Perhaps, the only real way forward would be a 
prospectively designed study, appropriately resourced and linked with a central image core 
lab repository.
8.3. Interpretation of results
Overall, the results of this thesis indicate that the migration of a fenestrated stent-graft does 
occur during follow-up. Migration can occur at both the proximal and distal (iliac) landing 
zones, but is not associated with a higher incidence of complications or reinterventions. The 
identification of risk factors for fenestrated stent-graft migration can have benefits to 
patients, clinicians and manufacturers. An in-depth discussion on the interpretation of the 
results formed a key element within of each of the chapters. It must be made clear, that 
there are many novel findings and contributions from this thesis.
The novel findings in this thesis are: (i) a validated technique for the assessment of 
stent-graft migration, (ii) data on the incidence, timings and related-sequelae for proximal 
and distal migration of the Zenith fenestrated AAA stent-graft, and (iii) predictive factors for 
the proximal migration of fenestrated stent-grafts. This thesis presents for the first time (iv) 
a definition of stent-graft migration, which is based on an experimental analysis of routine CT 
techniques and commercially available stent-grafts. Moreover, presented here for the first 
time is (v) the incidence, timings and related-sequelae for migration of the Zenith fenestrated 
AAA stent-graft, using robust definitions and assessment techniques. This thesis also 
contributes to the literature in this field, by allowing for the first time (vi), the comparison of 
migration rates and timings between studies. This thesis also provides the first (vii)
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assessment complications detected using serial CT examinations, which are reported using
interval censored survival analysis. This technique accounts for the uncertainty in event time 
between adjacent CT scans. Such an approach would be also applicable to other 
complications such as component fracture, kinking, target vessel loss and endoleaks, which 
can occur asymptomatically between two time points. This thesis also contributes to the 
literature in this field, by showing for the first time (viii) risk factors for proximal stent-graft 
migration.
8.4. Suggestions for future research
Future research will fall into two categories: the identification of stent-graft migration and 
the reporting of risk factors. For the identification of stent-graft migration, other projects 
have already been suggested with this thesis, which investigate a series of additional factor 
that may be associated with CLL measurement accuracy and variability. These are likely to 
include differences between computer software packages, individual CT protocols and 
differences which may result from variation in AAA morphology. New investigations into the 
assessment of stent-graft migration must consider using a current range of commercially 
available stent-grafts. These will have individual device-specific landmarks, which must be 
factored into the study design. Work is needed to identify alternative measurement 
techniques, which will not exclude a significant number of patients because of technical 
variations (e.g. iliac limbs with HA occlusions or unenhanced CT scans). Measurements from 
CT data can also be prone to observer variability and can take time. Consideration should be 
made to investigations of automated migration measurement techniques. They may provide 
greater measurement accuracy and could be applied within each participating centre, thus 
avoiding problems with data transfer agreements, observer training and variability.
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Further work is needed in order to provide more evidence surrounding the predictive 
factors for fenestrated stent-graft migration. In this thesis, conclusions were limited because 
of a large number of missing CT scans and data within the GLOBALSTAR registry. Further 
studies must consider methods to ensure greater compliance. This may be from a 
prospective trial, although follow-up would need to be long enough and resources in place to 
collect data across the whole duration of the study. One option would be that professional 
bodies take the lead in designing and delivering national registries. These must have the 
necessary permits and mechanisms for robust data collection. The National Vascular 
Database within the UK has a good history of capturing surgical outcomes across the UK. 
Many clinicians believe that it is a professional obligation to audit practice and this may need 
to evolve to monitoring more widespread outcomes. Device manufacturers also have an 
obligation to facilitate the collection of this information. Difficulties can arise when 
attempting to negotiate international boundaries. Before approving a drug or medical device 
within the US, the FDA can request additional data collection and analyses. This should be a 
consideration within the UK, before a device is approved for investigational use there should 
to be clear data collection methodologies in place for monitoring outcomes.
A final option for research is into new technologies. Durability has always been a 
concern following EVAR. Manufacturers are now starting to move to alternative devices, 
which are no longer based on a fabric covered metal skeleton. For example, the Nellix device 
uses bilateral stents and an endobag filled with a biostable polymer. This new concept of 
endovascular aortic aneurysm sealing (EVAS), avoids the complications of collateral perfusion 
and achieves fixation from total anatomic apposition. This device is thought to be novel and 
will avoid migration and its related complications. This can only be proven with careful
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evaluation, using appropriate migration assessment techniques, which is tailored to the 
specific device and has sufficient follow-up.
As previously discussed within the thesis, MDCT take a snapshot of a stent-graft 
deployed in a pulsatile vessel. New techniques are now available, which can imaging the 
aorta during the cardiac cycle and will provide information of stent-graft movement during a 
heartbeat. Further investigation into this area may improve the accuracy of stent-graft 
migration measurements and also allow greater understanding of which patients may 
encounter complications from stent-graft migration.
MDCT has been used to follow-up patients after both EVAR and FEVAR. The costs 
associated with follow-up have impacted on the applicability of endovascular repair. For 
conventional stent-grafts, there has been a trend towards surveillance using ultrasound and 
abdominal radiography, instead of MDCT. If this trend moves across to FEVAR devices, then 
there will need to be validate methods for measuring stent-graft migration using abdominal 
radiography.
8.5. Conclusions
Fenestrated aortic stent-grafts continue to provide a valuable treatment option for patients 
with AAA, who are not amenable to open surgery. Endovascular techniques, such as 
fenestrated aortic stent-graft repair, are now the dominate management option but are not 
without complications. The lower 30-days mortality rates associated with aortic stent-grafts 
still requires a careful balance against the need for life-long surveillance and the increased 
possibility of complications. For fenestrated repair, concerns regarding the possibility of 
device migration have stemmed from reports involving infrarenal devices and the theoretical
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possibility that even small movements could be potentially catastrophic. Findings presented 
in thesis confirm that migration of a fenestrated stent-graft can occur, both at the proximal 
and distal landing zones. Results from this thesis are unlike reports for infrarenal stent- 
grafts, in that there appears to be a low complication and reintervention rate associated with 
fenestrated stent-graft migration.
This thesis sheds light for the first time on the need for an appropriately validated 
migration assessment technique (Chapter 4). Understanding and comparing migration rates 
within the literature has been problematic. Measurement techniques are usually absent or 
poorly documented and definitions can vary between reports, often without justification. 
The assessment of subtle changes in stent-graft position is complex, factors influencing the 
accuracy and variability of measurements are likely to include the measurement technique, 
imaging protocol, AAA morphology, type of device and experience of the observer. Findings 
presented in this thesis will hopefully raise awareness within the vascular community, that 
there must be robust migration assessment techniques and the relevant quality-control 
mechanisms must be clearly stated within any outcome data.
When assessing stent-graft migration using a CT CLL, the estimated bias is small and 
insignificant from a practical point of view. This thesis provides confidence that a CT CLL 
technique provides an accurate reflection of any changes in device position. Observer 
variability was also a consideration and was tested in phantom and on human CT datasets. 
Minor measurement variability both between and within observers exists and this should 
also be factored into any clinical decision making. This thesis has demonstrated that when 
using 2 mm MDCT scans, it is feasible to detect stent-graft positional changes which are > 4
mm. It is important to stress that a CT CLL analysis should not be used in isolation. If
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migration is suspected, then a full and detailed evaluation using all CT imagery must be
implemented. This latter point is important as it will help evaluate issues such as the 
presence of related complications, focal elongation and allow the consideration of possible 
management options.
Initial pilot work reported in this thesis, based on a single centre sample of fifty-five 
patients, demonstrated that migration at the proximal and distal landing zones occurs in 
around a quarter of patients by four years. The majority of migrations are less than six 
millimetres in length, however, movements greater than ten millimetres were reported at 
both the proximal and distal landing zones. Despite this, migration still appears to take a 
relatively benign course. In order to have a greater understanding of this phenomenon, 
further analysis of a larger number of patients and migration events are required. Evaluation 
of fenestrated stent-graft migration with a larger, multicentre cohort (154 patients, nine 
centres) confirmed that migration at the proximal landing zones occurs in around a third of 
patients by four years. The incidence of proximal migration peaks twice, once during the first 
year after repair and a second between years 3 and 4. This early peak raises the issue of barb 
engagement into the aortic wall and mirrors data reported using lab-based studies. Results 
presented in this thesis are encouraging in that proximal migration does not appear to be 
significantly associated with proximal type I endoleak or target vessel loss.
Iliac limb migrations showed a similar incidence to proximal migration. This incidence 
peaked between years 2 and 3 and a third of patients had at least one iliac limb migration by 
4 years. As with proximal migration, iliac related complications and reinterventions were 
rare. Assessment techniques are, however, needed that can access iliac limb migration in the 
presence of an occluded internal iliac artery.
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Concerns still exist regarding any post-EVAR rupture and whether there will be any 
association with migration. Several ruptures have been reported for FEVAR, none from this 
thesis. At present there is no evidence to suggest that post-FEVAR rupture is related to 
migration, however, studies involving a greater number of patients with longer follow-up are 
required. Since migration can occur at any time point, routine follow-up imaging is 
recommended.
This thesis establishes the incidence of proximal migration for fenestrated stent- 
grafts. This focus must now turn to the identification of risk factors. Establishing risk factors 
could inform patient selection, allow improvements in stent-graft design or allow follow-up 
strategies to be tailored to individual risk profiles. A shorter 1st postoperative CT aortic neck 
length has been consistently identified as a risk factor for proximal fenestrated stent-graft 
migration. Other risk factors, which must be considered, include the contralateral iliac limb 
diameter, postoperative changes in the aortic diameter at the level of the caudal renal artery 
and changes in the SMA to cranial renal artery length. As previously stated the inclusion of 
risk factors other than 1st postoperative neck length can have some dependence of the event 
time definitions used and individual Cox regression modelling processes. Other variables 
were suggested using univariate analysis but were not included in the resultant multivariate 
model. This may be, in part, explained by a large number of missing values, especially those 
that would have been obtained from preoperative CT scans, further research in this area is, 
therefore, warranted. Based on data reported in this chapter, there are identifiable risks 
factors for proximal migration and the clinical utility of these must be carefully considered.
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10. Appendices
Minimum diameter 
(intima-intima)
A-E, G-H.
Thrombus\Calcification
Score
None 0%
Mild 1-33%
Moderate 34-66%
Severe 67-100%
Segment A-E, 2*6, 34
A B C D E f G/H T/
C
C* Th
Oia. / A-E
a PI A-B B-C c- D-E 0- •2- •3- 2-
1 D "1 G H G
Length 3-
H
309
APP_1 Summary statistics for demographic, clinical and pre-operative morphological factors 
(continuous variables)
Baseline characteristics n Missingness n, %
Normality 
test, P value
Mean SD Median IQR Min, Max
Age (years) 1S1 3, 2% 0.062 73.9 6.8 74.0 69.0 to 79.0 54.0, 87.0
Body mass index (kg/m2) 95 59, 38% <0.001 27.8 4.5 26.8 25.1 to 30.6 19.1, 45.4
Heart rate (beats per minute) 105 49, 32% 0.003 71 13 70 61 to 81 48,112
Systolic blood pressure (mmHg) 105 49, 32% 0.016 142 23 140 125 to 152 92, 208
Serum haemoglobin (g/dl) 109 45, 29% 0.003 13.8 1.6 13.9 13.0 to 15.1 9.5,16.6
Pre-operative CT scan
Coeliac axis (CA) 94 60, 39% 0.059 25.6 2.8 26.0 24.0 to 27.0 19.0, 34.0
Superior mesenteric artery 
(SMA) 95 59, 38% 0.107 24.3 2.9 24.0 22.0 to 26.0 18.0, 33.0
U
cu'
3
Cranial renal arteries (CrRA) 95 59, 38% 0.077 23.6 3.6 23.0 21.0 to 25.0 16.0,33.0
(t>
3
Caudal renal arteries (CaRA) 94 60, 39% 0.015 23.7 4.4 23.0 21.0 to 26.0 14.0, 38.0
3
3
Bottom aortic neck (BN) 95 59, 38% 0.302 24.4 4.5 24.0 21.0 to 27.0 14.0, 38.0
Maximum aneurysm 152 2,1% <0.001 66.4 9.5 65.0 59.3 to 72.0 52.0,108
Maximum common iliac 
artery 94 60, 39% <0.001 14.4 4.5 13 11.0 to 15.3 8.0, 31.0
CA to SMA 93 61,40% 0.404 19.5 5.5 19.0 15.5 to 23.5 5.0, 34.0
SMA to CrRA 94 60, 39% 0.014 12.4 6.9 11.0 7.0 to 16.0 0.0, 34.0
ro
3 CrRA to CaRA 93 61,40% <0.001 7.7 6.4 6.0 4.0 to 10.0 0.0, 39.0
ZT
3
CaRA to BN 94 60, 39% <0.001 8.4 8.8 6.5 0.0 to 13.0 0.0, 46.0
3 BN to aortic bifurcation 94 60,39% 0.209 129.6 19.5 127.5 115.0 to 143.3 84.0,180.0
Common iliac artery (mean) 93 61,40% 0.422 62.9 14.4 63.0 52.3 to 74.0 33.5,106.5
>
3 Maximum coronal neck 95 59, 38% <0.001 25.8 17.2 23.0 12.0 to 37.0 0.0, 70.000c
Qj
S’
D
•
Maximum sagittal neck 95 59, 38% 0.005 29.2 15.7 27.0 19.0 to 39.0 1.0, 85.0
IQR, inter-quartile range. Min, minimum. Max, maximum. Normality was tested using the Shapiro-Wilk test. Shading indicates the
appropriate summary statistics based on the distribution of the data.
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APP_2 Summary of demographic, clinical, preoperative morphological and graft- 
related factors(categorical variables)
Baseline characteristics Available 
cohort, n
Missingness 
n, %
Characteristic present 
n, %
Gender, men 154 0,0% 141,92%
Smoking status, ex- or current 123 31, 20% 84, 68%
Ischaemic heart disease 127 27,18% 64, 50%
Heart failure 126 28,18% 9,7%
Hypertension 127 27,18% 84, 66%
Chronic renal insufficiency 126 28,18% 10, 8%
Diabetes mellitus 127 27,18% 15,12%
ASA grade £ 3 117 37, 24% 84,72%
Pre-operative CT scan
Aortic neck calcification 95 59, 38% 8,8%
Aortic neck thrombus 95 59, 38% 46,48%
CIA calcification 93 60,40% 40,43%
CIA thrombus 93 60,40% 33,36%
Stent-graft details
Design 154
Bifurcated 0,0% 112,93%
AU1 0,0% 5, 4%
Tube 0, 0% 4, 3%
Target vessel configuration
> 1 TV stented 154 0, 0% 137,89%
> 2 TV stented 154 0, 0% 40, 26%
Aortic neck calcification/thrombus was defined as present if it could be subjectively quantified as 
moderate or severe. CIA calcification and thrombus was treated in the same way and but the maximum 
score for the two vessels was recorded. AUI, aorto-uni-iliac. TV, target vessel.
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APP_3 A summary of variables available from the 1st post-operative CT scan and 
database records (categorical variables)
Covariate Available 
cohort, n
Missingness 
n, %
Characteristic present 
n, %
Target vessel loss 154 0,0% 7,5%
Any endoleak 154 0,0% 24,16%
Device kinking 154 0,0% 5,3%
Component fracture 153 1,1% 1,1%
Iliac limb occlusion 152 2,1% 9, 6%
Variables were assessed using the 1st postoperative CT and from entries in the respective databases.
APP_5 A summary of variables available during follow-up (categorical variables) 
not from 1st CT scan.
Covariate Available
cohort
Missingness 
n, %
Characteristic present 
n, %
Target vessel loss 154 0,0% 16,10%
Any endoleak 154 0,0% 30, 20%
Kinking 154 0,0% 19,12%
Component fracture 154 0,0% 20,13%
Iliac limb occlusion 151 3,2% 1,1%
Variables were assessed using the 1st postoperative CT and from entries in the respective databases.
APP_4 A summary of variables available from the 1st post-operative CT scan and database records 
(continuous variables)
Covariate n
Missingness 
n, %
Normality test. 
Rvalue
Mean SD Median IQR Min, Max
Coeliac axis (CA) 150 4,3% <0.001 24.0 3.9 24.0 21.0 to 26.0 17.0, 42.0
Superior mesenteric artery 
(SMA) 151 3,2% <0.001 23.1 3.8 23.0 20.0 to 25.0 16.0, 36.0
q
m’ Cranial renal arteries (CrRA) 151 3, 2% <0.001 23.0 4.1 22.0 20.0 to 25.0 15.0,40.0
3
fD
Cl
Caudal renal arteries (CaRA) 150 4, 3% <0.001 22.8 4.4 22.0 20.0 to 25.0 14.0, 37.0
3
3 Bottom aortic neck (BN) 151 3, 2% <0.001 23.8 4.5 23.0 20.0 to 26.0 16.0, 37.0
Maximum aneurysm 152 2,1% <0,001 68.6 10.9 67.0 60.0 to 74.8 51.0 to 112.0
Maximum common iliac artery 150 4, 3% <0,001 14.0 2.9 14.0 12.0 to 16.0 8.0, 24.0
CAtoSMA 150 4, 3% <0.001 19.4 6.6 18.0 15.0 to 23.0 5.0, 53.0
SMA to CrRA 150 4, 3% 0.007 14.5 7.0 14.0 8.8 to 19.3 0.0, 34.0
r™n>
u CrRA to CaRA 149 5, 3% <0.001 5.7 6.5 5.0 0.0 to 8.0 0.0, 48.0
rr
3
CaRA to BN 150 4,3% <0.001 5.6 6.4 4.0 0.0 to 10.0 0.0, 25.0
3
BN to aortic bifurcation 150 4,3% <0.001 124.1 18.6 121.0 111.0 to 134.3 86.0, 190.0
Common iliac artery (mean) 150 4, 3% 0.059 56.8 13.1 56.2 47.5 to 64.6 29.5,101.5
>ra(jqC_
Maximum coronal neck 153 1,1% <0.001 16.9 11.4 15.0 9.0 to 22.0 0.0, 51.0
5*
=>
Maximum sagittal neck 153 1,1% 0.002 21.6 9.5 20.0 15.0 to 28.0 2.0,44.0
SMA to proximal stent-graft 154 0,0% <0.001 41.4 21.7 36.4 29.4 to 49.4 10.5,140.6
CIA to ipsilateral limb 127 27,18% <0.001 16.8 11.8 16.1 9.7 to 23.5 -46.8, 53.6
CD CIA to contralateral limb 131 23,15% <0.001 17.8 14.0 17.5 9.0 to 25.2 -50.0, 73.8
S'
3
§
CA to distal bifurcated body 143 11, 7% 0.411 59.0 15.9 58.0 47.0 to 69.0 22.0,106.0
Ipsilateral limb diameter 138 16,10% <0.001 13.6 2.8 13.0 12.0 to 15.0 9.0, 23.0
Contralateral limb diameter 139 15,10% <0.001 13.6 3.3 13.0 12.0 to 15.0 7.0, 28.0
IQR, inter-quartile range. Min, minimum. Max, maximum. Normality was tested using the Shapiro-Wilk test. Shading indicates the
appropriate summary statistics based on the distribution of the data.
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APP_6 A summary of changes during follow-up (continuous variables)
Covariate n Missingness 
n, %
Normality 
test, P value
Mean SD Median IQR Min, Max
Coeliac axis (CA) 149 5, 3% <0.001 1.4 2.4 1.0 0.0 to 2.0 -4.0,14.0
Superior mesenteric artery 
(SMA)
150 4,3% <0.001 2.2 2.2 2.0 1.0 to 3.0 -2.0,11.0
o
S'
3
Cranial renal arteries (CrRA) 150 4,3% <0.001 2.7 2.6 2.0 1.0 to 4.0 -3.0,12.0
rt>i-*
tJi
Caudal renal arteries (CaRA) 148 6,4% <0.001 3.2 2.6 3.0 1.0 to 5.0 -1.0,12.0
3 Bottom aortic neck (BN) 150 4, 3% <0.001 3.1 3.2 3.0 1.0 to 5.0 -4.0,15.0
3
Maximum aneurysm 151 3, 2% 0.013 -8.6 10.9 -7.0 -17.0 to -1.0 -35.0,30.0
Maximum common iliac 
artery
148 6, 4% <0.001 1.5 2.0 1.0 0.0 to 2.0 -3.0,12.0
CA to SMA 149 5, 3% <0.001 0.6 4.8 0.0 -2.0 to 2.0 -12.0,24.0
i-m
3
IT
SMA to CrRA 149 5, 3% <0.001 0.6 5.0 1.0 -2.0 to 3.0 -22.0 to 18.0
CrRA to CaRA 147 7, 5% <0.001 0.3 3.8 0.0 -1.0 to 2.0 -16.0,11.0
3
CaRA to BN 149 6, 3% <0.001 7.5 13.1 4.0 0.0 to 11.0 -12.0, 95.0
3 BN to aortic bifurcation 147 7, 5% <0.001 -3.2 10.5 -2.0 -9.0 to 1.0 -53.0, 30.0
Common iliac artery (mean) 145 9, 6% <0.001 1.6 6.5 1.5 -0.5 to 3.0 -46.0. 27.0
>
3
era
fU
Maximum coronal neck 152 2,1% 0.011 -2.3 8.6 -2.0 -7.0 to 3.0 -26.0, 28.0
O
3 Maximum sagittal neck 152 2,1% 0.042 -4.0 7.4 -4.0 -9.0 to 0.0 -21.0, 25.0
cn•n
Oi
CA to distal bifurcated body 
length
140 14, 9% <0.001 4.2 7.9 3.0 1.0 to 7.0 -30.0,56.0
P
3
Ipsilateral limb diameter 135 19,12% <0.001 2.6 4.6 2.0 1.0, 4.0 -0.4,48.0
3 Contralateral limb diameter 137 17,11% <0.001 2.2 2.4 2.0 1.0, 4.0 -8.0,9,0
1QR, inter-quartile range. Min, minimum. Max, maximum. Normality was tested using the Shapiro-Wilk test. Shading indicates the 
appropriate summary statistics based on the distribution of the data. A negative value indicates a reduction in change. All 
distances are in millimetres.
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APP 7 A summary of present and missing values for demographic and clinical covariates
Proximal migration (> 4 mm)
Covariate
No
(n=121)
Present, n (%) Missing, n (%)
Yes
(n=33)
Present, n (%) Missing, n {%)
P
Value
Age (years) 119 (77%) 2 (1%) 32, (21%) 1, (1%) 0.518
Gender 121 (79%) 0 (0%) 33, (21%) 0, (0%) ***
Body mass index (kg/m2) 78 (51%) 43 (28%) 17, (11%) 16, (10%) 0.125
Heart rate (b.p.m) 84 (55%) 37 (24%) 21, (14%) 12, (8%) 0.396
Systolic blood pressure (mmHg) 84 (55%) 37 (24%) 21, (14%) 12, (8%) 0.396
Serum haemoglobin (g/dl) 87 (56%) 34 (22%) 22, (14%) 11, (7%) 0.491
Smoking status 97 (63%) 24 (16%) 26, (17%) 7, (5%) 0.516
Ischaemic heart disease 101 (66%) 20 (13%) 26, (17%) 7, (5%) 0.346
Heart failure 100 (65%) 21 (14%) 26, (17%) 7, (5%) 0.388
Hypertension 101 (66%) 20 (13%) 26, (17%) 7, (5%) 0.346
Chronic renal insufficiency 100 (65%) 21 (14%) 26, (17%) 7, (5%) 0.388
Diabetes mellitus 101 (66%) 20 (13%) 26, (17%) 7, (5%) 0.346
ASA grade 93 (60%) 28 (18%) 24, (16%) 9, (6%) 0.388
P values were derived using Fisher's exact test. *** there were no missing values for this covariate.
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APP 8 A summary of present and missing values for preoperative CT covariates
Covariate (n
Present,
n{%)
Proxima
No
=121)
Missing,
n(%)
migration
Yes
(n=33
Present,
n(%)
Missing,
n(%)
P Value
Coeliac axis (CA) 81 (53%) 40 (26%) 13(8%) 20(13%) 0.004
o Superior mesenteric artery (SMA) 82 (53%) 39 (25%) 13(8%) 20(13%) 0.003o>
3 Cranial renal artery (CrRA) 82 (53%) 39 (25%) 13(8%) 20(13%) 0.003
r? Caudal renal artery (CaRA) 81 (53%) 40 (26%) 13(8%) 20 (13%) 0.004
3 Bottom aortic neck (BN) 82 (53%) 39 (25%) 13(8%) 20 (13%) 0.003
3
Maximum AAA (maxAAA) 120 (78%) 1 (1%) 32(21%) 1 (1%)
Maximum common iliac artery (maxCIA) 81 (53%) 40 (26%) 13(8%) 20(13%) 0.004
CAtoSMA 80 (52%) 41 (27%) 13(8%) 20(13%) 0.024
r~
(to
SMA to CrRA 81 (53%) 40 (26%) 13(8%) 20(13%) 0.016
3
'S3“ CrRA to CaRA 80 (52%) 41 (27%) 13(8%) 20(13%) 0.021
On
3 CaRAto BN 81 (53%) 40 (26%) 13(8%) 20(13%) 0.016
3 CaRA to aortic bifurcation 81 (53%) 40 (26%) 13(8%) 20(13%) 0.016
Common Iliac Artery (mean) 80 (52%) 41 (27%) 13(8%) 20(13%) 0.005
>
3cnc
Maximum coronal neck 82 (53%) 39 (25%) 13 (8%) 20(13%) 0.003
o’
3
O Maximum sagittal neck 82 (53%) 39 (25%) 13 (8%) 20(13%) 0.003
Aortic neck calcification 82 (53%) 39 (25%) 13(8%) 20(13%) 0.003
nO) Aortic neck thrombus 80 (52%) 41 (27%) 13(8%) 20 (13%) 0.005
reereo Visceral artery patency 82 (53%) 39 (25%) 13(8%) 20 (13%) 0.003
n
QJ_
CIA calcification 80 (52%) 41 (27%) 13(8%) 20(13%) 0.005
CIA thrombus 80 (52%) 41 (27%) 13(8%) 20(13%) 0.005
P values were derived using Fisher's exact test. *** there were no missing values for this covariate.
APP 9 A summary of present and missing values for graft design covariates
Proximal migration
Covariate
No
(n=131)
Present, n (%) Missing, n (%)
Yes
(n=33)
Present, n (%) Missing, n (%) P value
Stent-graft diameter 67 (44%) 54 (35%) 16(10%) 17(11%) 0.306
Stent-graft length 57 (37%) 64 (42%) 11 (7%) 22 (14%) 0.112
Graft shape 121 (79%) 0 (0%) 33(21%) 0 (0%) ***
Target vessel configuration 121 (79%) 0 (0%) 33 (21%) 0 (0%) AAA
Stent-graft diameters and lengths refer to the proximal component. Graft shape; bifurcated, aorto-uni-iliac or tube. 
Target vessel configuration refers to details above the number and type of target vessels incorporated into the graft. P 
values were derived using Fisher's exact test. *** there were no missing values for this covariate.
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APP_10 A summary of present and missing values for variables acquired from the 1st postoperative 
CT scan
Proximal migration
No Yes
<n:=121) (n=33)
Covariate Present, n (%) Missing, n (%) Present, n (%) Missing, n (%) P value
Coeliac axis (CA) 117 (76%) 4 (3%) 33 (21%) 0 (0%) 0.377
Superior mesenteric artery (SMA) 118 (77%) 3 (2%) 33 (21%) 0(0%) 0.482
o
CL)"
3
Cranial renal artery (CrRA) 118(77%) 3 (2%) 33(21%) 0(0%) 0.482
n)
fD Caudal renal artery (CaRA) 117 (76%) 4(3%) 33 (21%) 0 (0%) 0.263
in
3
Bottom aortic neck (BN) 118 (77%) 3 (2%) 33 (21%) 0 (0%) 0.350
3 Maximum AAA (maxAAA) 119 (77%) 2 (1%) 33(21%) 0 (0%) 0.905
Ipsilateral CIA 115 (75%) 6 (4%) 31 (20%) 2 (1%) 0.543
Contralateral CIA 108 (70%) 13 (8%) 30 (19%) 3 (2%) 0.538
CAto SMA 117 (76%) 4 (3%) 33 (21%) 0 (0%) 0.377
l— SMA to CrRA 118 (77%) 3(2%) 32 (21%) 1 (1%) 0.623
ZJ CrRA to CaRA 117 (76%) 4(3%) 32 (21%) 1 (1%) 0.709
3"yi CaRA to BN 118 (77%) 3 (2%) 32 (21%) 1 (1%) 0.623
3 CaRA to aortic bifurcation 118 (77%) 3 (2%) 32 (21%) 1(1%) 0.623
Ipsilateral CIA 106 (69%) 15 (10%) 30 (19%) 3 (2%) 0.432
Contralateral CIA 107 (69%) 14 (9%) 30 (19%) 3 (2%) 0.484
>3TO
C_
01
Maximum coronal neck 120 (78%) 1 (1%) 33 (21%) 0 (0%) 0.786
o
p
o Maximum sagittal neck 120 (78%) 1 (1%) 33 (21%) 0 (0%) 0.786
SMA to proximal stent-graft 121 (79%) 0 (0%) 33 (21%) 0 (0%) ***
Q
CIA to ipsilateral iliac limb 106 (69%) 15 (10%) 30 (19%) 3(2%) 0.432
s CIA to contralateral iliac limb
CA to distal bifurcated
107 (69%) 14 (9%) 30 (19%) 3 (2%) 0.484
3
3 component 111 (72%) 10 (6%) 32 (21%) 1 (1%) 0.271
Ipsilateral limb diameter 108 (70%) 13(8%) 30 (19%) 3 (2%) 0.538
Contralateral limb diameter 108 (70%) 13 (8%) __ 31 (20%)______
33 (21%)
2(1%)
0 (0%)
0.554
O
su
(D
Target vessel patency 119 (77%) 2 (1%) 0.616
Endoleak 118 (77%) 3 (2%) 33 (21%) 0 (0%) 0.482
CQ
O Kinking 120 (78%) 1(1%) 33 (21%) 0 (0%) 0.786
Q)_ Component fracture 120 (78%) 1(1%) 33 (21%) 0 (0%) 0.786
Iliac limb occlusion 119(77%) 2 (1%) 33(21%) 0 (0%) 0.616
P values were derived using Fisher's exact test. *** there were no missing values for this covariate.
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APP 11 A summary of present and missing values for variables ascertained from changes during follow-up
Proximal migration
No Yes
(n=121) (n=33)
Covariate Present, n {%) Missing, n [%) Present, n (%) Missing, n (%) P value
Coeliac axis (CA) 116 (96%) 5 (4%) 33 (100%) 0(0%) 0.29
Superior mesenteric artery (SMA) 117 (97%) 4 (3%) 33 (100%) 0 (0%) 0.38
q£>' Crania! renal artery (CrRA) 115 (95%) 6 (5%) 33 (100%) 0 (0%) 0.23
3
ft)
f?
Caudal renal artery (CaRA) 115 (95%) 6 (5%) 33 (100%) 0 (0%) 0.23
Irt Bottom aortic neck (BN) 121 (100%) 0 (0%) 33 (100%) 0 (0%) ***
3
3 Maximum AAA (maxAAA) 121 (100%) 0 (0%) 33 (100%) 0(0%) ***
Ipsilateral CIA 112 (93%) 9 (7%) 31 (94%) 2 (6%) 0.57
Contralateral CIA 105 (87%) 16 (13%) 30 (91%) 3 (9%) 0.38
CAto SMA 116 (96%) 5 (4%) 33 (100%) 0 (0%) 0.29
SMA to CrRA 117 (97%) 4(3%) 32 (97%) 1 (3%) 0.71
a
3
‘S
3"
CrRA to CaRA 115 (95%) 6 (5%) 33 (100%) 0 (0%) 0.23
CaRAto BN 117 (97%) 4 (3%) 32 (97%) 1 (3%) 0.71
3
3 CaRA to aortic bifurcation 116 (96%) 5(4%) 31 (94%) 2(6%) 0.47
Ipsilateral CIA 103 (85%) 18 (15%) 27 (82%) 6 (18%) 0.41
Contralateral CIA 104 (86%) 17 (14%) 27 (18%) 6 (18%) 0.36
>3OQC
CU
Maximum coronal neck 119 (98%) 2 (2%) 33 (100%) 0 (0%) 0.62
6*3
O Maximum sagittal neck 119 (98%) 2(2%) 33 (100%) 0 (0%) 0.62
SMA to proximal stent-graft 121 (100%) 0 (0%) 33 (100%) 0 (0%) Irk*
CIA to ipsilateral iliac limb 102 (84%) 19 (16%) 27 (82%) 6 (18%) 0.46
o CIA to contralateral iliac limb 103 (85%) 18 (15%) 27 (82%) 6 (18%) 0.41
0)
pp CA to distal bifurcated body 108 (89%) 13(11%) 32 (97%) 1 (3%) 0.15
Ipsilateral limb diameter 105 (87%) 16(13%) 30 (91%) 3 (9%) 0.38
Contralateral limb diameter 106 (88%) 15(12%) 31 (94%) 2 (6%) 0.25
Target vessel patency 119(77%) 2 (1%) 33 (21%) 0 (0%) 0.616
o Endoleak
119(77%) 2(1%) 33 (21%) 0 (0%) 0.616
fDCDO Kinking
119(77%) 2(1%) 33 (21%) 0 (0%) 0.616
o'
DJ_ Component fracture 120 (78%) 1 (1%) 33 (21%) 0 (0%) 0.786
Iliac limb occlusion 118(77%) 3 (2%) 33(21%) 0 (0%) 0.482
P values were derived using Fisher's exact test. *** there were no missing values for this covariate.
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R Code
Kaplan Meier survival analysis using the beginning of the interval
library(survival)
mydata=read.csv("filename.csv") 
mysurv=Surv(mydata$beginning, mydata$event)
plot(survfit(my.surv~l)/ yscale=100, xaxp =€(0,48,4), xlim=c(l,48), yaxs="i", frame.plot=F) 
title(main="Type of analysis", sub-"1,
xlab="Time from 1st follow-up CT scan, months", ylab="Cumulative survival") 
summary(survfit{my.surv~l), times=c(6,12, 24, 36,48))
Kaplan Meier survival analysis using the midpoint of the interval
library(survival)
mydata=read.csv("filename.csv") 
mysurv=Surv(mydata$midpoint, mydata$event)
plot(survfit(my.surv~l), yscale=100, xaxp =c(0,48,4), xlim=c(l,48), yaxs="i", frame.plot=F) 
title(main="Type of analysis", sub="",
xlab="Time from 1st follow-up CT scan, months", ylab="Cumulative survival") 
summary(survfit(my.surv~l), times=c(6,12, 24, 36, 48))
Kaplan Meier survival analysis using the end of the interval
library(survival)
mydata=read.csv("filename.csv") 
mysurv=Surv(mydata$end, mydata$event)
plot{survfit(my.surv~l), yscale=100, xaxp =c(0,48,4), xlim=c(l,48), yaxs="i", frame.plot=F) 
title(main=nType of analysis", sub="",
xlab=,'Time from 1st follow-up CT scan, months", ylab="Cumulative survival") 
summary(survfit(my.surv~l), times=c(6,12, 24, 36, 48))
Kaplan Meier survival analysis, usinR interval censoring
libra ry(survival)
mydata=read.csv("fiiename.csv")
mysurv=Surv(mydata$left, mydata$right, type="interval2")
plotfsurvfitlmy.surv^l), yscale=100/ xaxp =0(0,48,4), xlim=c(l,48), yaxs="i", frame.plot=F) 
title(main="Type of analysis", sub="",
xlab="Time from 1st follow-up CT scan, months", ylab="Cumulative survival") 
summary(survfit(my.surv~l), times=c(6,12, 24, 36, 48))
Cox proportional hazards model using the beginning of the interval
libra ry(survival)
mydata=read.csv("filename.csv")
coxph(formula = Surv(beginning, event) ~ variablel +variable2 + factor(variable3) +variable4 
+ variables + variables,data = mydata)
Cox proportional hazards model using the midpoint of the interval
library(survival)
mydata=read.csv("filename.csv")
coxph(formula = Surv(midpoint, event) ~ variablel +variable2 + factor(variable3) +variable4 + 
variables + variables,data = mydata)
Cox proportional hazards model using the end of the interval
libra ry(survival)
mydata=read.csv(',filename.csv")
coxph(formula = Surv(end, event) ~ variablel +variable2 + factor(variable3) +variab!e4 + 
variables + variables, data = mydata)
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Cox proportional hazards model using interval censoring
libra ry(intcox)
mydata=read.csv{"filename,csv")
intcox(Surv(left,right, type="interval2") ~ variablel +variable2 + factor(variable3) +variable4 + 
variables + variables, data=mydata, na.action=na.pass)
Bootstrapping technique to generate 95%CI for Intcox hazard ratios
n=100
co=matrix(0,n,6)
for (i in seq(l,100)){
databoot=data[sample(nrow{data),size=length(data[,l]),replace=TRUE),]
databoot=databoot[order(databoot[,l]),l:20]
sol=intcox(Surv(left, right, type="interval2")~ variablel +variable2 + factor{variable3) 
+variable4 + variables + variables, data=databoot, na.action=na.pass)
co[i,]=sol$coef
}
variablelJower_95CI=sort(co[,l])[3]
variablel_upper_95CI=sort(co[,l])[97]
variable2jower_95CI=sort{co[,2])[3]
variable2_upper_95CI=sort(co[,2])[97]
variable3_lower_95CI=sort(co[,3])t3]
variable3_upper_95CI=sort(co[,33)[97]
variable4jower_95CI=sort(co[,4])[3]
variable4_upper_95CI=sort(co[,4])[97]
variables Jower_95CI=sort(co[,5])[3]
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variable5_upper_95CI=sort(co[,5])[97]
variableGJower^SC^sortfcobeiHB]
variableb^ppe^SC^sortlcot.GlJtgy]
variableX_lower_95Cl
variablel_upper_95CI
variable2_lower_95CI
variable2_upper_95CI 
variables Jower_95CI 
variable3_upper_95CI 
variable4_lower_95CI 
variable4jjpper_95CI 
variable5_lower_95CI 
variable5_lower_95CI 
variable6_lower_95CI 
variable6_upper_95CI
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